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PART I: Development of Novel Methods for the Synthesis of Homoallylic Alcohols 
In the development of novel methods for the synthesis of homoallylic alcohols, two 
conceptual strategies to access cis- and trans-linear homoallylic alcohols will be revealed. 
The first methodology reveals a conceptually different strategy to access cis-linear 
homoallylic alcohols with moderate to high yields. This approach features the following 
highlights: (1) First efficient method that controls, in situ, both the enantioselectivity (up 
to 99% ee) and the olefinic geometry (up to 99% Z) of cis-linear homoallylic alcohols; 
(2) The chemoselective crotyl transfer is highly feasible for aliphatic substrates; (3) 
Excess chiral camphor-derived branched homoallylic alcohol (89% recovery) and the 
camphor (83% recovery) generated from the reaction can be recovered and reused, thus, 
making this method attractive for scale-up preparation. We anticipate that this new 
Brönsted acid catalyzed allyl transfer reaction will be an indispensable tool in the 
synthesis of complex natural products, thereby allowing this methodology to undergo an 














Up to 99% ee and 99% Z
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The second methodology describes a novel Lewis acid-catalyzed enantioselective linear 
homoallylic alcohol transfer reaction, from sterically hindered starting material to its 
sterically less hindered analogue via a branched-adduct intermediate. In all cases, the 
whole rearrangement is thermodynamically favorable and a steric effect is the driving 
force of this reaction. The preservation of the stereocenter and olefin geometry together 
with the isolation of the branched-adduct homoallylic alcohols in one isomeric form have 
warranted the proposed mechanism. 
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In the next chapter, a short and multigram scale process has been developed for the 
synthesis of (–)-epibatidine from commercially available starting materials using mild 
vi 
and easily controlled reactions. There are several significant features in this synthetic 
route: (1) the synthesis of (–)-epibatidine requires only a total of 12 steps and delivers the 
alkaloid with a 12% yield over the longest linear sequence; (2) both enantiomers of 
epibatidine can be obtained by simply switching the chiral auxiliary; (3) the facile 
method of obtaining enantiomerically pure cyclohexenylamines and the first RCM of 
unprotected amines have been achieved; (4) the bottleneck of the synthesis, the 
bromination procedure, was overcame by recycling the undesired 164 to 153 through a 
reductive elimination of the former; (5) the entire synthetic route is straightforward and 
convenient for gram scale synthesis.  
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Br-CSA (1S)-(+)-3-bromocamphor-10-sulfonic acid hydrate 
brs broad singlet 
c concentration (100mg/1mL) 
calcd calculated 
CH3CN acetonitrile 
CITES Convention on International Trade in Endangered Species 
CSA (1R)-(-)-10-camphorsulfonic acid 
d density 
d doublet 
dd doublet of a doublet 
ddd doublet of a doublet of a doublet 
dddd doublet of a doublet of a doublet of a doublet 
de diastereoselectivity excess 
DIBAL-H dissiobutylaluminium hydride 
DMAP 4-N,N-dimethylaminopyridine 
DMF N,N-dimethylformamide 
DMP Dess-Martin periodinane 
DMSO dimethyl sulfoxide 
dt doublet of a triplet 
ee enantioselectivity excess 




FTIR fourier transform infrared spectroscopy 
h hour 
HPLC high performance liquid chromatography 
HRMS high resolution mass spectroscopy 
Hz hertz 
IR infrared 
LDA lithium dissopropylamide 
M molar 
m multiplet 





NMR nuclear magnetic resonance 
NOE nuclear Overhauser effect 
OAcCF3 trifluoro-acetyl acetonate 
OTf triflate (trifluoromethanesulfonate) 
Ph phenyl 
ppm part per million  
pTSA para-toluenesulfonic acid 
q quartet 
RCM ring closing metathesis 
Rf retardation factor 
s singlet 





Tf trifluoromethanesulfonyl (triflyl) 
TFA trifluoromethanesulfonyl acid 
THF tetrahydrofuran 
TIPS triisoproplysilyl 













Enantioselective Allyl Transfer 




Over the last few decades, homoallylic alcohols have become an indispensable 
moiety for the construction of complex organic molecules, securing their widespread 
involvement in both natural products and medicinal agent synthesis.1 Being important 
building blocks and versatile synthons, homoallylic alcohols are featured in many 
medicinal agents such as prostaglandin E3,2 prostaglandin F3a,2 (+)-amphidinolide K,3 and 





(Exerts a diverse array of physiological 












(+) - Amphidinolide K 





(Chemotactic agent)  
Figure 1. Importance of homoallylic alcohols. 
_____________________________ 
1 (a) Nicolaou, K. C.; Kim, D. W.; Baati. R. Angew. Chem. Int. Ed. 2002, 41, 3701. (b) Hornberger, K. 
R.; Hamblet, C. L.; Leighton, J. L. J. Am. Chem. Soc. 2000, 122, 12894. (c) Felpin, F. X.; Lebreton. J. 
J. Org. Chem. 2002, 67, 9192. 
2 (a) Corey, E. J.; Shirahama, H.; Yamamoto, H.; Terashima, S.; Venkateswarlu, A.; Schaaf, T. K. J. 
Am. Chem. Soc. 1971, 93, 1490. (b) Corey, E. J.; Albonico, S. M.; Schaaf, T. K.; Varma, R. K. J. Am. 
Chem. Soc. 1971, 93, 1491. (c) Corey, E. J.; Ohuchida, S.; Hahl, R. J. Am. Chem. Soc. 1984, 106, 3875. 
3 William, D. R.; Meyer, K. G. J. Am. Chem. Soc. 2001, 123, 765. 
4 For the first total synthesis, see: (a) Corey, E. J.; Marfat, A.; Goto, G.; Brion, F. J. Am. Chem. Soc. 
1980, 102, 7984. For a recent stereocontrolled total synthesis, see: (b) Kerdesky, F.; Schmidt, S. P.; 
Brooks, D. W. J. Org. Chem. 1993, 58, 3516. 
Enantioselective Crotyl Transfer 
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Among the many methods for the synthesis of homoallylic alcohols, the most frequently 
employed methodology is the allylation of aldehydes and ketones with allylic metals 
(Scheme 1).5 The use of organometallic reagents is today so common that hardly any 
synthesis is now completed without the inclusion of at least one step involving an 
organometallic reagent. Beginning in the late 1970s, considerable synthetic interest began 
to surface in the control of the stereochemistry of C – C bond formation in the reactions 
of allylmetals with aldehydes and ketones. This widespread use of allylic organometallics 
in stereocontrolled organic synthesis appears to have been triggered by three papers: 
Heathcock’s breakthrough that the Hiyama (E)-crotylchromium reagent undergoes highly 
anti-selective addition to aldehydes (Scheme 2);6a Hoffmann’s discovery that (Z)-
crotylboronates produce syn-homoallylic alcohols stereoselectively;6b and Yamamoto’s 
innovation that the Lewis acid mediated reaction of crotyltins with aldehydes produces 
syn-homoallylic alcohols regardless of the initial geometry of the double bond of the 























Metal = Li, Mg, Ba, Zn, Cd, Ca, In, Sn, Si, Sm, Ce, Cr or B.
HO R1 HO R1
1
 





5 (a) Roush, W. R. In Comprehensive Organic Synthesis; Trost, B. M., Fleming, I., Heathcock, C. H., 
Eds.; Pergamon: Oxford, 1991; Vol. 2, pp 1 – 53. (b) Yamamoto, Y.; Asao, N. Chem. Rev. 1993, 93, 
2207. 
6 (a) Buse, C. T.; Heathcock, C. H. Tetrahedron Lett. 1978, 1685. (b) Hoffmann, R. W.; Zeiss, H.-J. 
Angew. Chem., Int. Ed. Engl. 1979, 18, 306. (c) Yamamoto, Y.; Yatagi, H.; Naruta, Y.; Maruyama, K. 
J. Am. Chem. Soc. 1980, 102, 7107. 
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Scheme 3. Yamamoto’s report on addition of crotyltrialkyltins to aldehydes. 
 
From a synthetic point of view, the ready formation of homoallylic alcohols into the 
corresponding aldols renders the addition of organometallic allylic reagents to carbonyls 
complementary to the aldol additions of metal enolates. Furthermore, the great versatility 
of the alkene functionality, which is capable of the conversion to aldehydes via 
ozonolysis, the facile one-carbon homologation to δ-lactones via hydroformylation, the 
selective epoxidation for introduction of a third stereogenic center, or the cross olefin 
metathesis to various linear homoallylic alcohol fragments, offers the additions of allylic 
metals a considerable advantage over the aldol counterpart (Scheme 4). 
 

































Scheme 4. Versatile building block – homoallylic alcohol. 
 
The development of new highly enantioselective C – C bond formation methods is 
therefore an utmost task to organic chemists.7 In this aspect, extensive efforts have been 
devoted to the exploration of chiral reagents and catalysts for the carbonyl-allylation and 
carbonyl-ene reactions, since the resulting homoallylic alcohols are versatile building 
blocks in the synthesis of many natural products and pharmaceuticals.5,8 In the past two 
decades, several asymmetric allylation methods have been developed based on either 













7 Ojima, I. In Catalytic Asymmetric Synthesis; 2nd Ed.; Wiley-VCH, 2000; pp 465 – 498. 
8 Mikami, K.; Shimuzu, M. Chem. Rev. 1992, 92, 1021. 
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The most well studied and widely used chiral allylation reagents are allylboranes.9 A 
series of chiral B-allylborolanes have been successfully developed (Figure 2). These 
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9 (a) Roush, W. R.; Walts, A. E.; Hoong, L. K. J. Am. Chem. Soc. 1985, 107, 8186. (b) Racherla, U. S.; 
Brown, H. C. J. Org. Chem. 1991, 56, 401. (c) Ito, H.; Tanikawa, S.; Kobayashi, S. Tetrahedron Lett. 
1996, 37, 1795. (d) Schreiber, S.; Groulet, M. T. J. Am. Chem. Soc. 1987, 109, 8120. (e) Corey, E. J.; 
Yu, C.-M.; Kim, S. S. J. Am. Chem. Soc. 1989, 111, 5495. (f) Roush, W. R.; Hoong, L. K.; Palmer, M. 
A. G.; Park, J. C. J. Org. Chem. 1990, 55, 4109. 
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Scheme 5. Application of chiral B-allylborolanes in natural product synthesis. 
 
Besides the extensively studied allylborane reagents, many other chiral allylation 
reagents have also attracted substantial attention, and been well-developed. For instance, 
allyltrichlorosilane, pretreated with (+)-diisopropyl tartrate, has been used to react with 






10 Wang, Z.; Wang, D.; Sui, X. J. J. Chem, Soc., Chem. Commun. 1996, 2261. 

























Scheme 6. Chiral allylsilane reagent for allylation. 
 
A dialkoxyallylchromium complex possessing N-benzoyl-L-proline gave excellent 















+ THF, − 78 oC ROH =
28 29 30  
Scheme 7. Chiral allylchromium reagent for allylation. 
 
Organotitanates modified with a carbohydrate auxiliary were also successfully 
















Ether, − 78 oC
31 32 33  








11 Sugimoto, K.; Aoyagi, S.; Kibayashi, C. J. Org. Chem. 1997, 62, 2322. 
12 Riediker, M.; Duthaler, R. O. Angew. Chem. Int. Ed. Engl. 1989, 28, 494.  
Enantioselective Crotyl Transfer 
9 
On the other hand, several enantioselective catalytic allylation methods have been 
developed. Various BINOL-based titanium complexes have been demonstrated to 
catalyze the enantioselective addition of aldehydes with allylstannanes or allylic silanes 
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Scheme 9. Allylation catalyzed by BINOL-based titanium complexes. 
 
In the presence of a chiral (Acyloxy)borane (CAB) complex, derived from tartaric 
acid, allylic silanes or allylic stannanes can react with aldehydes to produce the 









13 (a) Gauthier, D. R. Jr.; Carreira, E. M. Angew. Chem. Int. Ed. Engl. 1996, 35, 2363. (b) Keck, G. E.; 
Tarbet, K. H.; Geraci, L. S. J. Am Chem. Soc. 1993, 115, 8467. 
14 (a) Ishihara, K.; Mouri, M.; Gao, Q.; Maruyama, T.; Furuta, K.; Yamamoto, H. J. Am. Chem. Soc. 
1993, 115, 11490. (b) Marchall, J. A.; Tang, Y. Synlett 1992, 653. 



































Scheme 10. Allylation catalyzed by CAB complexes. 
 
Recently, Yamamoto et al. reported that BINAP-Ag complexes are efficient chiral 
catalysts for enantioselective allylation reactions (Scheme 11).15 Our group found out that 
this complex can catalyze enantioselective allylation in aqueous medium (EtOH/H2O, v/v 




























Scheme 11. Allylation catalyzed by BINAP-Ag complexes. 
 
______________________________ 
15 (a) Yanagisawa, A.; Nakashima, H.; Ishiba, A.; Yamamoto, H. J. Am. Chem. Soc. 1996, 118, 4723. 
(b) Yanagisawa, A.; Kageyama, H.; Ishiba, A.; Yamamoto, H. Angew. Chem. Int. Ed. 1999, 38, 3701. 
16 Loh, T.-P.; Zhou, J.-R. Tetrahedron Lett. 2000, 41, 5261. 
Enantioselective Crotyl Transfer 
11 
Our group has always been very interested in the development of enantioselective 
synthesis of homoallylic alcohols, especially the linear adducts. In fact, we are very much 
concerned with the stereocontrol of the C – OH bond and the olefinic geometry. Even 
though extensive efforts have been devoted to the exploration of chiral reagents and 
catalysts for the carbonyl-allylation and carbonyl-ene reactions to produce homoallylic 
alcohols, almost all current methods produce branched (γ-adducts) homoallylic alcohols 
42 exclusively,17 except for a few special cases, hence limiting access to the linear (α-
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17 For reviews, see: (a) Yamamoto, Y.; Asao, N. Chem. Rev. 1993, 93, 2207. (b) Helmchen, G.; 
Hoffmann, R.; Mulzer, J.; Schaumann, E. Eds. In Stereoselective Synthesis, Methods of Organic 
Chemistry (Houben-Werl), 21st ed; Thieme Stuttgart: New York, 1996; Vol. 3, pp 1357-1602. (c) 
Denmark, S. E.; Fu, J. P. Chem. Rev. 2003, 103, 2763. 
18 For some examples, see: (a) Nokami, J.; Yoshizane, K.; Matsuura H.; Sumida, S. J. Am. Chem. Soc. 
1998, 120, 6609. (b) Tan, K. T.; Cheng, H. S.; Chng, S. S.; Loh, T. P. J. Am. Chem. Soc. 2003, 125, 
2958. (c) Loh, T. P.; Lee, C. L. K.; Tan, K. T. Org. Lett. 2002, 17, 2985. (d) Cheng, H. S.; Loh, T. P. J. 
Am. Chem. Soc. 2003, 125, 4990. (e) Hirashita, T.; Yamamura, H.; Kawai, M.; Araki, A. Chem. 
Commun. 2001, 387. (f) Okuma, K.; Tanaka, Y.; Ohta, H.; Matsuyama, H. Heterocycles, 1993, 1, 37. 
Enantioselective Crotyl Transfer 
12 
In general, four common strategies are employed for the synthesis of linear 
homoallylic alcohols, namely, barium-mediated allylation (Scheme 12),19 Lewis acid 
catalyzed ene-reactions of chiral glyoxylates (Scheme 13),20 transmetallation (Scheme 
14)21 and thermodynamic conversion from the corresponding kinetic branched 
homoallylic alcohol adduct (Scheme 15).22  
 
The strict anhydrous procedure of barium-mediated allylation limits its application, 
and moreover, the reaction is difficult to handle due to its sensitivity towards moisture. 



















Scheme 12. Barium-mediated allylation. 
 
As for the ene-reaction, the limitation in substrates confines this method to a limited 
scope of homoallylic alcohols. The high specificity to substrate associated with 






 _____________________________ 19 Yanagisawa, A.; Habaue, S.; Yamamoto, H. J. Am. Chem. Soc. 1991, 113, 8955. 
20 (a) Whitesell, J. K.; Lawrence, R. M.; Chen, H.-H. J. Org. Chem. 1986, 57, 4779. (b) Whitesell, J. K. 
Acc. Chem. Res. 1985, 18, 280, and references cited therein. 
21 (a) Cohen, T.; Bhupathy, M. Acc. Chem. Res. 1989, 22, 152. (b) Depew, K. M.; Danishefsky, S. J.; 
Rosen, N.; Sepp-Lorenzino, L. J. Am. Chem. Soc. 1996, 118, 12463. 
22 Hong, B.-C.; Hong, J.-H.; Tsai, Y.-C. Angew. Chem. Int. Ed. Engl. 1998, 37, 468. 









































Scheme 14. Transmetallation method in the synthesis of tryprostatin B. 
 
Therefore, the thermodynamically-controlled conversion of a branched homoallylic 
alcohol to its corresponding linear homoallylic alcohol appears to be an appealing 
complementary approach. For example, Hong et al. demonstrated such an example in 
their synthesis of xestovanin A (Scheme 15). 
 




































Scheme 15. Thermodynamic conversion in the synthesis of rosiridol A. 
 
Despite tremendous advances achieved in the past two decades, there are no general 
and yet efficient methods developed that exhibit α-regioselectivity. Hoffmann et al. had 
demonstrated that cis-linear homoallylic alcohols could be obtained in a two-step 
pathway: an allylboration reaction with α-substituted allylboronates followed by a 


















R1 = C6H11, R2 = H
63
79%, >99% ee, 67% Z
64
75%, >99% ee, 86% Z
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23 (a) Hoffmann, R. W.; Giesen, V.; Fuest, M. Liebigs Ann. Chem. 1933, 629. (b) Stürmer, R.; 
Hoffmann, R. W. Synlett 1990, 759. 
Enantioselective Crotyl Transfer 
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Recently, Nokami et al. disclosed a novel concept in the α-regiospecific allylation of 
aldehydes via a Sn(OTf)2-catalyzed allyl transfer reaction from the corresponding 
branched (γ-adducts) homoallylic alcohols X derived from acetone (Scheme 17).24 Other 
branched homoallylic alcohol donors derived from 2-butanone, cyclohexanone and 
cyclopentanone were found to exert a similar effect as that derived from acetone 67, but a 















Scheme 17. Sn(OTf)2 catalyzed allyl transfer by Nokami et al. 
 
Subsequently, Nokami et al. further developed the method into a strategy for the 
Sn(OTf)2-catalyzed conversion of the kinetic branched homoallylic alcohol 65 to the 
corresponding thermodynamic linear homoallylic alcohol 66, in the presence of a 
catalytic amount of the parent aldehyde 8.25 The mechanism for this allyl transfer reaction 
was postulated to proceed via an oxycarbenium ion intermediate 70 that undergoes a 2-






24 (a) Nokami, J.; Yoshizane, K.; Matsuura, H.; Sumida, S. I. J. Am. Chem. Soc. 1998, 120, 6609. (b) 
Nokami, J.; Nomiyama, K.; Shafi, S. M.; Kataoka, K. Org. Lett. 2004, 6, 1261. 
25 Sumida, S. I.; Ohga, M.; Mitani, J.; Nokami, J. J. Am. Chem. Soc. 2000, 122, 1310. 
26 (a) Hopkins, M. H.; Overman, L. E. J. Am. Chem. Soc. 1987, 109, 4748. (b) Hopkins, M. H.; 
Overman, L. E.; Rishton, G. M. J. Am. Chem. Soc. 1991, 113, 5354. 
























































In the case where R1 = R = R2 = H, the sequence degenerates to conversion of the γ−adduct 






Scheme 18. Proposed mechanism for the allyl transfer reaction. 
 
It was also suggested that the reaction could be driven toward products derived from 
the most stable cations or those containing sterically less hindered homoallylic alcohols 
and/or thermodynamically more stable olefins. These findings supplied new opportunities 
for the development of linear homoallylic alcohols. 
 
In our laboratory, chiral branched homoallylic sterols successfully transferred their 
chirality and allyl species to other aldehydes for the preparation of optically active linear 
homoallylic alcohols as depicted in Scheme 19.27 Allyl transfer reactions using these 
chiral branched homoallylic sterols afforded desired linear homoallylic alcohols in both 






27 Loh, T. P.; Hu, Q. Y.; Chok, Y. K.; Tan, K. T. Tetrahedron Lett. 2001, 42, 9277. 












Up to 99% ee and 99% E  
Scheme 19. Allyl transfer from γ-adduct 22β-sterol to various aldehydes. 
 
While the enantioselective crotyl transfer reactions developed by Nokami28 and our 
group have been shown to be useful for the synthesis of trans-linear homoallylic alcohols, 
there are no reported examples for a one-pot synthesis of enantiomerically cis-linear 
homoallylic alcohols. 
 
Based on Scheme 19, it can be concluded that if another chiral auxiliary29 can be 
judiciously chosen to effectively present an asymmetric steric environment, in which the 
formation of the branched homoallylic alcohols precursor is highly diastereometrically 
preferred, stereoselective access to the linear homoallylic alcohols would be achieved. It 
is hence conceivable that this crotyl transfer reaction would provide a valuable platform 







28 Nokami, J.; Nomiyana, K.; Matsuda, S.; Imai, N.; Kataoka, K. Angew. Chem. Int. Ed. 2003, 42, 1273, 
and references therein. 
29 For an extensive list of chiral auxiliaries, see: (a) Rahmen, A. U.; Shah, A. Stereoselective Synthesis 
in Organic Chemistry, Springer, Berlin, 1993. (b) I. Seyden-Penne, Chiral Auxiliaries and Ligands in 
Asymmetric Synthesis, Wiley, New York, 1995. (c) Ager, D. J.; Prakash, J.; Schaad, D. R. Chem. Rev. 
1996, 96, 835. 
Enantioselective Crotyl Transfer 
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In the next section, a new methodology to prepare enantiomerically enriched cis-
linear homoallylic alcohols will be discussed first. A range of catalysts, aldehydes, and 
solvents were investigated to obtain the optimum yield, enantioselectivity, and cis 
olefinic geometry. Following that, the first enantioselective linear homoallylic alcohol 
transfer reaction will be revealed. Both methodologies are derived from a mechanism 
based on the 2-oxonia-[3,3]-sigmatropic rearrangement. 
Enantioselective Crotyl Transfer 
19 
1.2 SYNTHESIS OF  ENANTIOMERICALLY CIS-LINEAR HOMOALLYLIC  
             ALCOHOLS BASED ON THE STERIC INTERACTION MECHANISM OF  
             CAMPHOR SCAFFOLD30 
  
The abundance, crystallinity and manifold transformations of (+)-camphor 77 have 
attracted considerable interest throughout the history of organic chemistry.31 By means of  
various rearrangements and functionalizations at C(3), C(5), C(8), C(9), and C(10), as 
well as the cleavage of the C(1)/C(2) and C(2)/C(3) bonds, camphor has served as a 
fascinating versatile starting material for the synthesis of enantiomerically pure natural 
products (Figure 4). This chemistry, which entails incorporation of the camphor topicity 



























30 Chi-Lik Ken Lee, Cheng-Hsia Angeline Lee, Kui-Thong Tan, Teck-Peng Loh. An Unusual 
Approach Towards the Synthesis of Enantiomerically Cis-Linear Homoallylic Alcohols Based on 
the Steric Interaction Mechanism of Camphor Scaffold. Organic Letters 2004, 6, 1281. 
31 For a review on camphor-based chiral auxiliaries, see: Oppolzer, W. Tetrahedron 1987, 43, 1969.  
32 Money, T. Natural Prod. Reports 1985, 253. 
Enantioselective Crotyl Transfer 
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Our initial efforts were focused on synthesizing a series of chiral auxiliaries based on 
the camphor scaffold. The Grignard procedure allows the reaction of the allylmetal 
species with the camphor 77 to be performed at low temperatures, but only 80 and 81 
were successfully synthesized in this way (Table 1, entries 1 and 2).33 The reason for the 
lack of formation of 82 and 8334 may be due to the bulky nature in phenyl and ester group, 
that might hinder allyl attack on the carbonyl group of camphor. Notably, 3b was isolated 
as an inseparable mixture of diastereomers with a syn/anti ratio of 70/30, based on 1H 
NMR and 13C NMR determination. 
 











77 80 − 8379  
 
Entry R1 R2 Temp (o C) Time (h) Product Yield (%) 
1 H H 0 1.5 80 82 
2 CH3 H 0 2.0 81 87 
3 Ph H 0 12.0 82 - 













33 Dimitrov, V.; Simova, S.; Kostova, K. Tetrahedron. 1996, 52, 1699. 
34 Method used for the preparation of 83: Alkylation of 77 (10 mmol, 1 equiv) with ethyl crotonate (20 
mmol, 2 equiv) using lithium diisopropylamide (LDA) (40 mmol, 4 equiv) in anhy THF (40 mL) 
stirring at – 78 oC. 
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Our initial studies of the crotyl transfer reaction entailed stirring a diastereomeric 
mixture (syn/anti = 70/30) of the camphor branched homoallylic alcohol 81 (0.5 mmol, 1 
equiv.) with 3-phenylpropanal 37 (0.75 mmol, 1.5 equiv.) in dichloromethane (2 mL) at 
room temperature, under the catalysis of indium(III) triflate. In accordance with the 
recent surge in interest in metal triflates, indium(III) triflate has emerged as a promising 
choice particularly in our research group.35 However, no desired product was obtained for 
this crotyl transfer reaction when In(OTf)3 was employed as the acid catalyst (Table 2, 
entry 1). This prompted us to explore the use of other acids, for instance Brönsted acids. 
 













Entry Acid Temp (oC) Time (h) Yield (%) % ee (Z:E) 
1 In(OTf)3 25 18 - -- 
2 pTsOH 25 18 <7 96 (95:5) 
3 TFA 25 18 <7 94 (94:6) 
4 CSA 25 18 25 93 (94:6) 












35 (a) Loh, T. P.; Hu, Q. Y.; Ma, L. T. J. Am Chem. Soc. 2001, 123, 2450. (b) Loh, T. P.; Hu, Q. Y.; 
Tan, K. T.; Cheng, H. S. Org. Lett. 2001, 3, 2669. (c) Loh, T. P.; Tan, K. T.; Hu, Q. Y. Angew. Chem., 
Int. Ed. Engl. 2001, 40, 2921. (d) Cheng, H. S.; Loh, T. P. J. Am. Chem. Soc. 2003, 125, 4990. 
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When p-toluene sulfonic acid (pTsOH) and trifluoroacetic acid (TFA) were employed, 
the crotyl transfer reactions were successfully catalyzed (Table 2, entries 2 and 3). 
Although the yield for pTsOH was rather low, the desired linear homoallylic alcohol 
obtained showed high cis-olefinic geometry (Z:E = 95:5) and enantioselectivity (96% ee). 
A similar observation was made when TFA was used (Z:E = 95:5; 94% ee). Remarkably, 
1R-(+)-camphor sulfonic acid (CSA) proved to be the acid catalyst of choice when it gave 
a moderate yield of 25% with significant cis-olefinic geometry (Z:E = 96:4) and 
enantiomeric excess (93% ee). This superior catalytic efficiency exhibited by CSA 
prompted us to select this Brönsted acid for further exploration. 
 
Table 3. Crotyl transfer reaction from 81 to 37 under various temperature  











8437 (0.75 mmol)  
 
Entry Conditions Time (h) Yield (%) % ee (Z:E) 
1 - 78 oC 24 15 93 (97:3) 
2 0 oC 24 20 93 (97:3) 
3 25 oC 24 25 93 (94:6) 
4 reflux 24 11 93 (96:4) 
 
We next focused on optimization of the reaction conditions by investigating on the 
temperature (Table 3) and solvent (Table 4) effects. It is evident from Table 3 that the 
crotyl transfer reaction performed at 25 oC remained the preeminent condition, giving the 
product in the highest yield (25%). In all cases, the olefinic geometries and 
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enantioselectivities did not fluctuate to any great extent. As shown in Table 4, the best 
yield was significantly improved when the crotyl transfer reaction was carried out in 
dichloromethane (Table 4, entries 2 and 3). The reactions employing toluene and 
chloroform were unimpressive, providing rather low yields of 8% and <7% respectively 
(Table 4, entries 1 and 3). It is important to note that the polarity of solvents had no direct 
relationship with the crotyl transfer reaction due to the observations obtained using 
toluene and chloroform. 
 











8437 (0.75 mmol)  
 
Entry Solvent Polarity index Time (h) Yield (%) % ee (Z:E) 
1 Toluene 2.4 24 8 93 (98:2) 
2 CH2Cl2 3.1 24 25 93 (94:6) 
3 CH2Cl2 3.1 120 56 92 (98:2) 
4 CHCl3 4.1 24 <7 94 (98:2) 
5 THF 4.0 24 - - 
6 Diethyl ether 2.8 24 - - 
7 CH3CH2OH 5.2 24 - - 
 
When the reaction was carried out using an excess of camphor homoallylic alcohol 81 
and it took a time of 120 h for the disappearance of 37 on the TLC to afford the desired 
product 84 with an improved yield of 56%. Optimal results were obtained when the 
reaction was carried out at ambient temperature and at a higher concentration (6.0 molar 
solution) with 3 equivalents of the branched homoallylic alcohol 81 being added slowly 
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to a stirred solution of 1 equivalent of 3-phenylpropanal 37 and 0.1 equivalent of CSA for 












84 (94% ee; 99% Z)37 (0.3 mmol)  
Scheme 20. Optimized reaction conditions for the crotyl transfer reaction of 81. 
 
With these optimized conditions, we carried out the crotyl transfer reactions on 
various aldehydes. While the slightly bulkier substrate (Table 5, entry 4) gave a moderate 
yield, the linear ones offered excellent yields (Table 5, entries 2 and 3). Reactions of the 
dioxygenated substrates (Table 5, entries 5, 6 and 7) afforded the desired products with ee 
up to 99% and cis-olefinic geometries almost predominantly. It is worthwhile to mention 
that reactions of the (1S)-(-)-camphor branched homoallylic alcohol with 4 furnished the 
other enantiomer of 84 (60% yield; 93% ee; 99% Z). 
 
This reaction can also tolerate other functional groups. Using cis-hept-4-enal, fine 
yields were obtained with comparable ee and cis olefinic geometry (>99% ee, 84% Z) 
(Table 5, entry 8) while the α,β-unsaturated ethyl ester type aldehyde needed a longer 
time before moderate yields were achieved with excellent ee and cis-olefinic geometry 
(>99% ee, 97% Z) (Table 5, entry 9). Based on the sluggish reactivity of aromatic 
aldehydes (Table 5, entries 10 and 11), a chemoselective study revealed that the transfer 
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selectively react with the aliphatic substrate even in the presence of a more reactive 
aldehyde (Scheme 21). 
 












85a − 85k  
 
Entry R Time (h) 85 Yield (%) % ee (% Z) 
1 PhCH2CH2 120 85a 88 94 (99) 
2 n-C5H11 144 85b 68 97 (>99) 
3 n-C8H17 144 85c 95 90 (94) 
4 c-C6H11  144 85d 40 92 (96) 
5 BnO(CH2)2  120 85e 74 97 (>99) 
6 BnO(CH2)3 96 85f 94 99 (>99) 
7 BnO(CH2)4 96 85g 80 98 (98) 
8 CH3CH2CH=CH(CH2)2 96 85h 83 >99 (84) 
9 EtO2CCH=CH(CH2)3 240 85i 66 98 (99) 
10 Ph 240 85j <10 - 






















Scheme 21. Chemoselective study. 
 
In order to broaden the scope and overcome of this methodology on aromatic 
substrates, intense attempts were made trying to obtain the desired product 85j when 
Enantioselective Crotyl Transfer 
26 
benzaldehyde was used as the starting material aldehyde. As depicted in Table 6, the 
crotyl transfer reaction is indeed bound by the steric limitation of the aldehyde as none of 
the acid catalyst was able to afford the desired product in a useful yield. 
 









25 oC, 120 h
Ph
OH
85j5 (0.3 mmol)  
 
Acid catalyst Yield (%) % ee (% Z) Acid catalyst Yield (%) % ee (% Z) 
HCl - - Yb(OTf)3 - - 
TMS(OTf) Trace - Lu(OTf)3 - - 
TIPS(OTf) Trace - Ho(OTf)3 - - 
InF3 - - Tm(OTf)3 - - 
InCl3 Trace - Er(OTf)3 - - 
InBr3 Trace - Dy(OTf)3 - - 
In(OAcCF3)3 - - Tb(OTf)3 - - 
TfOH - - Nd(OTf)3 - - 
Sn(OTf)3 - - Pr(OTf)3 - - 
Cu(OTf)2 - - Gd(OTf)3 - - 
Zn(OTf)2 - - Eu(OTf)3 - - 
Ag(OTf) - - Y(OTf)3 - - 
La(OTf)3 - - Ce(OTf)4 - - 
Sc(OTf)3 Trace - Sm(OTf)3 - - 
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Of mechanistic interest is the recovery of the excess chiral camphor homoallylic 
alcohol 81, which is enriched as its anti isomer 81b (syn/anti = 40/60) from an original 
diastereomeric ratio of syn/anti = 70/30. From the molecular model for the transition state 
of the corresponding camphor branched homoallylic alcohol 81 depicted in Scheme 22, 
we realized that only one isomer, the syn-branched homoallylic alcohol 81a, was allowed 














































Scheme 22. Proposed transition state of crotyl transfer reaction. 
 
_____________________________ 
36 Another reaction was performed with only the pure syn-branched homoallylic alcohol 81a (0.36 
mmol; 1.2 equiv), 3-phenylpropanal (0.3 mmol; 1 equiv), and CSA (0.03 mmol; 0.1 equiv) in CH2Cl2
(0.1 mL; 3.0 M), furnished the desired linear homoallylic alcohol (81% yield; 98% ee and 99% Z).
The syn isomer was prepared by a slow elution on the flash column chromatography. On numerous 
occasions before the complete elution of the syn isomer, the anti isomer eluted and hence the latter was 
not successfully purified. 
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The branched homoallylic alcohol 81 probably formed oxonium-type ions with the 
aldehyde catalyzed by the acid catalyst, revealing two possible transition states. The anti 
branched homoallylic alcohol 81b would most likely adopt a transition state similar to 
that of 90. Based on a Zimmerman-Traxler six-membered transition state,37 it is evident 
that the methyl groups from the anti isomer 81b will develop severe steric repulsion with 
the C-6 of the camphor scaffold, which explains why the trans-linear isomer 92 was not 
observed at all.  
 
On the contrary, the transition state 88 shows that the syn isomer’s methyl group is 
fixed in a manner where it avoids any close contacts with the camphor’s methylene 
protons before undergoing the rearrangement to furnish the thermodynamically preferred 














37 Zimmerman, H. E.; Traxler, M. D. J. Am. Chem. Soc. 1957, 79, 1920. 
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1.3 THE FIRST EXAMPLE OF ENANTIOSELECTIVE ALLYL TRANSFER  
              FROM A LINEAR HOMOALLYLIC ALCOHOL TO AN ALDEHYDE38 
 
In the past few years, indium complexes have found widespread application in 
organic synthesis including their application for the catalysis of various C−C bond 
formation reactions in aqueous media.39 Besides our interest in indium chemistry,40 our 
group has also exploited the special characteristics of indium complexes to catalyze a 
wide variety of organic transformations.41  
 
In a recent paper, our group reported a novel In(OTf)3 catalyzed (3,5) oxonium-ene 
type cyclization for the facile construction of various multisubstituted tetrahydrofurans 
and tetrahydropyrans.42 It was noted that a disubstituted double bond of a homoallylic 
alcohol is essential for this oxonium-ene type cyclization. During the course of our 
studies on the scope and limitations of this oxonium-ene reaction, we carried out the 
reaction of the homoallylic alcohol 93 with a different aldehydes in the presence of 







38 Teck-Peng Loh, Chi-Lik Ken Lee, Kui-Thong Tan. The First Example of Enantioselective Allyl 
Transfer from a Linear Homoallylic Alcohol to an Aldehyde. Organic Letters 2002, 4, 2985. 
39 Chan, T. H. Organic Reactions in Aqueous Media; John Wiley & Sons: New York, 1997. 
40 (a) Wang, R. B.; Lim, C. M.; Tan, C. H.; Lim, B. K.; Sim, K. Y.; Loh, T. P. Tetrahedron: Asymmetry
1995, 6, 1825. (b) Loh, T. P.; Li, X. R. Angew. Chem., Int. Ed. Engl. 1997, 36, 980. (c) Loh, T. P.; 
Chua, G. L.; Vittal, J. J.; Wong, M. W. Chem. Commun. 1998, 861. 
41 (a) Loh, T. P.; Hu, Q. Y.; Ma, L. T. J. Am. Chem. Soc. 2001, 123, 2450. (b) Loh, T. P.; Tan, K. T.; 
Hu, Q. Y. Angew. Chem., Int. Ed. Engl. 2001, 40, 2921.  
42 Loh, T. P.; Hu, Q. Y.; Tan, K. T.; Cheng, H. S. Org. Lett. 2001, 3, 2669.  
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      To our surprise, the homoallylic alcohol 93 gave no desired tetrahydrofuran product 
95 but instead another linear homoallylic alcohol 96 was obtained as shown in Scheme 23. 
Herein, an unprecedented pathway leading to this linear homoallylic alcohol and the 















Scheme 23. Unexpected observation. 
 
We chose to examine the most effective protocol for the crotyl transfer reaction by 
employing substrates that were easily obtained via indium mediated allylation (Table 
6).43 Treatment of the linear homoallylic alcohol (1.25 mmol, 2.5 equiv) and 3-
phenylpropanal 37 (0.5 mmol, 1 equiv)) with 10 mol% of In(OTf)3 in CH2Cl2 (3 mL) at 
room temperature was initially examined to test the feasibility of the crotyl transfer 
reaction. The reactions were heated reflux when TLC showed no desired product after 
stirring for 18 h at room temperature (Table 7, entries 2 and 3). This preliminary study 
not only produced the desired linear homoallylic alcohol 103, but also a small amount 
(between 5 – 10 %) of the Prins cyclization product 105 was formed.44  
 
______________________________ 
43 (a) Loh, T. P.; Tan, K. T.; Yang, Y. J.; Xiang, C. L. Tetrahedron Lett. 2001, 42, 8701. For some 
examples of α-allylation, see: (b) Ito, A.; Kishida, M.; Kurusu, Y.; Masuyama, Y. J. Org. Chem. 2000, 
65, 494. (c) Yamamoto, Y.; Maeda, N.; Maruyama, K. Chem. Commun. 1983, 48, 1564. (d) 
Yanagisawa, A.; Habaue, S.; Yamamoto, H. J. Am. Chem. Soc. 1991, 113, 8955.  
44 (a) For some examples of Lewis acid catalyzed Prins cyclizations, see: Cloninger, M. J.; Overman, L. 
E. J. Am. Chem. Soc. 1999, 121, 1092. (b) Nishizawa, M.; Shigaraki, T.; Takao, H.; Imagawa, H.; 
Sugihara, T. Tetrahedron Lett. 1999, 40, 1153. (c) Yang, X. F.; Mague, J. T.; Li, C. J. J. Org. Chem. 
2001, 66, 739.  
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Table 7. Crotyl transfer reaction from various linear homoallylic alcohols to 37   




















Entry Reactants R Temp (oC)a Time (h) Yield %b (103:104) (E/Z)c 105 
1 97 c-C6H11 25 2.0 25 (100:0) (80/20) 105a 
2 98 (CH3)2CH 40 5.0 23 (100:0) (80/20) 105b 
3 99 n-C8H17 40 6.0 25 (76:24) (80/20) 105c 
4 100 Ph 25 1.5 45 (100:0) (80/20) 105d 
5 101 c-C6H11 25 5.0 49 (100:0) (80/20) 105e 
6 102 tBu 25 2.0 69 (100:0) (80/20) 105f 
aThe reactions were heated to reflux when TLC shows no desired product after stirring for 18 h at room 
temperature. bCombined yield based on 9a. cDetermined by 1H NMR and 13C NMR. 
 
Using a more sterically congested substrate (Table 7, entry 6), an improved yield of 
the product 103 was obtained. It was found that this crotyl transfer reaction was largely 
dependent on the steric effect of the substituents on the allylic alcohol and aldehyde. In 
many cases, improved yields of the desired linear homoallylic alcohol arose because the 
amount of the Prins product decreased. Switching the substrate to the nonyl fragment 
(Table 7, entry 3) proved interesting as a substantial amount of the branched homoallylic 
adduct 104 was isolated. 
 
Given the success of the development of a standard substrate for the crotyl transfer, 
Table 8 demonstrates a broad scope of the effect of catalysts on this allylation. The 
failure of the initial attempts with several catalysts was quite puzzling (Table 8, entries 1 
to 5). Perhaps the Lewis/Brönsted acidities of these catalysts were not suitable enough for 
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this demanding crotyl transfer reaction. However, it is noteworthy to mention that trace 
amount 105f was isolated. 
 















103 105f  
  
Entry Catalyst Temp (oC) Time (h) Yield 9a (%) (α:γ) (E/Z) Yield 11f (%) 
1 InBr3 40 48 - 2 
2 Ag(OTf) 40 48 - - 
3 La(OTf)3 40 48 - 7 
4 Lu(OTf)3 40 48 - 5 
5 CSA 40 48 - 13 
6 Yb(OTf)3 25 48 15 (75:25) (100/0) 5 
7 Cu(OTf)2 25 5 22 (23:77) (80/20) 3 
8 Sc(OTf)3 40 18 40 (99:1) (82/18) 28 
9 Sn(OTf)2 25 4 55 (100:0) (80/20) 23 
10 In(OTf)3 25 3 69 (100:0) (80/20) 10 
 
The investigations on the effects of solvent showed intriguing results (Table 9). 
Although water, tetrahydrofuran and dimethylformamide all showed negative results for 
the crotyl transfer reaction, the reaction in hexane yielded more Prins product than the 
desired linear homoallylic alcohol product. Further studies on this phenomenon revealed 
that the selectivity towards getting the Prins product can be increased by carrying out the 
reaction in hexane and 4Å molecular sieves. 
 
In fact, when this condition was carried out, formation of the linear homoallylic 
alcohol was almost totally suppressed (< 7% yield) and afforded 62% yield of the Prins 
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product. Nonetheless, dichloromethane became the solvent of choice for the crotyl 
transfer reaction when it gave the desired product in good yield. 
 















103 105f  
 
Entry Solvent Temp (oC) Time (h) Yield 102 (%) (α:γ) (E/Z) Yield 105f (%)
1 H2O 40 48 - - 
2 THF 40 48 - - 
3 DMF 40 48 - - 
4 Hexane 40 48 15 (100:0) (80/20) 37 
5 CHCl3 40 48 30 (100:0) (80/20) 10 
6 CH2Cl2 25 3 69 (100:0) (80/20) 10 
 
In order to understand the mechanism of this crotyl transfer reaction, optically active 
steroid linear homoallylic alcohol (ee > 97%) was used to study the stereochemistry of 
this reaction (Scheme 24). The enantiomeric excess of the product was determined. It was 
found that the chirality of the alcohol, ee and regiochemistry were preserved. 
Furthermore, a trace amount of the branched homoallylic alcohol in one isomeric form 













ee > 97%  
Scheme 24. Stereochemical study of the linear to linear crotyl transfer reaction. 
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From the reactions and results illustrated by Scheme 24, Table 7, 8 and 9, a plausible 
mechanism can be proposed. Scheme 25 outlines a mechanistic rationale based upon (i) 
the branched γ-adduct homoallylic alcohol 111 was generated from the In(OTf)3 
promoted crotyll transfer reaction from the linear homoallylic alcohol 108, perhaps 
through a 2-oxonia [3,3]-sigmatropic rearrangement. Following that, 111 underwent a 
thermodynamic conversion to the preferred linear regioisomer 113, plausibly by the 
similar concerted rearrangement as mentioned previously.28 (ii) The stereochemistry was 
retained after the crotyl transfer reaction from steroid homoallylic alcohol. (iii) Steric 
effects are very important, and the whole rearrangement was driven by the difference in 
steric bulk of the two substrates, with the less bulkier substrate being more stable. (iv) 
The Prins product was derived from the oxonium ions 109 which can cyclize to give a 





































Scheme 25. Mechanistic Rationale for the linear to linear crotyl transfer reaction and 
Prins cyclization reaction. 
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With such understanding of the mechanism, this crotyl transfer reaction was then 
carried out with 4 different aldehydes. Starting material 116 with ee > 97 % and E/Z ratio 
100/0 was used to perform this reaction. As shown from Table 10, the regio and 
stereochemistry remained unchanged after the reaction.  It is interesting to point out that 
this crotyl transfer reaction can also work well with the lactol substrate 119 (Table 10, 
entry 3). Especially noteworthy, the stereoselective crotyl transfer reaction of 116 with 
aldehyde 120 in entry 4, demonstrated the assembly of the C15 - C22 fragment of (+)-
amphidinolide K (Figure 1).45 
 






























3 41 (100/0) > 97b 
3 119 
O OH  




2 35 (100/0) > 97c 
 
_____________________________ 
45 (a) William, D. R.; Meyer, K. G. J. Am. Chem. Soc. 2001, 123, 765. (b) Loh, T. P.; Hu, Q. Y.; Chok, 
Y. K.; Tan, K. T. Tetrahedron Lett. 2001, 42, 9277. 
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 1.4 CONCLUSION 
 
In conclusion, two novel methods have been developed for the enantioselective 
synthesis of linear homoallylic alcohols. In the first section, a conceptually different 
strategy to prepare cis-linear homoallylic alcohols, with moderate to high yields, has been 
developed in this laboratory. To the best of our knowledge, this is the first efficient 
method24b that controls, in situ, both the enantioselectivity (up to 99% ee) and the olefinic 
geometry (up to 99% Z) of cis-linear homoallylic alcohols. Our investigations have also 
shown that this chemoselective crotyl transfer reaction is highly feasible for aliphatic 
substrates. Moreover, excess chiral camphor-derived branched homoallylic alcohol (89% 
recovery) and the camphor (83% recovery) generated from the reaction can be recovered 
and reused, thus, making this method attractive for scale-up preparation of cis-linear 
homoallylic alcohols with high enantioselectivities. We anticipate that this new Brönsted 
acid catalyzed crotyl transfer reaction will be an indispensable tool in the synthesis of 
complex natural products, thereby allowing this methodology to undergo an exciting 














Up to 99% ee and 99% Z
177
Up to 98% ee and 99% E 116
8
81  
Scheme 26. New protocols to prepare enantiomerically enriched linear homoallylic 
alcohols. 
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The second methodology describes the Lewis acid catalyzed enantioselective linear 
homoallylic alcohol transfer reaction, from a sterically hindered starting material to its 
sterically less hindered analogue via its branched-adduct intermediate, has been 
developed. In all cases, the whole rearrangement is thermodynamically favorable and 
steric effects drive the reaction. The preservation of the stereocenter and the olefin 
geometry together with the isolation of the branched-adduct homoallylic alcohols in one 










      Multigram Synthesis of (−)-Epibatidine 
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2.1 HISTORY AND THE DISCOVERY OF EPIBATIDINE 
 
In the mid-1970s, a novel class of amphibian alkaloid epibatidine 13 was first isolated 
by Daly et al. at the National Institute of Health in trace amount from the skin of the 
Ecuadorian poison frog, Epipedobates tricolor of the family Dendrobatidae.25 Its 
structure was elucidated by this research group in 1992,26 revealing the relative 
stereochemistry and  an unprecedented structure with a strained nitrogen-bridged six-
membered carbon ring system (7-azabicyclo[2.2.1]heptane) with an exo-orientated 3-(6-
chloropyridyl) substituent. Because of the very small quantities of the natural product (ca. 
1 mg isolated from 750 frogs), the assignment of the absolute stereochemistry was 











121: (+)-Epibatidine  







25 Daly, J. W. J. Nat. Prod. 1998, 61, 162. 
26 Spande, T. F.; Garraffo, H. M.; Edwards, M. W.; Yeh, H. J. C.; Pannel, L.; Daly, J. W. J. Am. Chem. 
Soc. 1992, 114, 3475. 
27 (a) Fletcher, S. R.; Baker, R. B.; Chambers, M. S.; Hobbs, S. C.; Mitchell, P. J. J. Chem. Soc. Chem. 
Commun. 1993, 1216. (b) Fletcher, S. R.; Baker, R. B.;  Chambers, M. S.; Herbert, R. H. Hobbs, S. C.; 
Thomas, S. R.; Verrier, H. M.; Watt, A. P.; Ball, R. G. J. Org. Chem. 1994, 3, 1771. 
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      The discovery of epibatidine’s pharmacological properties and the travails 
surrounding its chemical isolation and characterization is a fascinating story – one that 
holds a lesson about our environment. As related by Daly et al., the initial skin extracts 
collected from Epipedobates tricolor in 1974 yielded a small amount of an alkaloid that 
when injected into mice produced the Straub-tail effect characteristic of opioids.28 
 
Subsequent extractions of the additional frog skins collected two years later yielded 
ca. one milligram of active material, which was shown to have potent analgesic activity 
that contained at least eleven carbons, two nitrogens and a chlorine atom, but elucidation 
of its structure would have to await for more complete purification and sensitive methods 
for structural scrutiny.29 Therefore, the small amount of relatively pure extract that 
remained was stored for future study. 
 
In 1984, the Convention on International Trade in Endangered Species (CITES) put 
all the dendrobatid frogs on their Appendix II listing. From a scientist’s standpoint, such 
a CITES listing means that no investigator will ever be able to obtain permits to collect 
the requisite hundreds or more specimens required for structure elucidation of minor and 







28 (a) Daly, J. W. J. Med. Chem. 2003, 46, 445. (b) Daly, J. W. J. Nat. Prod. 1998, 61, 162. (c) Badio, 
B.; Garraffo, H. M.; Spande, T. F.; Daly, J. W. Med. Chem. Res. 1994, 4, 440.  
29 Daly, J. W.; Myers, C. W.; Whittaker, N. Toxicon 1987, 25, 1023. 
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       To complicate matters further, the skin extracts that could be collected contained 
very little of the active alkaloid (possibly due to the changes in their native habitat). 
Worse still, it was soon realized that the skin extracts from frogs raised in captivity in 
Daly’s labs did not contain the analgesic material, reinforcing speculation that the active 
compound itself, or an essential precursor, is derived from a dietary source (perhaps 
insects) indigenous to the frog’s Ecuadorian habitat and then sequestered in the frog’s 
skin.30  
 
In 1990 the small amount of extract that had been stored by Daly and his colleagues 
a decade earlier was essentially the only remaining supply of the potent analgesic 
material remaining. The power and sensitivity of NMR advanced remarkably and so Daly 
and his colleagues gambled the remaining material on gas chromatography-infrared 
spectroscopy and NMR analyses after its conversion to the N-acetyl derivative. This 
strategy worked and the structure of epibatidine was published in 1992.26 However, the 
N-acetyl derivative proved to be biologically inactive and efforts to recover epibatidine 
from the derivative were unsuccessful. Thus further work on the pharmacological 
properties of epibatidine would have to await de novo synthesis. Interestingly, the (+)- and 








30 (a) Daly, J. W.; Secunde, S. I.; Garraffo, H. M.; Spande, T. F.; Wisnieski, A.; Cover, J. F. Toxicon
1994, 32, 657. (b) Daly, J. W.; Garraffo, H. M.; Spande, T. F.; Jaramillo, C.; Rand, A. S. J. Chem. Ecol. 
1994, 20, 943. 
31 Badio, B.; Daly, J. W. Mol. Pharmacol. 1994, 45, 563. 
32 Damaj, M. I.; Creasy, K. R.; Grove, A. D.; Rosecrans, J. A.; Martin, B. R. Brain Res. 1994, 664, 34. 
33 Li, T.; Qian, C.; Eckman, J.; Huang, D. F.; Shen, T. Y. Bioorg. Med. Chem. Lett. 1994, 3, 2759. 
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2.2 BIOLOGICAL ACTIVITY OF EPIBATIDINE 
 
Historically, amphibian skin has provided many biologically active compounds. 
Vasoactive, analgetic, and antibiotic peptides, such as physalaemin, caerulein, sauvagine, 
dermorphin, and magainin,34,35 biogenic amines, including serotonins, tryptamines, 
histamines, and tyramines,34 cardioactive steroidal bufadienolides,36 tetrodotoxins,37 and 
one novel structural class of steroidal alkaloids, the smandarines,38 have been found in 
amphibian skin. Over the years, a rich harvest of unique alkaloids have been isolated, 
some of which have had a major impact on biomedical research where radiolabeled 














34 Erspamer, V.; Basic Appl. Histochem. 1981, 25, 3. 
35 Berkowitz, B. A.; Bevins, C. L.; Zasloff, M. A. Biochem. Pharmocol. 1990, 39, 625. 
36 Meyer, K.; Lindle, H.; Bücherl, W.; Buckley, E. E. Eds.; Academic Press: New York, 1971; Chapter
40, pp 521. 
37 Kim, Y. H.; Brown, G. H.; Mosher, H. S.; Fuhrman, F. A. Science 1975, 189, 151. 
38 Habermehl, G.; Manske, R. H. F. Ed.; Academic Press: New York, 1967; Vol 9, pp 427. 




























































Figure 6. Natural products as pharmacodynamic probes: structures and targets. 
Development of radioligands is indicated. 
 
 Epibatidine has been shown to possess potent analgesic activity.39 The analgesic 
effects were not blocked by administration of the potent opiate receptor antagonist 
naloxone 123 (Figure 7).26,28(c),31,40–42 However, the analgesic activity was antagonized by 
the neuronal nicotinic acetylcholine receptor channel blocker, mecamylamine 124 but 
was not affected by the nicotinic acetylcholine receptor antagonist, hexamethonium 125. 
Since hexamethonium has been shown to be incapable of crossing the blood–brain barrier, 
it is believed that the primary mechanism of action of epibatidine is mediated through 




39 Heard, N. E.; Turner, J. J. Org. Chem. 1995, 60, 4302. 
40 Qian, C.; Li, T.; shen, T. Y. Eur. J. Pharm. 1993, 150, R13. 
41 Li, T.; Eckman, J.; Huang, D. F.; Shen, T. Y. Bio-Org. Med. Chem. Lett. 1993, 3, 2759. 
42 Dukat, M.; Damaj, M. I.; Glassco, W.; Dumas, D.; May, E. L.; Martin, B. R.; Glennon, R. A. Med. 
Chem. Res. 1994, 4, 131. 


















Figure 7. Structures of receptor antagonists, blocker and nicotine. 
 
Limited structure activity relationships (SAR) studies have demonstrated that both 
the (+) and (–) enantiomers of epibatidine exhibit equipotent analgesic activity. Both 
enantiomers also equally displaced bound [3H]nicotine 126 from rat brain, making 
epibatidine one of the most potent nicotinic acetylcholine receptor ligands known to 
date.31,32,42 In addition, it was found that removal of the chlorine atom has little effect on 
the binding affinity.43 A decade ago, it has been shown that (±)-[3H]epibatidine binds to 
two sites in rat brain with affinities of 15 and 360 pM (IC50).44 Epibatidine was also 






















43 Corey, E. J.; Loh, T.-P.; Achyutha Rao, S.; Daley, D. C.; Sarshar, S. J. Org. Chem. 1993, 58, 5600. 
44 (a) Houghtling, R. A.; Dávila-García, M. I.; Hurt, S.; Kellar, K. J. Med. Chem. Res. 1994, 4, 538. (b) 
Houghtling, R. A.; Dávila-García, M. I.; Kellar, K. J. Mol. Pharmacol. 1995, 48, 280. 
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Studies with (–)-epibatidine in vivo have further demonstrated that the 
pharmacological activity of this novel alkaloid is mediated by nicotinic acetylcholine 
receptors in the central and autonomic nervous systems.31,32,42,44–46 On top of the 
analgesic activity, (–)-epibatidine brought forth similar effects to those of other nicotinic 
acetylcholine receptor ligands, albeit with much greater potency. Moreover, epibatidine 
has been shown to be an extremely potent toxin producing convulsions and death at doses 
of 40 – 86 µg/kg in mice.47  
 
With the availability of synthetic (±), (+), and (–)-epibatidine, a number of useful 
nicotinic acetylcholine receptor probes have been developed. [3H]Epibatidine has been 
employed as chemical probe for the study of nicotinic receptors in chick retina and in 
rodent and human brains.44,48 Besides this, the 4’-substituted 18F and 123I analogues have 
also being investigated as useful imaging agents for emission tomography (PET).49 More 
importantly, a number of nicotinic acetylcholine receptor ligands have been reported that 
are selective for neuronal nicotinic acetylcholine receptor subtypes and may have 






45 Fisher, M.; Huangfu, D.; Shen, T. Y.; Guynet, G. J. Pharmacol. Exp. Ther. 1994, 270, 702. 
46 Sullican, J. P.; Briggs, C. A.; Donnelly-Roberts, D.; Brioni, J. D.; Radek, R. J.; McKenna, D. G.; 
Campbell, J. E.; Arneric, S. P.; Decker, M. W.; Bannon, A. W. Med. Chem. Res. 1994, 4, 502. 
47 Bonhaus, D. W.; Bley, K. R.; Broka, C. A.; Fontana, D. J.; Leong, L.; Lewis, R.; Sheih, A.; Wong, E. 
H. F. J. Pharmacol. Exp, Ther. 1995, 272, 1199. 
48 Lehn, J. M. Chem. Forsch. 1970, 15, 311. 
49 London, E. D.; Scheffel, U.; Kimes, A. A.; Kellar, K. J. Eur. J. Pharmacol. 1995, 278, R1. 
50 Decker, M. W.; Bannnon, A. W.; Curzon, P.; Gunther, K. L.; Brioni, J. d.; Holladay, M. W.; Lin, N.-
H.; Li, Y.; Daanen, J. F.; Buccafusuco, J. J.; Prendergast, M. A.; Jackson, W. J.; Arneric, S. P. J. 
Pharmacol. Exp. Ther. 1997, 283, 247; and references cited therein. 
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 The introduction of epibatidine as a nicotinic agonist and analgesic provided the 
impetus for major synthetic efforts to obtain an analogue that would retain analgesic 
activity while being much less toxic. One such analogue, ABT 594, underwent phase I 
and II clinical trials as an analgetic.51 Undoubtedly other analogues are still under 
investigation. The relative activity of (–)-epibatidine at four major subtypes of nicotinic 




































Abbott labs. Clinical Trials as Analgesic  
Figure 8. Nicotinic agents: epibatidine (relative activity indicated) and analogues and 






51 Daly, J. W.; Garraffo, H. M.; Spande, T. F. Decker, M. W.; Sullivan, J. P.; Williams, M. Nat. Prod. 
Rep. 2000, 17, 131. 
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2.3 RELEVANT STUDIES ON THE ENANTIOSELECTIVE TOTAL SYNTHESIS   
             OF EPIBATIDINE 
 
The exciting biological properties of epibatidine, unique structure, combined with its 
scarcity in nature (ca. 1 mg of the alkaloid was isolated from the skin extract of some 750 
frogs) have aroused the interest of synthetic chemists around the world. In a relatively 
short time after its intriguing structure has been elucidated back in 1992, a vast number of 
synthetic approaches were published. Surprisingly, while approximately 50 total27,52 and 
formal53 syntheses have been reported, few full syntheses are enantioselective. It is useful 
to note that in some cases, epibatidine’s availability in enantiomeric pure forms have only 
occurred through resolution at some point in the synthesis of the final product. The fact 
that the collection of dendrobatid frogs has been prevented by an international treaty 
enacted in 1984 for the protection of endangered species has also spurred synthetic 





52 For the first total synthesis of epibatidine, see: (a) Broka, C. A. Tetrahedron Lett. 1993, 34, 3251. For 
subsequent total synthesis of epibatidine, see: (b) Huang, D. F.; Shen, T. Y. Tetrahedron Lett. 1993, 34, 
4477. (c) Corey, E. J.; Loh, T.-P.; Achyutha Rao, S.; Daley, D. C.; Sarshar, S. J. Org. Chem. 1993, 58, 
5600. (d) Clayton, S. C.; Regan, A. C. Tetrahedron Lett. 1993, 34, 7493. (e) Senokuchi, K.; Nakai, H.; 
Kawamura, M.; Katsube, N.; Nonaka, S.; Sawaragi, H.; Hamanaka, N. Synlett 1994, 343. (f) Szántay, 
C.; Kardos-Balogh, Z.; Moldvai, I.; Szántay, C., Jr.; Temesvári-Major, E.; Blaskό, G. Tetrahedron Lett. 
1994, 35, 3171. (g) Sestani, K.; Melenski, E.; Jirkovsky, I. Tetrahedron Lett. 1994, 35, 5417. (h) 
Pandey, G.; Bagul, T. D.; Lakshmaiah, G. Tetrahedron Lett. 1994, 35, 7439. (i) Albertini, E.; Barco, A.; 
Benetti, S.; De Risi, C.; Pollini, G. P.; Romagnoli, R.; Zanirato, V. Tetrahedron Lett. 1994, 35, 9297. (j) 
Ko, S. Y.; Lerpiniere, J.; Linney, I. D.; Wriddlesworth, R. J. Chem. Soc., Chem.. Commun. 1994, 1775. 
(k) Okabe, K.; Natsume, M. Chem. Phar. Bull. Jpn. 1994, 42, 1432. (l) Kotian, P. L.; Carroll, F. I. 
Synth. Commun. 1995, 25, 63. (m) Xu, R.; Chu, G.; Bai, D. Tetrahedron Lett. 1996, 37, 1463. (n) Bai, 
D.; Xu, R.; Chu, G.; Zhu, X. J. Org. Chem. 1996, 61, 4600. (o) Zhang, C.; Trudell, M. L. J. Org. Chem. 
1996, 61, 7189. (p) Giblin, G. M.; Jones, C. D.; Simkins, N. S. Synlett 1997, 589. (q) Pavri, N. P.; 
Trudell, M. L. Tetrahedron Lett. 1997, 38, 7993. (r) Pandey, G.; Bagul, T. D.; Sahoo, A. K. J. Org. 
Chem. 1998, 63, 760. (s) Sirisoma, N. S.; Johnson, C. R. Tetrahedron Lett. 1998, 39, 2059. (t) 
Habermann, J.; Ley, S. V.; Scott, J. S. J. Chem. Soc., Perkin Trans, 1 1999, 1253. (u) Olivo, H. F.; 
Hemenway, M. S. J. Org. Chem. 1999, 64, 8969. (v) Roy, B.; Watanabe, H.; Kitahara, T. Heterocycles 
2001, 55, 861. 
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Epibatidine is one of the few natural products known which contains the unique 7-
azabicyclo[2.2.1]heptane ring system as a structural element.54 Furthermore in the first 
synthesis of epibatidine described by Broka in 1993, this desired ring system was invoked 
from an intramolecular displacement strategy (Scheme 27).52a While this synthetic route 
portrayed a non-enantioselective pathway, it would seem that by incorporating a suitable 




53 For some examples of formal total synthesis of epibatidine, see: (a) Hernández, A.; Marcos, M.; 
Rapport, H. J. Org. Chem. 1995, 60, 2683. (b) Davis, C. R.; Johnson, R. A.; Ciadella, J. I.; Liggett, W. 
F.; Mizsak, S. A.; Marshall, V. P. J. Org. Chem. 1997, 62, 2244. (c) Singh, S.; Basmaddjian, G. P. 
Tetrahedron Lett. 1997, 38, 6829. (d) Ikeda, M.; Kugo, Y.; Kondo, Y.; Yamazaki, T.; Sato, T. J. Chem. 
Soc., Perkin Trans, 1 1997, 3339. (e) albertini, E.; Barco, A.; Benetti, S.; De Risi, C.; Pollini, G. P.; 
Zanirato, V. tetrahedron 1997, 53, 17177. (f) Clive, D. L.; Yeh, V. S. C. Tetrahedron Lett. 1998, 39, 
4789. 
54 For a review on 7-azabicyclo[2.2.1]heptane ring system, see: Chen, Z.-M.; Trudell, M. L. Chem. 
Review 1996, 96, 1179. 
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Scheme 27. First total synthesis of (±)-epibatidine by Broka. 
 
In 1993, Corey et al. reported a simple, efficient, and stereocontrolled synthesis of 
epibatidine (Scheme 28).52c As the absolute configuration of epibatidine was unknown at 
that time, this synthesis was developed to provide both possible enantiomers of 
epibatidine.  
 








(i)  LiAlH4, THF, 0 oC
                 60%
(ii) PCC, CH2Cl2, 23 oC








, toluene, 190 oC







      toluene, 85 oC.
(ii) TMSCH2CH2OH, 85 oC
                   95%
(PhO)2P N3
O
(i)  TBAF, THF, 55 oC
(ii) (CF3CO)2O, Et3N,
      CH2Cl2, 23 oC
                80%
Et4N+Br-
Br2, CH2Cl2, − 78 oC
96%
KOt-Bu,






























Scheme 28. Stereocontrolled total synthesis of (+) and (-)-epibatidine by Corey et al. 
 
Trost and Cook demonstrated the first enantioselective synthesis of (–)-epibatidine in 
1996 by employing a Pd catalyzed desymmetrization of cis-3,6-dibenzoyloxy-2-
cyclohexene and a Pd catalyzed cross-coupling as key reactions (Scheme 29).55 This 
synthetic route revealed the possibility to provide entry into either enantiomer of 
epibatidine which proceeds through the Boc derivative of enantiomerically pure 4-
aminocyclohex-2-enone, a potentially versatile intermediate. In addition, it also 
represents a useful entry to enantiomerically pure 7-azabicyclo[2.2.1]heptanes without 
the need to effect resolutions. 
 
_____________________________
55 Trost, B. M.; Cook, G. R. Tetrahedron Lett. 1996, 37, 7485. 
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Scheme 29. Asymmetric synthesis of (-)-epibatidine by Trost et al. in 1996. 
 
Szántay et al. designed two different syntheses of (–)-epibatidine in 1996 (Scheme 
30).56 While this synthesis was carried out using easily accessible reagents and 
convenient reaction conditions, the key step involved the ring closure of the prochiral 
trans-chloropyridinenitrohexenone catalyzed by optically active α-phenylethylamine to 
afford the chloropyridinenitrocyclohexanone in over 80% ee. 
 
_____________________________
56 Szántay, C.; Kardos-Balogh, Z.; Moldvai, I.; Szántay, C., Jr.; Temesvári-Major, E.; Blaskό, G. 
Tetrahedron 1996, 52, 11053. 
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Scheme 30. Enantioselective synthesis of (-)-epibatidine by Szántay et al. 
 
In 1997, Kosugi et al. reported the asymmetric synthesis of (–)-epibatidine by 
employing the enantioselective protonation of the achiral lithium enolate of 
cyclohexanone derivative with chiral β-hydroxylsulfoxide (Scheme 31).57  
 
_____________________________
57 Kosugi, H.; Abe, M.; Hatsuda, R.; Uda, H.; Kato, M. Chem. Commun. 1997, 1857. 
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Scheme 31. Asymmetric synthesis of (-)-epibatidine by Kosugi et al. 
 
A year later in 1998, Jones and Simpkins revealed the asymmetric synthesis of (−)-
epibatidine by the use of a novel enantioselective sulfinate elimination reaction (Scheme 
32).58 A vicinal bis-sulfone having the 7-azabicyclo[2.2.1]heptane skeleton underwent a 
novel type of asymmetric elimination on treatment with the sodium alkoxide derivative of 




58 Jones, C. D.; Simpkins, N. S.; Giblin, G. M. P. Tetrahedron Lett. 1998, 39, 1023. 
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Scheme 32. Asymmetric synthesis of (-)-epibatidine by Jones and Simpkins. 
 
In the same year, Kibayashi et al. reported an interesting enantioselective synthesis of 
(–)-epibatidine based on an asymmetric hetero Diels-Alder cycloaddition with an N-
acylnitroso dienophile bearing 8-(2-naphthy)menthol as the chiral auxiliary (Scheme 
33).59 It was postulated that π – π stacking interaction between the naphthyl and 
nitrosocarbonyl groups may have contributed to the facial control.  
 
_____________________________
59 (a) Aoyagi, S.; Tanaka, R.; Naruse, M.; Kibayashi, C. Tetrahedron Lett. 1998, 39, 4513. (b) Aoyagi, 
S.; Tanaka, R.; Naruse, M.; Kibayashi, C. J. Org. Chem. 1998, 63, 8397. 
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Scheme 33. Asymmetric total synthesis of (-)-epibatidine by Kibayashi et al. 
 
The latest report on the enantioselective synthesis of (–)-epibatidine was 
accomplished by Evans et al. utilizing a highly exo-selective asymmetric hetero Diels-
Alder reaction (Scheme 34).60 The key steps employed to transform the resulting bicycle 




60 Evans, D. A.; Scheidt, K. A.; Downey, C. W. Org. Lett. 2001, 3, 3009. 
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2.4 OUR STRATEGY 
 
In our approach towards the total synthesis of (–)-epibatidine, we had several goals in 
mind. First, we would like to make use of the metal mediated allylation reactions 
developed in our group to perform some of the carbon-carbon bond formation reactions 
for the molecule.61 The principle behind our synthetic scheme is to provide the core 
structure (7-azabicyclo[2.2.1]heptane ring) in the shortest number of steps, making 
provision for a simple and efficient multigram scale synthesis that could be applicable in 
the drug industry. The synthetic route must also be versatile, allowing easy access to 
different analogues. 
 
Our retrosynthetic analysis for (–)-epibatidine is shown in Scheme 35. The 7-
azabicyclo[2.2.1]heptane ring of 122 was envisioned to arise by an intramolecular 
nucleophilic cyclization between the amine and the electrophilic brominium-bearing 
carbon of the intermediate precursor 123.62 The latter could have come from the 
bromination reaction involving N-bromosuccinimide (NBS) and the cyclohexenylamine 
124. We planned to utilize ring-closing metathesis (RCM) on the chiral homoallylic 
amine precursor 125 using the established ruthenium (Ru) type catalysts. The homoallylic 
amine may be prepared by an In-mediated Barbier type allylation between chiral imine 
126 and 5-((E)-3-bromoprop-1-enyl)-2-chloropyridine 127.63  
_____________________________
61 For some representative ezamples, see: (a) Lin,  M.-J.; Loh, T.-P. J. Am. Chem. Soc. 2003, 125, 
13042. (b) Tan, K.-T; Chng, S.-S; Cheng, H.-S; Loh, T.-P. J. Am. Chem. Soc. 2003, 125, 2958. (c) Loh, 
T.-P; Lin, M.-J; Tan, K.-L. Tetrahedron Lett. 2003, 44, 507. (d) Loh, T.-P; Tan, K.-T; Hu, Q.-Y. 
Tetrahedron Lett. 2001, 42, 8705. (e) Loh, T.-P; Zhou, J.-R; Yin, Z. Org. Lett. 1999, 1, 1855. (f) Loh, 
T.-P; Zhou, J.-R. Tetrahedron Lett. 1999, 40, 9115. 
62 Chen, Z.-M.; Trudell, M. L. Chem. Review 1996, 96, 1179. 
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      Our experience with imine allylation suggested that the ability to control the 
stereochemistry at C1 and C2 may be related to the judicious choice of chiral auxiliary 
used.64 The chiral imine can be easily prepared through condensation from commercially 
available reagents. We see the commercially cheap methyl-6-chloronicotinate 128 as the 



























































Scheme 35. Our general synthetic strategy. 
 _____________________________
63 For a discussion of the mechanism, see: (a) Molle, B. J. Am. Chem. Soc. 1982, 104, 348175. For 
some representative examples, see: (b) Blomberg, C.; Hartog, F. A. Synthesis 1977, 18. (c) Einhorn, C.; 
Einhorn, J.; Luche, J.-L. Synthesis 1989, 787. (d) Molander, G. Chem. Rev. 1992, 92, 29. (e) Cintas, P. 
Synthesis 1992, 248. (f) Curran, D. P.; Fevig, T. L.; Jasperse, C. P.; Totleben, M. J. Synlett 1992, 943. 
(g) Li, C.-J. Chem. Rev. 1993, 93, 2023. 
64 (a) Huang, J.-M; Xu, K.-C; Loh, T.-P. Synthesis-Stuttgart 2003, 5, 755. (b) Loh, T.-P; Huang, J.-M; 
Xu, K.-C; Goh, S.-H; Vittal, J. J. Tetrahedron Lett. 2000, 41, 6511. (c) Loh, T.-P; Wang, R.-B; Tan, K.-
L; Sim, K.-Y. Main Group Met. Chem. 1997, 20, 237. (d) Loh, T.-P; Ho, D. S. C; Xu, K.-C; Sim, K.-Y. 
Tetrahedron Lett. 1997, 38, 865. 
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The next section describes our progress towards the multigram scale total synthesis of 
(–)-epibatidine 122. The synthesis commences from the commercially available methyl 
chloro-nicotinate 128, by way of the homoallylic amine key intermediate 152, to give the 
advanced intermediate 153. Like most investigations in organic synthesis, we 
encountered several surprises and interesting results in our synthesis of (–)-epibatidine. 
Even though some changes were made in our synthetic strategy, subsequent 
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2.5 RESULTS AND DISCUSSION I 
 
Retrosynthetic analysis (Scheme 35) identified the commercially available methyl 6-
chloronicotinate 128 as the starting material, which undergoes reduction with NaBH4 in 
THF and MeOH (4:1) at 0 oC to provide the primary alcohol 129 in quantitative yield. 
The conversion of 129 to aldehyde 130 can be simply achieved by means of Swern 
oxidation.65 Indeed, when the primary alcohol was introduced into a stirred solution of 
oxalyl chloride, dimethyl sulfoxide and CH2Cl2 at – 78 oC, a quantitative yield of the 
desired aldehyde was obtained when the reaction mixture was further stirred in 
triethylamine.66 Aldehyde 130 then underwent a Grignard addition with vinylmagnesium 
bromide 131 in THF at 0 oC to provide the allylic alcohol 132 in 96% yield. The initial 
reaction conditions for the bromination procedure of the allylic alcohol 132 proved 
difficult in view of its rather low yield, leading to the adoption of a revised course of 
action to circumvent this problem. In the modified method, more solvent was used (from 
0.3M to 0.1M) and this adaptation furnished the desired allylic bromide 127 with up to 
98% yield (Scheme 36). With a practical synthesis of 5-((E)-3-bromoprop-1-enyl)-2-
chloropyridine 127 realized (four steps, 97% yield from methyl 6-chloronicotinate 128), 
our studies entered into the next synthetic phase. 
 
_____________________________
65 Mancuso, A. J.; Swern, D. Synthesis 1981, 165. 
66 Pandey, G.; Bagul, T. D.; Sahoo, A. K. J. Org. Chem. 1998, 63, 760. 
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Scheme 36. Preparation of 5-((E)-3-bromoprop-1-enyl)-2-chloropyridine 127. 
 
It is well documented that amino acid methyl esters are cheap and efficient chiral 
auxiliaries for the formation of chiral imines.67 For that reason, a number of chiral 
auxiliaries, including a non-amino acid methyl ester type, were put to the test (Table 10). 
The optically pure amino acid methyl esters (134 and 135) were easily obtained by 
dissolving their hydrochloride salt form in saturated Na2CO3 and followed by extraction 
with diethyl ether. After drying and removal of solvent, the crude amines were used for 
subsequent reactions without any purification.  
 
____________________________
67 For an excellent review, see: Yamamoto, Y.; Asao, N. Chem. Rev. 1993, 93, 2207. For a list of 
representative examples, see: (a) Yamamoto, Y.; Nishii, S.; Maruyama, K.; Komatsu, T.; Ito, W. J. Am. 
Chem. Soc. 1986, 108, 7778. (b) Yamamoto, Y.; Ito, W. Tetrahedron 1988, 44, 5415. (c) Neumann, W.; 
Rogic, M. M.; Dunn, T. J. Tetrahedron Lett. 1991, 32, 5865. (d) Beuchet, P.; Le Martec, N.; Mosset, P. 
Tetrahedron Lett. 1992, 33, 5959. (d) Wu, M.-J.; Pridgen, L. N. Synlett 1990, 636. (e) We, M.-J.; 
Pridgen, L. N. J. Org. Chem. 1991, 56, 1340. (f) Dembélé, Y. A.; Belaud, C.; Villiéras, J. Tetrahedron: 
Asymmetry 1992, 3, 511. (g) Tanaka, H.; Inoue, K.; Pokorski, U.; Taniguchi, M.; Torii, S. Tetrahedron 
Lett. 1990, 31, 3023. (h) Dembélé, Y. A.; Belaud, C.; Hitchcock, P.; Villiéras, J. Tetrahedron: 
Asymmetry 1992, 3, 351. (i) Giammaruco, M.; Taddei, M.; Ulivi, P. Tetrahedron Lett. 1993, 34, 3635. 
(j) Bhuyan, P. J.; Prajapati, D.; Sandhu, J. Tetrahedron Lett. 1993, 34, 7975. (k) Laschat, S.; Kunz, H. 
Synlett 1990, 51. (l) Laschat, S.; Kunz, H. J. Org. Chem. 1991, 56, 5883. (m) Alvaro, G.; Martelli, G.; 
Savoia, D. J. Chem. Soc. Perkins Trans. 1998, 1, 777. (n) Bocoum, A.; Savoia, D.; Umani-Ronchi, A. J. 
Chem. Soc., Chem Commun. 1993, 1542. (o) Razavi, H.; Polt, R. J. Org. Chem. 2000, 65, 5693. 
Multigram Synthesis of (−)-Epibatidine 
62 









133 134 - 136 137 - 139  
 














139 4 87 
a1.0 equivalent of aldehyde was allowed to condense with 1.0 equivalent of chiral 
amine.  bCrude yield; which was determined by 1H NMR. 
 
The chiral imines were formed by stirring a mixture of the commercially available 
aldehyde 13368 and the amine in CH2Cl2 at 0 oC for up to 6 h. The crude imines were 
used for subsequent reactions without any purification. We next evaluated a number of 
substrates in the imine allylation pathway. Imines formed from (S)-phenylglycine methyl 
ester 134, (S)-valine methyl ester 135 and (S)-methylbenzylamine 139 were assessed. As 
revealed in Table 12, various allylation conditions on imine 139 were not successful 
(Table 12, entries 9, 10, 11 and 12). Despite the failure to attain the desired product using 
In mediated conditions (using DMF and MeOH as the solvent medium), the reactions 
using Zn/THF on the imine 138 did furnish the desired homoallylic amine product (Table 
12, entry 8). (S)-Phenylglycine methyl ester 134 appears to be the better chiral auxiliary 
in this case, providing a satisfactory 59% yield and a diastereoselectivity ratio (dr) of 
70:30 (Table 12, entry 4).69  
 
____________________________
68 cis-Hept-4-enal 133 was used initially in this study as pent-4-enal 150 was not available at that point 
of research. 
69 The absolute configuration was determined by X-ray crystallographic analysis of an intermediate at a 
later stage. 
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Entry Imines (R) Conditions Yield (140:141)a 
1 In, DMF, 0 oC - 
2 In, MeOH, 0 oC - 






Zn, THF, 0 oC 59% (70:30) 
5 In, DMF, 0 oC - 
6 In, MeOH, 0 oC - 




 Zn, THF, 0 oC 29% (65:35) 
9 In, DMF, 0 oC - 
10 In, MeOH, 0 oC - 






Zn, THF, 0 oC - 
aDiastereoselectivity ratio (dr) based on the only 2 isomers obtained from the reaction, 
determined by 1H NMR and 13C NMR. 
 
With (S)-phenylglycine methyl ester 134 being the chosen chiral auxiliary, we went 
on to investigate the allylation procedure in detail. It is noteworthy to point out that 
several side products were formed during the course of the Zn mediated allylation of 
imine 137 in THF (Scheme 38). One of them, the aldehyde side product 142, is believed 
to arise from the allylation of the aldehyde, which had probably been “cleaved off” from 
the imine. Even though detailed mechanistic studies were not performed, we postulate 
that the source of the protons needed for this kind of hydrolysis reaction would come 
from the HBr produced by the allylation reaction with the allylic bromide 127.  
 




























Scheme 38. Plausible explanation of the formation of 142. 
 
In order to circumvent this problem, the chiral amine 134 was added in excess for the 
formation of the imine 137. We postulated that the excess amine would serve as a base to 
neutralize the undesired acidic protons in the reaction. As revealed in Table 13, the 
excess chiral amine added proved to be the key factor in the reconsumption of the 
undesired aldehyde. Optimum conditions were obtained when a 0.5 M solution of the 
allylic bromide 127 in THF was slowly added a stirred suspension of Zn, imine 137 
(formed from 1.0 equivalent of aldehyde with 1.5 equivalent of chiral amine 134) and 
THF at 0 oC (Table 13, entry 3). 
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Imine 137 Entry 
Aldehyde (equiv) Amine (equiv) 
127 Yield (143:144)a 
1 1.0 1.0 Neat (solid) 59% (70:30) 
2 1.0 1.2 0.5 M solutionb 20% (95:5) 
3 1.0 1.5 0.5 M solutionb 75% (87:13) 
aDiastereoselectivity ratios were based on the 2 isomers isolated from the reaction. b127 was prepared as a 
0.5 M solution in THF. 
 
Because of the availability of efficient ruthenium and molybdenum catalysts, the 
olefin metathesis reaction has emerged as a new and powerful method in organic 
chemistry.70 More importantly, ring-closing metathesis (RCM) is widely recognized as a 
powerful method for creating heterocycles, constrained peptides, and complex natural 
products.71 Schrock’s molybdenum based catalyst 145 is characterized by its very high 
activity, however, its sensitivity towards air and moisture requires handling under 
rigorously dried solvents, under an inert atmosphere.72 In contrast, the Grubbs’ ruthenium 
catalysts 14673 and 14774 have been used most extensively in RCM because of their high 
reactivity, air-stability, and remarkable functional group tolerance (Figure 9).  
 _____________________________70 For a general review, see: (a) Grubbs, R. H.; Miller, S. J.; Fu, G. C. Acc. Chem. Res. 1995, 28, 446. 
(b) Grubbs, R. H.; Chang, S. Tetrahedron 1998, 54, 4413. (c) Fürstner, A. Angew. Chem., Int. Ed. 2000, 
39, 3012-3043. 
71 For excellent reviews on the RCM with nitrogen-containing compounds, see: (a) Deiters, A.; Martin, 
S. F. Chem. Rev. 2004, 104, 2199. (b) Pandit, U. K.; Overkleeft, H. S.; Borer, B. C.; Bieräugel, H. Eur. 
J. Org. Chem. 1999, 959. (c) Philips, A. J.; Abell, A. D. Aldrichimica Acta 1999, 32, 75.  
72 For some examples, see: (a) Schuster, M.; Blechert, S. Angew. Chem. 1997, 109, 2114. (b) Schuster, 
M.; Blechert, S. Angew. Chem. Int. Ed. Engl. 1997, 36, 2036. 
73 Nguyen, S. T.; Grubbs, R. H. J. Am. Chem. Soc. 1993, 115, 9858. 
74 Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999, 1, 953. 
























Figure 9. Schrock’s molybdenum and Grubbs’ ruthenium catalysts. 
 
While amino acids and amide type functional groups have enjoyed much success,75 
alkylated amines are typically incompatible with RCM owing to catalyst inhibition by the 
basic nitrogen.76 In our case, the scenario is made worse with the presence of another 
pyridine-type functional group. Since it was considered desirable to avoid the use of 
protecting group strategies during the assembly of the 7-azabicyclo[2.2.1]heptane ring, 
we first examined the cyclization of the homoallylic amine 148 without the presence of 
other addictives.  
 
_____________________________
75 For selective examples employing RCM for total synthesis of natural products, see: (a) Fürstner, A.; 
Müller, T. J. Am. Chem. Soc. 1999, 121, 7814. (b) Ono, K.; Nakagawa, M.; Nishida, A. Angew. 
Chemie. Int. Ed. 2004, 43, 2020. (c) Kim, S.; Lee, T.; Lee, E.; Tan, G.-J.; Lee, S. K.; Kim, D. J. Org. 
Chem. 2004, 69, 3144. (d) Davis, A. S.; Pyne, S. G.; Skelton, B. W.; White, A. H. J. Org. Chem. 2004, 
69, 3139. (e) Fürstner, A.; Langemann, K. J. Org. Chem. 1996, 61, 8746. (f) Felpin, F. X.; Boubekeur, 
K.; Lebreton, J. Eur. J. Org. Chem. 2003, 23, 4518. (g) Honda, T.; Namiki, H.; Kaneda, K.; Mizutani, 
H. Org. Lett. 2004, 6, 87. (h) Wang, X.; Porco, Jr. J. A. J. Am. Chem. Soc. 2003, 125, 6040. (i) Gaul, C.; 
Njardarson, J. T.; Danishefsky, S. J. J. Am. Chem. Soc. 2003, 125, 6042. (j) Schaudt, M.; Blechert, S. J. 
Org. Chem. 2003, 68, 2913. (k) Lindsay, K. B.; Pyne, S. G. J. Org. Chem. 2002, 67, 7774. (l) 
Humphrey, J. M.; Liao, Y.-S.; Ali, A.; Rein, T.; Wong, Y.-L.; Chen, H.-J.; Courtney, A. K.; Martin, S. 
F. J. Am. Chem. Soc. 2002, 124, 8584. (m) Fellows, I. M.; Kaelin, Jr. D. E.; Martin, S. F. J. Am. Chem. 
Soc. 2000, 122, 10781. (n) Fürstner, A.; Thiel, O. R. J. Org. Chem. 2000, 65, 1738. (o) Cook, G. R.; 
Shanker, P. S.; Peterson, S. L. Org. Lett. 1999, 1, 615. (p) Wallace, D. J.; Cowden, C. J.; Kennedy, D. 
J.; Ashwood, M. S.; Cottrell, I. F.; Dolling, U.-H. Tetrahedron Lett. 2000, 41, 2027. (q) Voigtmann, U.; 
Blerchet, S. Org. Lett. 2000, 2, 3971. (r) Maldaner, A. O.; Pilli, A. A. Tetrahedron Lett. 2000, 41, 7843. 
76 (a) Fürstner, A.; Langemann, K. Synthesis 1997, 792. (b) Wright, D. L.; Schulte II, J. P.; Page, M. A. 
Org. Lett. 2000, 2, 1847. 
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      The branched homoallylic amine 148 was submitted to RCM using Grubbs’ catalysts 
145 and 146 in various amounts and different reaction conditions. Based on classical 
RCM conditions, two reaction solvents for the reaction were chosen, CH2Cl2 and toluene. 
The results are presented in Table 14.  
 
RCM using catalyst 145 yielded no desired product (Table 14, entry 1). Exposure to 
catalyst 146 under reflux conditions when employing either toluene or CH2Cl2 as reaction 
solvent provided unsatisfactory results (Table 14, entries 1 and 2). Even though it has 
been demonstrated that ammonium salts can tolerate the ruthenium catalyst 146, the 
introduction of Brönsted and Lewis acids such as pTsOH and TiCl4 respectively, 
complicated the results further (Table 14, entries 3 and 5). Nevertheless, the desired 
cyclohexenylamine product 149 was isolated in 54% yield when the much robust catalyst 
146 was used (Table 13, entry 7). The homoallylic amine was cyclized productively 





77 For an example on the effects of concentration in some RCM reactions, see: Yamamoto, K.; Biswas, 
K.; Gaul, C.; Danishefsky, S. J. Tetrahedron Lett. 2003, 44, 3297. 
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Entry Cat. (mol %) Solvent Temp. (oC) Conditions Time (h) Yield (%) 
1 145 (10) CH2Cl2 25 - >24 - 
2 146 (20) CH2Cl2 40 - >24 15 
3 146 (20) CH2Cl2 25 pTSAb >24 -c 
4 146 (20) CH2Cl2 25 Sonicate 1 Trace 
5 146 (20) CH2Cl2 25 TiCl4d >24 - 
6 146 (10) Toluene 110 - >24 <10 
7 147 (20) CH2Cl2 25 - 7 54e (69)f 
8 147 (10) CH2Cl2 25 - 6 88g 
aA mixture of 2 isomers were used for RCM and the dr was maintained based on 1H NMR and 13C NMR of 
the products obtained. b1.0 equivalent of pTsOH added. cNo product was observed even when 2.0 
equivalent of pTSA was added. d0.2 equivalent of TiCL4 added. eSolvent concentration at 0.1 M. fSolvent 
concentration at 0.01 M. gReaction was carried out using 2 sequential loadings of 147. 
 
The yield was greatly improved (88%) when the catalyst was loaded on two separate 
occasions at about 0.5 h apart and with only a total loading of 10 mol % (Table 14, entry 
8). It was observed that the RCM could be effected without blocking the secondary 
nitrogen although these transformations would ultimately involve higher catalyst loading 
and longer reaction times than typical metathesis reactions. 
 
It is well documented that monosubstituted alkenes readily give the desired RCM 
product in excellent yields.70 To test this theory, the aldehyde 150 was used for the 
synthesis of the homoallylic amine 152 (Scheme 39). The desired homoallylic amine 152 
was isolated in excellent yields as a single isomer (93% yield). Even though mechanistic 
data was not available, we postulate that this improved selectivity, compared to chiral 
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imine 137 (Table 13, entry 3), was due to the excess chiral amine (0.5 equiv more) in the 
reaction mixture. The subsequent RCM went very smoothly to afford the desired 













































Multigram Synthesis of (−)-Epibatidine 
70 
2.5.1 ASYMMETRIC SYNTHESIS OF C-ALIPHATIC HOMOALLYLIC AMINES 
AND BIOLOGICALLY IMPORTANT CYCLOHEXENYLAMINE ANALOGS 
 
Given the success of the asymmetric synthesis of the homoallylic amine 152 and 
the cyclohexenylamine 153, we next explored their generality in order to test the viability 
of this strategy.78 Our initial studies on the Barbier tyope allylation revealed that a 
relatively high asymmetric induction can be accomplished using a variety of allylic 
bromides (Table 15). When cyclohexanecarbaldehyde was used as the corresponding 
aldehyde moiety for the construction of the chiral imine 37, the reactions with allylic 
bromides generally provide satisfactory yields. In fact, crotylation and prenylation of the 
chiral imine 154 provided excellent yields with good selectivities and syn/anti ratios 
(Table 15, entries 2 and 3). As expected, this Zn mediated allylation using THF as the 
solvent of choice gave the desired homoallylic amines derived from 3-phenylpropanal, 
although in modest yields (for allyl and metallyl bromides) except when prenyl and 
cinnamyl bromides were used (Table 14, entries 7 and 8). Nonetheless, good 











78 (a) Maier, M. E.; Lapeva, T. Synlett 1998, 891. (b) Quirante, J.; Vila, X.; Escolano, C.; Bonjoch, J. J. 
Org. Chem. 2002, 67, 2323. 
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R = c-C6H5 (154)
       PhCH2CH2  (155)
       CH2=CHCH2CH2 (151)
       CH3CH2CH=CHCH2CH2 (137)  
 
Entry R R1 R2 R3 Yield dr (S,R:S,S)b syn:antic 
1 c-C6H11 H H H 60 12:88 - 
2 c-C6H11 H CH3 H 94 80:20 75:25e 
3 c-C6H11 H CH3 CH3 92 89:11 - 
4 c-C6H11 H Ph H 65 88:12 82:18d 
5 c-C6H11 CH3 H H 65 11:89 - 
6 PhCH2CH2 H H H 20 18:82 - 
7 PhCH2CH2 H CH3 H 39 78:22 79:21e 
8 PhCH2CH2 H CH3 CH3 63 89:11 - 
9 PhCH2CH2 H Ph H 50 88:12 90:10d 
10 PhCH2CH2 CH3 H H 20 10:90 - 
11 CH2=CHCH2CH2 H H H 26 15:85 - 
12 CH2=CHCH2CH2 H CH3 H 52 75:25 86:14e 
13 CH2=CHCH2CH2 H CH3 CH3 63 89:11 - 
14 CH2=CHCH2CH2 H Ph H 55 10:90 95:5d 
15 CH2=CHCH2CH2 CH3 H H 25 35:65 - 
16 CH3CH2CH=CHCH2CH2 H H H 25 13:87 - 
17 CH3CH2CH=CHCH2CH2 H CH3 H 45 80:20 81:19d 
18 CH3CH2CH=CHCH2CH2 H CH3 CH3 92 90:10 - 
19 CH3CH2CH=CHCH2CH2 H Ph H 59 10:90 88:12f 
20 CH3CH2CH=CHCH2CH2 CH3 H H 15 27:73 - 
aAllylic bromides used (crotyl and cinnamyl) were predominantly trans. bDetermined by 1H NMR and 13C 
NMR; unless in some cases where the diastereomers can be well separated by flash column chromatography. 
cDetermined by 1H NMR and 13C NMR; syn/anti ratios refer to only the 2 major diastereomers. dTraces of linear 
homoallylic amines were isolated. eNo linear homoallylic amine was observed. 
 
The allylation of chiral imine 151 with pent-4-enal as the aldehyde, proceeded 
smoothly and afforded some of the desired homoallylic amines with relatively good 
yields, high diastereoselectivities and excellent syn/anti ratios. Prenyl bromide proved 
again to be the allylic bromide of choice when it gave the desired chiral homoallylic 
amine with 72% yield and 78% de (Table 15, entry 13). Though the reactions with crotyl 
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and cinnamyl bromides both gave slightly lower yields, fine syn/anti ratios were obtained 
(Table 15, entries 12 and 14). We next examined the ability of this methodology to cis-
hept-4-enal. Considerable variation of allylic bromides is possible without any significant 
loss in efficiency of diastereocontrol (up to 92% yield and 80% de). Besides, a relatively 
high ratio of syn adducts were obtained in all cases. It is interesting to note that the 
reactions of cinnamyl bromide with chiral imines 154 and 155 resulted in trace amount of 
the linear homoallylic amine adducts, but however, when the same bromide was injected 
into either chiral imines 137 or 151, no such side products were observed. 
 
The homoallylic amines synthesized from 151 in Table 15 were then converted to the 
corresponding cyclohexenylamines using the RCM approach.78 These chiral 
cyclohexenylamines are important building blocks for several alkaloids such as sarain 
A,79 aphanorphine,80 hetisine,81 and some of the Securinega group.82 More interestingly, 
some of these cyclohexenylamines, in the presence of inorganic pyrophosphate, have 












79 (a) Denhart, D. J.; Griffith, D. A.; Heathcock, C. H. J. Org. Chem. 1998, 63, 9616. (b) Irie, O.; 
Samizu, K.; Henry, J. R.; Weinreb, S. M. J. Org. Chem. 1999, 64, 587. (c) Downham, R.; Ng, F.-W.; 
Overman, L. E.; J. Org. Chem. 1998, 63, 8096. (d) Sung, M. J.; Lee. H. I.; Chong, Y.; Cha, J. K. Org. 
Lett. 1999, 1, 2017. 
80 (a) Tamura, O.; Yanagimachi, T.; Kobayashi, T.; Ishibashi, H. Org. Lett. 2001, 3, 2427, and 
references cited therein. 
81 Kwak, Y.-S.; Winkler, J. D. J. Am. Chem. Soc. 2001, 123, 7429. 
82 Liras, S.; Davoren, J. E.; Bordner, J. Org. Lett. 2001, 3, 703, and references cited therein 
83 (a) Mcgready, P.; Pyun, H.-J.; Coates, R. M.; Croteau, R. Arch. Biochem. Biophys. 1992, 299, 63. (b) 
Cane, D. E.; Yang, G.-Y.; Coates, R. M. Pyun, H.-J.; Hohm, T. M. J. Org. Chem. 1992, 57, 3454. 
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As revealed in Table 16, the homoallylic amines underwent ring-closing metathesis in 
excellent yields. These ring-closing reactions were performed by stirring a 
dichloromethane solution of the homoallylic amines in the presence of 10 mol % of the 
catalyst 147 for up to 12 hours. In all cases, the cyclohexenylamines derivatives can be 
obtained in very good yields.76 It is important to note that most of the homoallylic amines 
needed reflux conditions to allow full depletion. However, the cyclohexenylamine 
product 158 was obtained in excellent yield (92 %) with 10 mol% of the catalyst stirring 
at ambient temperature (Table 16, entry 3). 
 





















156 - 160  
 
Entry R1 R2 R3 Temp. (o C) Time (h) Product Yield (%) 
1 H H H 40 6 156 88 
2 H CH3 H 40 6 157 84 
3 H CH3 CH3 25 12 158 92 
4 H H H 40 6 159 86 
5 CH3 H H 40 6 160 78b 
aOnly the major (S,R)-diastereomer was allowed to undergo ring-closing metathesis. b15 mol % of 
the catalyst was used. 
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2.6 RESULTS AND DISCUSSION II 
 
With relatively large quantities of cyclohexenylamine 153 in hand, attention was 
turned to the synthesis of the 3-membered ring brominium intermediate 123 which will 
most probably undergo in situ intramolecular cyclization with the presence of the amine 
nucleophile. As reported by Corey et al., the unsaturated amide 161 could serve as a 
useful intermediate for the synthesis of azabicyclo[3.3.1]heptane analogues of epibatidine 
(Scheme 40).52c Reaction of 161 with N-bromosuccinimide in acetic acid at 0 – 23 oC for 










161 162  
Scheme 40. Novel intramolecular cyclization reported by Corey et al. in 1993. 
 
Upon attempting to brominate the cyclohexenylamine 153 under similar conditions 
described above, we observed no desired product 163 and instead, trace amount of 
dibrominated product 164 was isolated. As revealed in Table 17, bromination of 153 in 
other commonly known solvents proved futile, despite formation of trace amounts of 164 
in chlorinated solvents (entries 2 and 3). 
 
Our revised plan towards the construction of the 7-azabicyclo[2.2.1]heptane ring then 
turned to traditional bromination. We envisioned that with the desired dibromo isomer 
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formed, where the amino group and bromide atom are trans with respect to each other, 
intramolecular cyclization could arise. Bromination of 153 under various selected 
conditions is revealed in Table 17.  
 



































Cyclized Product Dibrominated Product Entry Conditions T (oC) 
Yield (%) Yield (%) (164:165) 
1 NBS, AcOHc 0 - -b 
2 NBS, CH2Cl2 − 78 - <10 (-) 
3 NBS, Et4N+Br-, CH2Cl2 − 78 - 53 (85:15) 
4 Br2, CH2Cl2 − 78 - 65 (>99:<1) 
5 Br2, Et4N+Br-, CH2Cl2 0 - 78 (93:7) 
6 Br2, Et4N+Br-, CH2Cl2c − 78 - 92 (66:34) 
aFor NBS reactions: they were performed in AcOH (10 mL) where NBS (2.4 mmol) was added into 153 (2 




A single-crystal X-ray structure of 164 confirmed that the bromination had occurred 
in the undesired fashion for further intramolecular cyclization, with the amino group and 
bromide atom being cis with respect to each other (Figure 10). Based on this 
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crystallographic analysis and simple retrosynthetic study, the absolute configurations of 
all the preceding intermediates were established. 
 
 
Figure 10. Single-crystal X-ray structure of 164. 
 
Although definitive mechanistic data has not been obtained, one possibility, outlined 
in Scheme 41, appears to be reasonable. The unsuccessful attempt using NBS in 
chlorinated solvents concluded that no nucleophilic attack of the amino group on the 
electrophilic carbon had taken place, that will eventually lead to the 7-
azabicyclo[2.2.1]heptane ring of 163. The formation of the 2 dibromo diastereomers 164 
and 165 suggested that the 3-membered brominium ion did formed, probably in the state 
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of intermediate 167. Subsequent ring opening by the bromide nucleophile (from Et4N+Br-) 







































Scheme 41. Proposed mechanism for the bromination (Br2/NBS) of Cyclohexenylamine 153. 
 
Through systematic investigations, the optimum conditions to afford the dibromo 
isomer with the desired trans stereochemistry required more dilute conditions to be added 
and in addition, the Br2 (further diluted with CH2Cl2) had to be introduced very slowly 
into the stirred mixture of 153 at – 78 oC (Table 17, entry 6). Under these optimized 
reaction conditions, the bromination could be efficiently carried out in excellent yield (92 
%) and moderate selectivity. The 66:34 mixture of diastereomers obtained was easily 
separable by flash column chromatography, and the undesired epimer was recycled in 
quantitative yield through a reductive elimination procedure.84 According to Scheme 42, 
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the reductive elimination of the undesired epimer 164 successfully afforded the 
















Major - 164 Minor - 165
Br2, Et4N+Br-,
CH2Cl2, − 78 oC
92% (66:34)










Scheme 42. Bromination and reductive elimination pathways. 
 
With the appropriate stereochemistry of the dibromo isomer in hand, completion of 
the 7-azabicyclo[2.2.1]heptane ring has now possible and began with intramolecular 
cyclization of 165. As revealed in Table 18, treatment of 165 with tBuOK did not afford 
the desired product (entry 1), although a somewhat similar substrate had been reported to 
undergo cyclization before.52c Nevertheless, refluxing 165 in toluene provided the desired 
product in good yields (72%) with trace amount of starting material being recovered 
(conventional yield = 80%; Table 18, entry 3).54 
 
_____________________________
84 Martin J. D.; Pérez, C.; Ravelo, J. L. J. Am. Chem. Soc. 1985, 107, 516. 
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Entry Conditions Yield (%) 
1 tBuOK, THF, - 78 oC, 16 h. -a 
2 CHCl3, 60 oC, 40 h. 32b 
3 Toluene, 110 oC, 45h. 72 (80)b,c 
aIntractable mixtures were formed. bStarting material 165 was 
recovered. cConventional yield in parentheses.  
 
Further efforts towards endo-epibatidine required the nitrogen-bridged intermediate 
163 to be stirred in catalytic amount of Pd/C and excess H2 (200psi) in 
MeOH/H2O/AcOH to effect deprotection of the tertiary amine.85 However, no desired 
product was formed (Scheme 43). Another alternative was to make use of a two-step 
reduction-oxidative cleavage sequence on the chiral auxiliary.86 Reduction of 163 was 
carried out and the desired primary alcohol 168 was obtained in 58% yield, with its X-ray 
crystal structure being depicted in Figure 11. Even after experimenting with various 
reagents for oxidative cleavage, no desired product 169 was generated. Nonetheless, the 
radical dehalogenation of 163 did provide the N-protected-endo-epibatidine 170 product 
in excellent yield (95%). 
 
_____________________________
85 For some representative examples, see: (a) Gray, B. D.; Jeffs, P. W. J. Chem. Soc., Chem. Commun. 
1987, 1329. (b) ElAmin, B.; Anantharamaiah, G. G.; Royer, G. P.; Means, G. E. J. Org. Chem. 1996, 
44, 3442. 
86 For oxidative cleavage employing Pb(OAc)4, see: (a) Wu, M. J.; Pridgen, L. N. J. Org. Chem. 1991, 
56, 1341. (b) Leonard, N. J.; Rebenstorf, M. A. J. Am. Chem. Soc. 1945, 67, 49. For oxidative cleavage 
employing H5IO6, see: (c) Chang, Z.-Y.; Coates, R. M. J. Org. Chem. 1990, 55, 3475. 











































(a) Pb(OAc)4, CH2Cl2/MeOH, 0 oC; (b) H5IO6, EtNH2, MeOH/H2O, 25 oC
170
 
Scheme 43. Attempts towards the synthesis of endo-epibatidine.  
 
 
Figure 10. Single-crystal X-ray structure of 168. 
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The inability to remove the N-protecting group prompted investigation of an 
alternative. We took one step back to the dibromo 165 where it was envisioned that the 
deprotection might be feasible. Indeed, 165 was converted into the primary amine 172 by 









1. DIBAL-H, CH2Cl2, 
    0 oC, 88%
2. Pb(OAc)4, CH2Cl2/MeOH,






165 172  
Scheme 44. A two-step deprotection sequence of 165. 
 
Conversion of the primary amine 172 to the nitrogen-bridged intermediate 169 was 
probed in great detail. As revealed in Table 19, treatment of 172 with tBuOK resulted in 
intractable mixtures, regardless of the solvents used (entries 1 and 2). Although toluene 
served as an ideal solvent for reflux pertaining to intramolecular cyclization of the N-
protected 165 (Table 18, entry 3), only trace amounts of desired 169 was formed when 
the same conditions were applied for the free amine 172 (Table 19, entry 3).  
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Entry Conditions Time (day) Yield 169:173:172a (%) 
1 tBuOK, THF, − 78 oC.- 0.6 -b 
2 tBuOK, DMF, benzene, 25 oC 1 -b 
3 Toluene, 110 oC 2 <10:0:65 
4 CHCl3, 60 oC 5 42:5:40 
5 CHCl3, 90 oC 5 15:32:43 
6 CHCl3, Et3N, 60 oC 4.5 28:10:35 
7 CH2(Cl)CH2Cl, 80 oC 5 -c 
8 CH3CN, 80 oC 2 85:5:5 
9 CH3CH2CN, 95 oC 2 45:10:30 
aRecovered starting material 172. bIntractable mixtures. cNo desired product where 172 was 
quantitatively recovered.  
 
It is important to note that the dehydrobrominated product 173 was isolated when 
chlorinated solvents were used, and its yield was more prominent when the temperature 
of the reaction increased (Table 19, entries 4, 5 and 6). CH3CN became the solvent of 
choice which managed to afford 169 in an impressive yield (85% isolated) together with 
trace amounts of 173 and starting material 172 (Table 19, entry 8). Although the success 
of this intramolecular cyclization was extremely sensitive toward temperature and 
reaction time, careful monitoring by TLC allowed us to prepare the desired nitrogen-
bridged intermediate 169 in >98% yield based on recovery. 
 
With the complete 7-azabicyclo[2.2.1]heptane carbon skeleton of epibatidine now 
assembled, the task of radical dehalogenation and the final epimerization step could now 
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be addressed. Treatment of 169 with excess Bu3SnH, catalytic amount of 
1,1’−αzobis(cyclohexanecarbonitrile) [ACCN] in benzene under reflux conditions afford 
the desired endo-epibatidine 174 in quantitative yield.87,88  
 
Our synthesis had now arrived at a late-stage intermediate similar to those featured in 
published syntheses of (–)-epibatidine and consequently, it was hoped that similar 
reaction conditions would provide success.52f,52t,56 All that remained was epimerization of 
the α-pyridyl proton of 174 to give the thermodynamically more stable exo-isomer of 
epibatidine 122.  While following very closely to Professor Szántay’s patented work on 
the epimerization procedure, we managed to obtain 122 in only 35% yield after refluxing 
the reaction mixture in tBuOK/ tBuOH for about 8 days.89 However, when tBuOK was 
added systematically over 4 days, the yield went up to 58% with 30% of the endo isomer 
















   ACCN, benzene,
    reflux, 100%
2. KOtBu, tBuOH,





122: (−)-epibatidine172 169  
Scheme 45. Synthesis of exo-epibatidine. 
 
_____________________________
87 1,1’-azobis(cyclohexanecarbonitrile) [ACCN], a more efficient radical initiator than AIBN, see: 
Keck, G. E.; Burnett, D. A. J. Org. Chem. 1987, 52, 2958. 
88 Another rationale for the replacement was that AIBN was not allowed to be shipped outside 
America/Europe/Japan anymore for security reasons. 
89 Szántay, C. U.S. Patent 5 545 741, 1996; Tetrahedron 1996, 52, 11053. 
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      The structure determination of 122 was accomplished by NMR studies and the 1H and 
13C NMR data are essentially identical to that documented by Evans et al.60 With the 
successful preparation of 122, a total synthesis of (–)-epibatidine was completed. 
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2.7 ATTEMPTS TO REFINE SYNTHETIC ROUTE 
 
To base our design on an epimerization as the last step in the synthesis was initially 
not on the agenda. Even though the Zn mediated allylation of the chiral imine 151 
managed to afford the homoallylic amine 152 with the desired absolute stereochemistry 
at C1, its syn-selectivity was not preferred. It is evident that with the trans relative 
stereochemistry, the late stage epimerization procedure would be omitted. 
 
This plan was probed by allowing the chiral imine 151, to react with the allylic 
bromide 127 under different reaction conditions. As revealed in Table 20, the 
introduction of several Lewis acids to “scramble” the selectivity did not provide 
satisfactory results (entries 1, 4 and 5), except for entry 6, where Et2AlCl seems to work 
with In metal. However, the moderate selectivity towards the anti isomer and the 
relatively low yield of the reaction makes this method unattractive for further 
investigation. 
 
Apparently, temperature is not a critical factor in controlling the relative 
stereochemistry of this allylation procedure (Table 20, entries 2 and 3). When gallium 
(Ga) was employed, no desired product was seen by TLC (Table 20, entries 7 and 8).  
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Entry Conditions Yield (syn:anti) 
1 Zn, THF, AgOTf,a 0 oC Trace (-) 
2 Zn, THF, reflux 64% (88:12) 
3 Zn, THF, − 78 oC 62% (>99:<1) 
4 In, DMF, La(OTf)3a, − 78 oC - 
5 In, DMF, In(OTf)3a, − 78 oC - 
6 In, DMF, Et2AlCl,a – 78 oC 33% (83:17) 
7 Ga, THF, 0 oC - 
8 Ga, MeOH, 0 oC - 
a0.1 equivalent was employed. 
 
Nevertheless, the minor product 176, initially assumed as the anti isomer, was 
brought forward to the bromination procedure after the RCM. To our dismay, the X-ray 
crystal structure of the minor brominated product 179 showed through retrosynthetic 
analysis that this minor product 176 possesses a syn stereochemistry (Scheme 46). 
 
















































Scheme 46. Synthesis and X-ray crystal structure of 179. 
 
A common feature of the α-amino acid esters as auxiliaries is the presence of a 
second heteroatom that is capable of rigidifying the transition state of the 1,2-addtion 
through chelation.92 This is also referred to as “chelation control”.93 Based on the 
absolute stereochemistry of 152 obtained, we postulate that the two heteroatoms of the 
(S)-phenylglycine methyl ester chelate with the zinc atom of the allylzinc reagent to form 
a five-membered ring. Simultaneously, a six-membered chair-like transition state is 
formed from the allylic system and the C=N double bond of the imine. The 1,2-addition 
proceeds in a concerted fashion by an allylic rearrangement (Scheme 47). 
 ______________________________ 
92 Juaristi, E.; Leon-Romo, J. L.; Reyes, A.; Escalante, J. Tetrahedron: Asymmetry 1999, 10, 2441. 
93 Neuman, W. L.; Rogic, M. M.; Dunn, T. J. Tetrahedron Lett. 1991, 32, 5865. 










































Scheme 47. Chelation-controlled addition of the allylic bromide 127 to chiral imine 151. 
 
The major homoallylic amine (mostly obtained as only a single isomer) probably 
formed from transition state 181 where the si-face 1,2-addition is preferred. With the 
pseudo-axial conformation of the R group, the less preferred transition state 180 will 
result in the minor isomer 176. It is evident from these transition states that having the 
chloronicotinyl group at the pseudo-axial position, instead of the pseudo-equatorial one 
as shown in Scheme 47, would probably give rise to the desired anti isomer.  
 
Efforts were then directed towards the synthesis of the corresponding 5-((Z)-3-
bromoprop-1-enyl)-2-chloropyridine 186. As revealed in Scheme 48, 5-((Z)-3-
bromoprop-1-enyl)-2-chloropyridine 186 was synthesized through a short 3 steps 
sequence. To our disappointment, no desired homoallylic amine was formed when 186 
was subjected to our optimized Zn mediated allylation conditions. 














































Scheme 48. Synthesis of 5-((Z)-3-bromoprop-1-enyl)-2-chloropyridine 186 and subsequent 
allylation. 
 
Taking a closer look at the transition state 181, we realized that if a bulky substituent 
like Br was to be placed at C2, the chloronicotinyl group perhaps will be forced to adopt 
a pseudo-axial position whereby the desired anti isomer 187 might preferentially formed. 
This plan was then probed by a 5 steps synthesis of allylic bromide 194/195, from the 
available starting material 130 (Scheme 49).  
 





































































Scheme 51. Unsuccessful attempt towards the synthesis of 197. 
 
The allylation of the chiral imine 151 with the two geometric dibromo allylic 
bromides 194 and 195 did not give any desired product, even when the reactions 
conditions were altered.94 Even though mechanistic data is not available, we believe that 
the dibromo allylic bromide is too bulky for the chelation to occur. 
 
We turned our attention to the bromination sequence. With the bromination occurring 
in an undesired fashion, whereby the major isomer is stereochemically not suitable for 
further intramolecular cyclization, we postulated that if the chiral auxiliary was removed 
before this procedure, then the selectivity might be reversed. Hence, the cyclohexenyl 
amine 153 underwent a two-step deprotection sequence to afford the primary amine 199 
with an overall yield of 43%.  
______________________________ 
94 Reflux condition, sonication and addition of Lewis acids [La(OTf)3] were in vain. 
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Unfortunately, bromination of 199 seemed rather complicated (Scheme 50). The 
reaction produced some intractable mixtures with traces of starting material 199 
recovered. Nevertheless, the bromination proceeded with a yield of 72% and a selectivity 









    CH2Cl2,
    0 oC, 63%
2. Pb(OAc)4,
    CH2Cl2/MeOH,




















200: Major 172: Minor
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In summary, a short, practical and large scale process has been developed for the 
synthesis of (–)-epibatidine 122 from commercially available starting materials using 
mild and easily controlled reactions (Scheme 51).90 There are several significant features 
in this synthetic route: (1) the synthesis of (–)-epibatidine requires only a total of 12 steps 
and delivers the alkaloid with a 12% yield over the longest linear sequence; (2) both 
enantiomers of epibatidine can be obtained by simply switching the chiral auxiliary 134; 
(3) the facile method of obtaining enantiomerically pure cyclohexenylamines and the first 
RCM of unprotected amines have been achieved; (4) the bottleneck of the synthesis, the 
bromination procedure, was overcame by recycling the undesired 164 to 153 through a 
reductive elimination of 164; (5) the entire synthetic route is straightforward and 
convenient for gram scale synthesis.  
______________________________ 
90 Lee, C. L. K.; Loh, T. P. Gram Scale Synthesis of (−)-Epibatidine. Submitted for publication.  








































   CH2Cl2, 
    0 oC, 88%
2. Pb(OAc)4, 
   CH2Cl2/MeOH,














    MeOH, 0 oC. quant.
2. (COCl)2, DMSO, Et3N,
    CH2Cl2, −78 oC. quant.
1.                   131
    THF, 0 oC. 94%
2. PBr3,


















   ACCN, benzene,
    reflux. quant.
2. KOtBu, tBuOH,
















Scheme 51. Total synthesis of (−)-epibatidine. 
 
Continuing efforts in our laboratory have the goal of further refining our synthetic 
route such that we may attain multigram quantities of epibatidine analogs, thereby aiding 
meaningful in vivo studies with this intriguing alkaloid. 
 
Preliminary investigations of several nitrogen-bridged intermediates (163, 168, 169, 
170 and 173), endo-(–)-epibatidine and (–)-epibatidine itself have all shown exciting 
biological activities on zebra fish embryos. More interesting results on the phenotype 
activities of these compounds are forthcoming. 
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Moreover, we have successfully described an efficient allylation of chiral C-aliphatic 
imines, affording the desired aliphatic homoallylic amines in high diastereoselectivities 
(up to 80% de).91 This methodology has enabled the preparation of a larger variety of 
chiral C-aliphatic homoallylic amines, including those inaccessible by conventional 
means. The simple synthesis of biologically important cyclohexenylamines by ring-
closing metathesis reaction has also been demonstrated. This course offers a valuable 
option to the Diels-Alder strategy to cyclohexenes with an electon donating substituent in 
the homoallylic position. The combination of the ring-closing metathesis reaction with 




























Up to 94% yield; 80% de  
Scheme 52. Asymmetric synthesis of C-aliphatic homoallylic alcohols and biologically 





91 Lee, C. L. K.; Ling, H. Y.; Loh, T. P. Asymmetric Synthesis of C-Aliphatic Homoallylic alcohols 
and Biologically Important Cyclohexenylamine Analogs. J. Org. Chem. 2004, 69, 7787. 
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2.9 FUTURE WORK 
 
Having achieved the total synthesis of (–)-epibatidine on a multigram scale, the next 
immediate target in our synthetic exploration currently focuses on the optimization of 
certain reaction conditions and overcoming certain inherent limitations. In the Zn-
mediated allylation of the chiral imine 151, the resultant syn-homoallylic amine 152 
(Scheme 39) was isolated as a single isomer. Undoubtedly, having the anti-homoallylic 
amine 187 will avoid the final epimerization procedure (Scheme 53). Moreover, we 
strongly believe that with the cis-cyclohexenylamine 187 would probably afford the 
desired 202 as the major diastereomer. Besides reducing the overall synthetic route by 






















































Scheme 53. Proposed strategy to shorten the overall synthetic route. 
 
Last of all, we have another much shorter and elegant synthetic strategy in mind. As 
shown in Scheme 54, the key towards the proposed synthetic route relies on the 
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intramolecular cyclization and the sp2 – sp3 coupling pathways since similar substrates of 
the homoallylic amine 207 and the cyclohexenylamine 206 had been mentioned before in 



























































Scheme 54. A much shorter and elegant strategy towards (–)-epibatidine. 
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The recent communication by Nakamura et al. on the iron-catalyzed cross coupling of 
secondary alkyl halides with aryl Grignard reagents has revealed promising insights into 
our proposed sp2 – sp3 coupling strategy (Scheme 55).95 It is important to note that 
reports on the use of secondary alkyl halides under cobalt96 or nickel catalysis97 also 
suggested a high potential for transition metal catalysis in this approach.98 
 
Br FeCl3, ArMgBr,





Scheme 55. Iron-catalyzed cross-coupling reported by Nakamura et al. 
 
______________________________ 
95 Nakamura, M.; Matsuo, K.; Ito, S.; Nakamura, E. J. Am. Chem. Soc. 2004, 126, 3686. 
96 Tsuji, T.; Yorimitsu, H.; Oshima, K. Angew. Chem., Int. Ed. 2002, 41, 4137. 
97 Zhou, J.; Fu, G. C. J. Am. Chem. Soc. 2003, 125, 14726. 













3.1 GENERAL INFORMATION 
 
Experiments involving moisture and/or sensitive compounds were performed under a 
positive pressure of nitrogen in flame-dried glassware equipped with a rubber septum 
inlet. Solvents and liquid reagents were transferred by oven-dried syringes cooled in a 
dessicator or via double-tipped cannular needles. Reaction mixtures were stirred with 
Teflon-coated magnetic stirring bars unless otherwise stated. Moisture in non-volatile 
reagents/compounds was removed by the addition of the stated amount of anhydrous 
THF, followed by the removal of the solvent and traces of moisture in vacuo by means of 
an oil pump (~30 mmHg, 23-50 oC) and subsequent purging with nitrogen. 
All experiments were monitored by analytical thin layer chromatography (refer to 
section under “Chromatography”). Solvents were removed in vacuo under ~30 mmHg 
and heated with a water bath at 23 oC using a Büchi rotary evaporator cooled with 
running water at 0 oC. 
 
Materials 
Reagents were purified prior to use unless otherwise stated following the guidelines 
of Perrin and Armarego.99 Solvents such as hexane, ethyl acetate, dichloromethane and 
water were freshly distilled prior to use. Anhydrous THF was obtained by distillation 
under nitrogen atmosphere from a deep purple solution resulting from sodium and 
benzophenone. Anhydrous dichloromethane was distilled over calcium hydride under 
nitrogen atmosphere.  
_____________________________ 
99 Perrin, D. D. and Armarego, W. L. Purification of Laboratory Chemicals; 3rd ed., Pergamon Press,    
   Oxford. 1988. 
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Both triethylamine and dimethyl sulfoxide were distilled over calcium hydride and 
stored over molecular sieves to maintain dryness. Activated Zn powder was obtained by 
“washing” commercial Zn powder using glacial acetic acid and subsequently filtered and 
washed with diethyl ether. Cyclohexanecarbaldehyde and 3-phenylpropanal were 
distilled over 4Å molecular sieve under nitrogen atmosphere. Concentrated NH4OH are 
used directly from the bottle stating 28% NH3 in water. Hydrochloric acid was diluted 
from concentrated 37% solution. Saturated solutions of ammonium chloride, sodium 
chloride, sodium bicarbonate, and sodium carbonate, sodium thiosulphate, potassium 
sodium tartrate, potassium carbonate were prepared from their respective solids. 
 
Chromatography 
Analytical thin layer chromatography was performed using Merck 60 F254 pre-coated 
silica gel plates (0.25 mm thickness). Visualization was accomplished with UV light (254 
nm) and iodine crystals, KMnO4 or ceric molybdate solution followed by heating on a hot 
plate. 
 
Flash column chromatography was performed using Merck Silica Gel 60 (0.010-
0.063 nm) and freshly distilled solvents. Columns were packed as slurry of silica gel in 
hexane/CH2Cl2 and equilibrated with the appropriate solvent/solvent mixture prior to use. 
The analyte was loaded neat or as a concentrated solution using the appropriate solvent 




Instruments & Equipments 
Infrared Spectroscopy 
Infrared spectra were recorded on a Bio-RAD FTS 165 FT-IR Spectrometer. Solid 
samples were analyzed as a KBr pressed-disk while liquid samples were either examined 
neat between KBr salt plates or as a solution in dichloromethane using NaCl liquid cells. 
 
Optical Rotation 
Optical rotations were measured using a JASCO DIP-1000 Digital Polarimeter 
equipped with a sodium vapour lamp at 589 nm. Concentration is denoted as c and was 
calculated as grams per milliliters (g/100 mL) whereas the solvent was indicated in 
parentheses (c, solvent). 
 
Mass Spectroscopy 
Mass spectrometries were performed by the staff from the Chemical and Molecular 
Analysis Center of the National University of Singapore 
(http://www.chemistry.nus.edu.sg/cmac/ms/MS_Instrument.html). MS (EI) spectra were 
recorded on a Hewlett-Packard 5890A chromatogram, and HRMS (EI) spectra were 
recorded on a V>G> Micromass 7035. MS and HRMS (ESI) spectra were recorded on a 
Finnigan/MAT LCQ quadrupole ion trap mass spectrometer, coupled with the TSP4000 
HPLC system and the Crystal 310 CE system. HRMS (FAB) spectra were recorded on a 





Nuclear Magnetic Resonance Spectroscopy 
Proton nuclear magnetic resonance (1H NMR) and carbon nuclear magnetic 
resonance (13C NMR) spectroscopy were performed on a 300 MHz Bruker ACF 300, 300 
MHz Bruker DPX 300 and 500 MHz Bruker AMX 500 NMR spectrometer.  
Chemical shifts are reported as δ in units of parts per million (ppm) downfield from 
tetramethysilane (δ 0.00), using the residual solvent signal as an internal standard: 
chloroform-d, CDCl3 (1H NMR, δ 7.26, singlet; 13C NMR, δ 77.04, triplet). 
Multiplicities are given as: s (singlet), d (doublet), t (triplet), q (quartet), qn (quintet), 
m (multiplets), br (broad), dd (doublet of doublets), dt (doublet of triplets), ddd (doublet 
of doublet of doublets) and ddt (doublet of doublet of triplets). Coupling constants (J) 
were recorded in Hertz (Hz). The number of protons (n) for a given resonance is 
indicated by nH. 
 
Nomenclature 
Systematic nomenclature for the compounds would follow the numbering system as 






3.2 AN UNUSUAL APPROACH TOWARDS THE SYNTHESIS OF  
             ENANTIOMERICALLY CIS-LINEAR HOMOALLYLIC ALCOHOLS BASED ON  
             THE STERIC INTERACTION MECHANISM OF CAMPHOR SCAFFOLD30 
 
General procedures for camphor-derived branched homoallylic alcohols 
To a cooled (0 oC) solution of (1R)-(+)-camphor (7.61 g, 50 mmol) in diethyl ether (100 mL) 
under nitrogen was added freshly prepared allyl/crotylmagnesium bromide (150 mmol) 
dropwise. The reaction mixture was allowed to warm up to room temperature slowly and stir 
for another 3 hours. The reaction mixture was quenched using 40 mL saturated NH4Cl solution 
and was extracted with diethyl ether (3 x 30 mL). The combined organic phases were washed 
with water, and then with brine, before drying over MgSO4. The crude mixture was then 
filtered and concentrated in vacuo. The crude product was purified via column chromatography 










Colorless oil (7,95 g, 82%);  
[α]D25 = + 6.7 o (1.0, CH2Cl2) 
Rf = 0.78 (2:1 hexane/ethyl acetate); 
1H NMR (300 MHz, CDCl3): δ 5.94-5.90 (m, 1H), 5.18-5.13 (m, 2H), 2.29-2.16 (m, 2H), 1.90 
(dt, J = 12.9, 3.5 Hz, 1H), 1.65-1.32 (m, 6H), 1.03 (s, 3H), 0.78 (s, 6H); 
13C NMR (75.4 MHz, CDCl3): δ 135.0, 118.8, 79.6, 52.1, 49.4, 46.0, 45.0, 44.5, 30.5, 27.0, 
21.4, 20.9, 10.9; 
FTIR (neat): 3487, 2949, 1638, 1456, 1390, 911 cm-1; 












(1R, 2S, 11R) (1R, 2S, 11S)(70:30)
 
Colourless oil (9.06 g, 87 %)  
1R, 2S, 11R – 81a/1R, 2S, 11S – 81b = 70/30 by 1H and 13C NMR: 
1H NMR: By integrating the peaks at δ 2.31 (81a) and δ 2.35 (81b), 13C NMR: By integrating 
the peaks at δ 80.9 (81a) and δ 82.1 (81b). Both sets of integrals approximately show a ratio of 
70:30; 
Rf = 0.70 (2:1 hexane/ethyl acetate); 
[α]D25 = – 2.7 o (1.0, CH2Cl2); 
1H NMR (300 MHz, CDCl3): (81a) δ 6.04 – 5.87 (m, 1H), 5.06 (dd, J = 15.2, 2.8 Hz, 1H), 4.95 
(dd, J = 10.6, 1.2 Hz, 1H), 2.31 (dq, J = 7.6, 7.2 Hz, 1H), 1.90 – 1.73 (m, 1H), 1.67 – 1.30 (m, 
6H), 0.99 (d, J = 4.0 Hz, 3H), 0.95 (s, 3H), 0.79 (s, 3H), 0.76 (s, 3H); 
13C NMR (75.4 MHz, CDCl3): (2 isomers) δ 141.4, 115.9, 114.2, 82.1, 80.9, 52.8, 52.4, 50.4, 
50.1, 47.3, 47.0, 46.3, 46.0, 44.7, 44.5, 29.7, 29.3, 27.6, 27.5, 21.4, 21.0, 15.5, 14.7, 12.2, 12.0; 
FTIR (neat): 3479, 3075, 2963, 2881, 1634, 1459, 1381, 1268, 1081, 1001, 913 cm-1; 
HRMS (EI) Calcd for C14H24O [M+]: 208.1827, found 208.1803. 
 
______________________________ 
33 Dimitrov, V.; Simova, S.; Kostova, K. Tetrahedron. 1996, 52, 1699.
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General procedures for crotyl transfer reaction from camphor homoallylic alcohol. 
To a solution of (1R)-(-)-10-camphorsulfonic acid (7 mg, 0.03 mmol) and aldehyde (0.3 mmol) 
in dichloromethane (0.05 mL) under nitrogen at room temperature was added 2-(but-3-en-2-yl)-
1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol (as a mixture of isomers 70:30; 187 mg, 0.9 mmol). 
The reaction mixture was allowed to stir for 5-6 days. The reaction mixture was diluted with 20 
mL diethyl ether, washed with saturated NaHCO3 solution and followed by brine, before drying 









 (94 % ee, 99% Z) 
Colorless oil (50 mg, 88 %);  
Rf = 0.35 (4:1 hexane/ethyl acetate); 
[α]D25 = – 21.2 o (1.0, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.28 – 7.09 (m, 5H), 5.59 (ddq, J = 10.8, 7.2, 0.8 Hz, 1H), 5.36 
(dtq, J = 10.8, 7.6, 1.6 Hz, 1H), 3.65 – 3.55 (m, 1H), 2.75 – 2.62 (m, 2H), 2.20 (t, J = 7.2 Hz, 
2H), 1.73 (dq, J = 13.5, 7.2 Hz, 2H), 1.58 (dd, J = 7.2, 0.8 Hz, 3H); 
13C NMR (75.4 MHz, CDCl3): δ 142.1, 128.4, 128.3, 127.5, 125.9, 125.8, 70.8, 38.4, 35.1, 
32.1, 13.0; 
FTIR (neat): 3376, 3062, 3022, 2929, 2862, 1661, 1602, 1494, 1447, 1407, 1373, 1361, 1049, 
395, 861, 744, 701, 580, 506 cm-1; 
HRMS (EI) Calcd for C13H180 [M+]: 190.1358, found: 190.1357. 
The enantiomeric excess and the E/Z selectivity were determined by HPLC analysis employing 
a Daicel Chiracel OD column (Hexane: i-propanol 99:1, 1.0 mL/min): t1 = 11.13, t2 = 13.21 and 
t3 = 21.80 min. 
 
______________________________ 






 (97 % ee, >99% Z) 
Colorless oil (32 mg, 68 %);  
Rf = 0.43 (4:1 hexane/ethyl acetate); 
[α]D25 = + 1.3 o (1.0, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 5.70 – 5.59 (m, 1H), 5.48 - 5.39 (m, 1H), 3.62 (q, J = 5.9 Hz, 
1H); 2.22 (t, J = 6.97 Hz, 2H), 1.64 (dd, J = 7.0, 0.7 Hz, 3H); 1.46 (bs, 2H), 1.30 (m, 4H), 0.89 
(t, J = 6.0 Hz, 3H); 
13C NMR (75.4 MHz, CDCl3): δ 127.2, 126.3, 71.6, 36.9, 35.0, 31.9, 25.5, 22.7, 14.1, 13.0;  
FTIR (neat): 3400, 3019, 2957, 2957, 2930, 2858, 2370, 2345, 1656, 1639, 1459, 1378, 1124, 
1030, 968 cm-1; 
HRMS (EI) Calcd for C10H100 [M+]: 156.1514, found: 156.1521. 
Product was derivatized with R-(+)-α-trifluoromethyl-α-methoxy-phenylacetic acid (Mösher 
acid) before the enantiomeric excess and the E/Z selectivity were determined by HPLC analysis 
employing a Daicel Chiracel AD column (Hexane: i-propanol 99.5:0.5, 0.5 mL/min): t1 = 7.77 
and t2 = 9.95 min.  
 
______________________________ 






 (90 % ee, 94% Z) 
Light yellow oil (24 mg, 95 %);  
Rf = 0.50 (4:1 hexane/ethyl acetate); 
[α]D25 = – 4.5 o (1.0, CH2Cl2);  
1H NMR (300 MHz, CDCl3): δ 5.58 (ddq, J = 10.9, 6.8, 1.6 Hz, 1H), 5.37 (dtq, J = 10.9, 7.2, 
0.8 Hz, 1H), 3.58 – 3.54 (m, 1H), 2.15 (dt, J = 6.8 Hz, 2H), 1.57 (dd, J = 6.8, 0.8 Hz, 3H), 1.40 
(m, 2H), 1.26 (m, 12H) 0.81 (t, J = 6.4 Hz, 3H); 
13C NMR (75.4 MHz, CDCl3): δ  127.2, 127.1, 71.5, 36.9, 35.0, 31.9, 29.7, 29.6, 29.3, 25.8, 
22.6, 14.1, 13.0; 
FTIR (neat): 3361, 3018, 2925, 2858, 1658, 1457, 1373, 1124, 1029, 859, 706 cm–1; 
HRMS (EI) Calcd for C13H260 [M+]: 198.1984, found: 198.1984. 
Product was derivatized with R-(+)-α-trifluoromethyl-α-methoxy-phenylacetic acid (Mösher 
acid) before the enantiomeric excess and the E/Z selectivity were determined by HPLC analysis 
employing a Daicel Chiracel AD column (Hexane: i-propanol 99.5:0.5, 1 mL/min): t1 = 5.86, t2 







 (92 % ee, 96% Z) 
Colorless oil (20 mg, 40 %);  
Rf = 0.51 (4:1 hexane/ethyl acetate); 
[α]D25 = – 2.5 o (1.0, CH2Cl2);  
1H NMR (300 MHz, CDCl3): δ 5.69 – 5.61 (m, 1H), 5.49 – 5.41 (m, 1H), 3.38 (dt, J = 6.6, 5.6 
Hz, 1H), 2.28 – 2.23 (m, 2H), 1.64 (d, J = 6.3 Hz, 3H), 1.32 – 1.27 (m, 1H), 1.13 – 1.09 (m, 
5H), 1.05 – 0.91 (m, 5H); 
13C NMR (75.4 MHz, CDCl3): δ 127.3, 126.7, 75.6, 43.2, 31.8, 29.3, 28.2, 26.6, 26.4, 26.2, 
13.0;  
FTIR (neat): 3591, 3020, 2925, 2854, 1625, 1448, 1261, 1086, 1065, 1030, 968, 892 cm–1;  
HRMS (EI) Calcd for C11H200 [M+]: 168.1514 , found: 168.1520. 
Product was derivatized with 3,5-dinitrobenzoyl chloride before the enantiomeric excess and 
the E/Z selectivity were determined by HPLC analysis employing a Daicel Chiracel OD 
followed by a Daicel Chiracel ODH column (Hexane: i-propanol 99:1, 0.3 mL/min): t1 = 68.86, 








 (97 % ee, >99% Z) 
Light yellow oil (27 mg, 40 %);  
Rf = 0.44 (2:1 hexane/ethyl acetate); 
[α]D25 = + 72.8 o (1.0, MeOH); 
1H NMR (300 MHz, CDCl3): δ 7.35 - 7.26 (m, 5H), 5.66 - 5.55 (m, 2H), 5.55 -  
5.29 (m, 2H), 4.52 (s, 2H), 3.89 - 3.81 (m, 1H), 3.73 (t, J = 6.42 Hz, 2H), 2.34-2.15 (m, 2H), 
1.79 - 1.74 (m, 2H), 1.63 (d, J = 6.6 Hz, 3H); 
13C NMR (75.4 MHz, CDCl3) δ 138.0, 128.5, 127.7, 126.7, 126.2, 73.4, 71.1, 69.1, 35.9, 
34.9, 13.0; 
FTIR (neat): 3429, 3031, 2939, 2858, 1638, 1453, 1095, 969, 697 cm-1; 
HRMS (EI) Calcd for C14H20O2 [M+]: 220.1463, found 220.1459. 
The enantiomeric excess and the E/Z selectivity were determined by HPLC analysis employing 









 (>99 % ee, >99% Z) 
Light yellow oil (66 mg, 94 %);  
Rf = 0.33 (4:1 hexane/ethyl acetate); 
[α]D25 = – 1.7 o (1.0, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.36 – 7.27 (m, 5H), 5.69 – 5.59 (m, 1H), 5.51 – 5.42 (m, 1H), 
4.53 (s, 2H), 3.72 – 3.62 (m, 1H), 3.53 (t, J = 5.9 Hz, 2H), 2.33 – 2.24 (m, 2H), 1.65 (d, J = 6.6 
Hz, 3H), 1.53 (q, J = 7.3 Hz, 2H), 1.31 – 1.25 (m, 2H); 
13C NMR (75.4 MHz, CDCl3) δ 138.3, 128.4, 127.7, 127.6, 126.8, 126.4, 73.0, 71.3, 70.5, 35.0, 
34.0, 26.4, 13.0; 
FTIR (neat): 3393, 3067, 2926, 1717, 1602, 1584, 1452, 1278, 1114, 1071, 1027, 859, 801, 715 
cm-1; 
HRMS (EI) Calcd for C15H22O2 [M+]: 234.1620, found 234.1617. 
The enantiomeric excess and the E/Z selectivity were determined by HPLC analysis employing 
a Daicel Chiracel OD followed by a Daicel Chiracel ODH column (Hexane: i-propanol 99:1, 









 (98 % ee, 98% Z) 
Light yellow oil (74 mg, 80 %);  
Rf = 0.35 (4:1 hexane/ethyl acetate); 
[α]D25 = – 2.0 o (1.0, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.36 – 7.27 (m, 5H), 5.71 – 5.61 (m, 1H), 5.49 – 5.41 (m, 1H), 
4.52 (s, 2H), 3.66 – 3.63 (m, 1H), 3.50 (d, J = 6.3 Hz, 2H), 2.26 – 2.21 (m, 2H), 1.65 (d, J = 6.6 
Hz, 3H), 1.57 – 1.44 (m, 4H), 1.31 – 1.25 (m, 2H); 
13C NMR (75.4 MHz, CDCl3) δ 138.6, 128.4, 127.6, 127.5, 127.2, 126.2, 72.9, 71.4, 70.3, 36.6, 
35.0, 29.7, 22.4, 13.0; 
FTIR (neat): 3414, 3026, 2932, 2858, 1720, 1452, 1364, 1101, 1028, 939, 735, 698 cm-1; 
HRMS (EI) Calcd for C16H24O2 [M+]: 248.1776, found 248.1770. 
The enantiomeric excess and the E/Z selectivity were determined by HPLC analysis employing 
a Daicel Chiracel OD followed by a Daicel Chiracel ODH column (Hexane: i-propanol 99:1, 







 (>99 % ee, 84% Z) 
Colorless oil (42 mg, 83 %);  
Rf = 0.35 (8:1 hexane/ethyl acetate); 
[α]D25 = – 7.4 o (1.0, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 5.67 – 5.59 (m, 1H), 5.47 – 5.33 (m, 3H), 3.67 – 3.61 (m, 1H), 
2.24 (dd, J = 6.6, 6.2 Hz, 2H), 2.16 (m, 2H), 2.06 (m, 2H), 1.63 (d, J = 6.6 Hz, 3H), 1.52 (m, 
2H), 0.96 (t, J = 7.5 Hz, 3H); 
13C NMR (75.4 MHz, CDCl3) δ 132.3, 128.6, 127.2, 126.1, 71.2, 36.7, 35.0, 23.6, 20.5, 14.3, 
13.0; 
FTIR (neat): 3399, 3007, 2963, 2930, 1653, 1449, 1373, 1305, 1163, 968, 866, 706 cm-1; 
HRMS (EI) Calcd for C11H20O [M+]: 168.1517, found 168.1507. 
Product was derivatized with R-(+)-α-trifluoromethyl-α-methoxy-phenylacetic acid (Mösher 
acid) before the enantiomeric excess and the E/Z selectivity were determined by HPLC analysis 
employing a Daicel Chiracel AD column (Hexane: i-propanol 99.5:0.5, 0.5 mL/min): t1 = 8.00 








 (98 % ee, 99% Z) 
Light yellow oil (42 mg, 66 %);  
Rf = 0.21 (4:1 hexane/ethyl acetate); 
[α]D25 = – 1.3 o (1.0, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 6.95 (dt, J = 15.7, 7.0 Hz, 1H), 5.82 (dt, , J = 15.7, 1.7 Hz, 1H), 
5.66 (ddq, J = 10.8, 7.0, 1.4 Hz, 1H), 5.43 (dtq, J = 10.8, 7.3, 1.7 Hz, 1H), 4.18 (q, J = 7.3 Hz, 
2H), 3.68 – 3.60 (m, 1H), 2.24 – 2.20 (m, 4H), 1.64 (dd, , J = 6.9, 0.7 Hz, 3H), 1.53 – 1.45 (m, 
4H), 1.28 (t, J = 7.3 Hz, 3H); 
13C NMR (75.4 MHz, CDCl3) δ 166.8, 149.0, 127.7, 125.9, 121.6, 71.2, 60.2, 36.2, 35.1, 32.2, 
24.3, 14.3, 13.1; 
FTIR (neat): 3431, 2980, 2934, 2863, 1718, 1653, 1446, 1369, 1270, 1189, 1042, 984, 859, 706 
cm-1; 
HRMS (EI) Calcd for C13H22O3 [M+]: 226.1569, found 226.1568. 
Product was derivatized with Mösher acid before the ee and the E/Z selectivity were 
determined by HPLC analysis employing a Daicel Chiracel ODH column (Hexane: i-propanol 




3.3 THE FIRST EXAMPLE OF ENANTIOSELECTIVE ALLYL TRANSFER  
              FROM A LINEAR HOMOALLYLIC ALCOHOL TO AN ALDEHYDE 
 
General procedure for crotyl transfer reactions from 2,2-dimethyl-5-hepten-3-ol 102 
A mixture of 2,2-dimethyl-5-hepten-3-ol 102 (0.18 g, 1.25 mmol) in 1 mL of CH2Cl2 was 
added to a round bottom flask containing In(OTf)3 (0.028 g, 0.05 mmol) and 1 mL of  CH2Cl2. 
Following that, the aldehyde (0.056 g, 0.5 mmol) in 1 mL of CH2Cl2 was slowly added to the 
reaction mixture in 10 to 15 minutes at room temperature. The reaction mixture was stirred for 
2 hours at ambient temperature. Ether was added to dilute the reaction mixture followed by 1 M 
HCl to quench the reaction. The reaction mixture was extracted with ether. The combined 
organic layer was washed with brine, and dried over anhydrous magnesium sulphate, filtered 
and the solvent was removed in vacuo. The crude product was purified by column 








 (97% ee, 100% E) 
Colourless oil (60 mg, 67%); 
Rf = 0.34 (4:1 hexane/ethyl acetate); 
[α]D25 = + 6.4 o, (1.8, MeOH); 
1H NMR (300 MHz, CDCl3) E isomer: δ 7.31 – 7.16 (m, 5H), 5.57 (dq, J = 15.3, 6.3 Hz, 1H), 
5.47 – 5.37 (m, 1H), 3.61 (br m, 1H), 2.86 – 2.63 (m, 2H), 2.29 – 2.05 (m, 2H), 1.81 – 1.58 (m, 
2H), 1.69 (d, J = 5.94 Hz, 3H); 
13C NMR (75.4 MHz, CDCl3) E isomer: δ 142.2, 129.2, 128.5, 128.4, 126.9, 125.8, 70.2, 40.9, 
38.4, 32.1, 18.1; 
FTIR (neat): 3568, 3412, 3083, 3064, 3028, 3001, 2963, 2932, 2868, 1640, 1545, 1000, 914, 
748, 700 cm–1; 
HRMS (EI) Calcd for C13H16 [M – H2O]+: 172.1252, found 172.1259. 
HPLC analysis employing a Daicel Chiralcel OD column (nhexane : i-propanol 99: 1; 1.0 
ml/min): t1 = 19.97 min and t2 = 13.21 min. 
 
______________________________ 
101 Nokami, J.; Ohga, M.; Nakamoto, H.; Matsubara, T.; Hussain, I.; Kataoka, K. J. Am. Chem. Soc.  







 (97% ee, 100% E) 
Light yellow oil (36 mg, 41%); 
Rf = 0.44 (4:1 hexane/ethyl acetate); 
[α]D25 = + 5.3 o, (1.6, MeOH); 
1H NMR (300 MHz, CDCl3) E isomer: δ 7.36 – 7.23 (m, 5H), 5.60 (ddd, J = 15.3, 6.3, 5.6 Hz, 
1H), 5.51 (dq, J = 15.3, 7.7 Hz, 1H), 3.86 (dddd, J = 7.7, 6.90, 5.6, 4.9 Hz, 1H), 2.82 (dd, J 
=13.9, 4.9 Hz, 1H), 2.75 (dd, J = 13.9, 7.7 Hz, 1H), 2.29 (dt, J = 13.9, 6.9 Hz, 1H), 2.16 (dt, J = 
13.9, 6.9 Hz, 1H), 1.73 (d, J = 6.9 Hz, 3H); 
13C NMR (75.4 MHz, CDCl3) E isomer: δ 138.6, 129.4, 129.0, 128.5, 127.0, 126.4, 72.0, 43.3, 
40.0, 18.1; 
FTIR (neat):ν 3562, 3407, 3027, 2933, 2917, 2732, 1602, 1496, 1454, 1080, 1031, 742 cm–1; 
HRMS (EI) Calcd for [C12H16O]+: 176.1201, found 176.1206. 
HPLC analysis employing a Daicel Chiralcel OD column (nhexane : i-propanol 99: 1; 1.0 







 (97% ee, 100% E) 
Colourless oil (41 mg, 52%); 
Rf = 0.14 (1:1 hexane/ethyl acetate); 
[α]D25 = + 13.0 o, (0.4, MeOH); 
1H NMR (300 MHz, CDCl3) E isomer: δ 5.55 (dt, J = 14.6, 6.3, 1H), 5.42 (ddq, J = 14.6, 6.3, 
1.4, 1H), 3.66 (t, J = 6.3 Hz, 2H), 3.62-3.56 (m, 1H), 2.23 (dddd, J = 11.1, 7.7, 6.3, 1.4 Hz, 
1H), 2.06 (ddd, J = 11.1, 7.7, 6.9 Hz, 1H), 1.70 (d, J = 6.3 Hz, 3H), 1.60 – 1.40 (m, 6H); 
13C NMR (75.4 MHz, CDCl3) E isomer: δ 129.0, 127.0, 70.7, 62.7, 40.6, 36.2, 32.5, 21.7, 17.9; 
Product was derivatized with R-(+)-α-trifluoromethyl-α-methoxy-phenylacetic acid (Mösher 
acid) before the enantiomeric excess and the E/Z selectivity were determined by 19F NMR. 
19F NMR (282.2 MHz, CDCl3) E isomer: δ 4.27 (integration = 1), 3.92 (integration = 0.015);  








 (97% ee, 100% E) 
Light yellow oil (71 mg, 35%); 
Rf = 0.39 (4:1 hexane/ethyl acetate); 
[α]D25 = – 7.7 o, (0.7, MeOH); 
1H NMR (300 MHz, CDCl3) E isomer: δ 7.69 – 7.67 (m, 4H), 7.46 – 7.36 (m, 6H), 5.62 – 5.39 
(m, 2H), 3.71 (t, J = 6.3 Hz, 2H), 3.66 – 3.58 (m, 1H), 2.29-2.06 (m, 3H), 1.80-1.40 (m, 4H), 
1.70 (dd, J = 5.91, 1.05 Hz, 3H), 1.07 (s, 9H); 
13C NMR (75.4 MHz, CDCl3) E isomer: δ 135.6, 133.9, 129.6, 128.7, 127.6, 127.2, 70.9, 64.1, 
40.7, 33.4, 28.8, 26.9, 19.2, 18.1; 
Product was derivatized with R-(+)-α-trifluoromethyl-α-methoxy-phenylacetic acid (Mösher 
acid) before the enantiomeric excess and the E/Z selectivity were determined by 19F NMR. 
19F NMR (282.2 MHz, CDCl3) E isomer: δ 4.16 (integration = 1), 3.68 (integration = 0.015); 
FTIR (neat): ν 3427, 2960, 2932, 2858, 2636, 1428, 1112, 969, 823, 740, 701 cm–1; 







 (97% ee, 95% E) 
Light yellow oil; 
Rf = 0.47 (4:1 hexane/ethyl acetate); 
[α]D25 = + 11.4 o, (5.2, MeOH); 
1H NMR (300 MHz, CDCl3) E isomer: δ 5.69 – 5.31 (m, 2H), 3.17 (dd, J = 10.4, 2.0, 1H), 2.36 
– 2.19 (m, 2H), 1.70 (d, J = 6.4, 3H), 0.90 (s, 9H); 
13C NMR (75.4 MHz, CDCl3) E isomer: δ 128.8, 128.3, 78.3, 35.2, 34.4, 25.7, 17.9; 
Product was derivatized with R-(+)-α-trifluoromethyl-α-methoxy-phenylacetic acid (Mösher 
acid) before the enantiomeric excess and the E/Z selectivity were determined by 19F NMR. 
19F NMR (282.2 MHz, CDCl3) E isomer: δ 4.33 (integration = 1), 3.12 (integration = 0.015); 
FTIR (neat): ν 3406.4, 3081.2, 2974.0, 2246.3, 1637.6, 1453.9, 1021.3, 912.8, 701.3; 
HRMS (EI) Calcd for C9H17O [M – H]+: 141.1279, found 141.1279. 
 
______________________________ 
102 Hayashi, T.; Iwamura, H.; Uozumi, Y. Tet. Lett. 1994, 35, 4813. 
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Light yellow oil; 
Rf = 0.38 (4:1 hexane/ethyl acetate); 
1H NMR (300 MHz, CDCl3) anti isomer: δ 7.30 – 7.17 (m, 5H), 5.82–5.68 (m, 1H), 5.14 – 5.05 
(m, 2H), 3.42 (ddd, J = 9.1, 6.0, 3.2 Hz, 1H), 2.86 (ddd, J = 13.9, 10.0, 5.1 Hz, 1H), 2.67 (ddd, 
J = 13.9, 10.0, 6.0 Hz, 1H), 2.23 (ddq, J = 8.3, 7.0, 6.0 Hz, 1H), 1.89 – 1.63 (m, 2H), 1.02 (d, J 
= 6.9 Hz, 3H); syn isomer: δ 7.30 – 7.17 (m, 5H), 5.77 (m, 1H), 5.15 – 5.08 (m, 2H), 3.53 (ddd, 
J = 8.9, 4.9, 3.1 Hz, 1H), 2.86 (ddd, J = 14.2, 10.0, 5.1 Hz, 1H), 2.65 (ddd, J = 14.2, 9.9, 6.5 
Hz, 1H), 2.31 (ddq, J = 7.5, 6.7, 4.9 Hz, 1H), 1.82 – 1.68 (m, 2H), 1.03 (d, J = 6.9 Hz, 3H); 
13C NMR (75.4 MHz, CDCl3) anti isomer: δ 142.1, 140.1, 128.3, 125.7, 116.4, 74.0, 44.3, 36.0, 
32.1, 16.2; syn isomer: δ 142.2, 140.7, 125.7, 128.4, 115.4, 73.9, 44.3, 35.7, 32.4, 14.2;  
FTIR (neat) 3429, 3084, 3012, 2968, 2930, 2870, 1640, 1603, 1496, 1454, 1218, 1038, 918, 
767, 700 cm–1; 









Light yellow oil; 
Rf = 0.38 (4:1 hexane/ethyl acetate); 
1H NMR (300 MHz, CDCl3): δ 7.25 – 7.15 (m, 5H), 3.27 (dt, J = 10.3, 4.6 Hz, 1H), 3.03 – 2.95 
(m, 1H), 2.93-2.80 (m, 2H), 2.78 – 2.59 (m, 1H), 2.12-1.88 (m, 3H), 1.79 – 1.62 (m, 8H), 1.27-
1.18 (m, 5H), 1.03 – 0.99 (m, 1H), 0.91 (d, J = 6.6 Hz, 3H); 
13C NMR (75.4 MHz, CDCl3): δ 142.6, 128.6, 128.3, 125.7, 125.7, 79.7, 79.5, 74.2, 44.3, 42.9, 
38.6, 34.9, 31.8, 29.4, 29.0, 26.6, 26.2, 26.1, 12.8; 
FTIR (neat) 3649, 3589, 3530, 3455, 3427, 1631, 455, 430 cm-1; 







Light yellow oil; 
Rf = 0.30 (4:1 hexane/ethyl acetate); 
1H NMR (300 MHz, CDCl3): δ 7.31 – 7.15 (m, 5H), 3.28 (dt, J = 10.5, 4.5 Hz, 1H), 2.99 – 2.92 
(m, 2H), 2.87 (dt, J = 2.6, 9.6 Hz, 1H), 2.72 – 2.59 (m, 1H), 2.05 – 1.88 (m, 2H), 1.82 – 
1.65(m, 2H), 1.39 – 1.16 (m, 2H), 1.03 (d, J = 6.6 Hz, 3H), 0.92 (d, J = 6.6 Hz, 6H); 
13C NMR (75.4 MHz, CDCl3): δ 142.7, 128.6, 128.3, 125.7, 80.5, 79.5, 74.2, 44.2, 38.5, 34.9, 
33.3, 31.8, 19.0, 18.8, 12.8, 5.1; 
FTIR (neat) 3630, 3568, 3475, 3423, 2958, 2874, 1456, 1152, 1008, 747, 699 cm-1; 







Light yellow oil; 
Rf = 0.33 (4:1 hexane/ethyl acetate); 
1H NMR (300 MHz, CDCl3): δ 7.31 – 7.15 (m, 5H), 3.30 – 3.22 (m, 2H), 2.87 (dt, J = 2.8, 9.8 
Hz, 1H), 2.82 – 2.59 (m, 2H), 2.03 – 1.88 (m, 12H), 1.83 – 1.28 (m, 1H), 0.92 (d, J = 6.6 Hz, 
3H), 0.86 (t, J = 7.1 Hz, 3H); 
13C NMR (75.4 MHz, CDCl3): δ 142.6, 128.6, 128.4, 125.8, 79.6, 75.3, 73.9, 44.2, 41.6, 36.2, 
35.6, 34.8, 31.9, 31.8, 29.7, 29.4, 25.8, 22.7, 14.3, 5.1; 




105d: 3-Methyl-2-phenethyl-6-phenyl-tetrahydro-pyran-4-ol  
O
OH  
Light yellow oil; 
Rf = 0.33 (4:1 hexane/ethyl acetate); 
1H NMR (300 MHz, CDCl3): δ 7.42 – 7.16 (m, 10H), 4.41 (dd, J = 1.7, 11.5 Hz, 1H), 3.52 – 
3.46 (m, 1H), 3.14 (dt, J = 2.8, 9.4 Hz, 1H), 2.95 – 2.70 (m, 3H), 2.27 (ddd, J = 2.1, 4.5, 12.5 
Hz, 1H), 2.09 – 1.98 (m, 2H), 1.46-1.37 (m, 1H), 1.01 (d, J = 6.6 Hz, 3H); 
13C NMR (75.4 MHz, CDCl3): δ 142.6, 142.4, 128.6, 128.4, 127.4, 125.9, 125.8, 125.7, 80.2, 
76.9, 74.0, 43.7, 43.0, 34.8, 31.6, 12.9; 







Light yellow oil; 
Rf = 0.24 (4:1 hexane/ethyl acetate); 
1H NMR (300 MHz, CDCl3): δ 7.28 – 7.15 (m, 5H), 3.33-3.24 (m, 1H), 2.94 – 2.87 (m, 2H), 
2.86 (dt, J = 3.3, 9.6 Hz, 1H), 2.66 (dt, J = 1.7, 7.4 Hz, 1H), 1.99 – 1.89 (m, 2H), 1.76 – 1.64 
(m, 1H), 1.32 – 1.13 (m, 2H), 0.95 (s, 9H), 0.92 (d, J = 6.6 Hz, 3H); 
13C NMR (75.4 MHz, CDCl3): δ 142.9, 128.6, 128.3, 125.7, 82.7, 79.6, 74.7, 44.1, 35.6, 35.0, 
34.2, 26.2, 12.9; 
FTIR (neat) 3648, 3629, 3477, 3383, 2954, 698, 458, 431 cm-1; 
HRMS (EI) Calcd for C18H28O2 [M+]: 276.2089, found 276.2081. 
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THF, MeOH, 0 oC
128 129  
 
A solution of the commercially available ester 128 (1.80 g, 10.50 mmol) in THF (20 mL) was 
stirred at 0 oC for 30 minutes, followed by the addition of NaBH4 (1.58 g, 42.00 mmol) and 
the resulting mixture was allowed to stir for another 30 minutes. MeOH (5 mL) was then 
added dropwise into the mixture and stirred at 0 oC for a further 2 hours. When TLC had 
shown the full depletion of the starting material 128, 1 M HCl (10 mL) was then added to the 
resultant mixture. The mixture was filtered and the filtrate was then concentrated in vacuo. 
CH2Cl2 (5 x 15 mL) was used to extract the resultant mixture and the combined extracts were 
washed with brine (20 mL), dried (Na2SO4) and evaporated in vacuo. The residual oil was 
purified via flash column chromatography (8:1 hexane/ethyl acetate), yielding 1.50 g (10.47 
mmol, ~100%) of the primary alcohol 129 as a yellow oil. 
Rf = 0.28 (1:1 hexane/ethyl acetate); 
1H NMR (300 MHz, CDCl3): δ 8.28 (d, J = 1.74 Hz, 1H), 7.67 (dd, J = 8.36, 2.44 Hz, 1H), 
7.29 (d, J = 8.02 Hz, 1H), 4.68 (d, J = 4.53 Hz, 2H), 3.24 (s, 1H); 
13C NMR (75.4 MHz, CDCl3): δ 150.1, 147.9, 137.9, 135.7, 124.2, 61.3; 
FTIR (neat): 3387, 1647, 1570, 1458, 1384, 1284, 1203, 1105, 1022, 822, 736 cm-1; 




















Et3N, CH2Cl2, − 78 o CN
Cl
HO
129 130  
 
A solution of oxalyl chloride (2.57 mL, 29.46 mmol) in CH2Cl2 (25 mL) was stirred at – 78 
oC for 30 minutes, followed by the dropwise addition of dimethyl sulfoxide (4.18 mL, 58.92 
mmol) and the resulting mixture was allowed to stir at the same temperature for another 30 
minutes. 129 (1.41 g, 9.82 mmol) in CH2Cl2 (20 mL) was then introduced into the mixture 
and the latter was allowed to stir for 30 minutes before triethylamine (12.32 mL, 88.38 mmol) 
was added. Water (15 mL) was added into the reaction mixture before CH2Cl2 (5 x 20 mL) 
was used to extract the aqueous layer. The combined organic extracts were dried in Na2SO4 
and evaporated in vacuo. The crude solid was purified via flash column chromatography (20:1 
hexane/ethyl acetate), yielding 1.39 g (9.81 mmol, ~100%) of the aldehyde 130 as a light 
yellow solid. 
Rf = 0.51 (2:1 hexane/ethyl acetate); 
1H NMR (300 MHz, CDCl3): δ 10.09 (s, 1H), 8.86 (dd, J = 0.72, 2.46 Hz, 1H), 8.13 (dd, J = 
2.46, 8.37 Hz, 1H), 7.51 (d, J = 8.37 Hz, 1H); 
13C NMR (75.4 MHz, CDCl3): δ 189.2, 157.0, 152.4, 137.9, 130.2, 125.2; 
FTIR (KBr): 2873, 1701, 1586, 1106 cm-1; 












1M in THF solution of vinyl bromide (3.00 mL, 3.00 mmol) was added into a round bottom 
flask containing Mg turnings (5.00 g, 205.68 mmol) and a small crystal of iodine. The 
resultant mixture was stirred at 25 oC before vinyl bromide (213.00 mL, 213.00 mmol) was 
added dropwise when the yellow coloration of iodine has decolorized. After the bromide has 
depleted, the reaction mixture was allowed to stir for a further 1 hour. The vinylmagnesium 
















130 131 132  
 
A solution of vinyl magnesium bromide 131 (100.00 mL, 100.00 mmol) in THF was added 
dropwise into another solution of 130 (5.66 g, 39.98 mmol) in THF (300 mL) at 0 oC and the 
resulting mixture was allowed to stir for 2 hours.  When TLC had shown the full depletion of 
the starting material 130, saturated ammonium chloride (100 mL) was then used to quench the 
reaction. The mixture was filtered and the filtrate was then concentrated in vacuo where ethyl 
acetate (5 x 100 mL) was used to extract the aqueous layer. The combined extracts were 
washed with brine (50 mL), dried (MgSO4) and evaporated in vacuo. The residual oil was 
purified via flash column chromatography (10:1 hexane/ethyl acetate), yielding 6.51 g (38.38 
mmol, 96%) of the allylic alcohol 132 as a dark yellow oil. 
Rf = 0.43 (2:1 hexane/ethyl acetate); 
1H NMR (300 MHz, CDCl3): δ 8.38 (d, J = 2.07 Hz, 1H), 7.68 (dd, J = 2.46, 8.37 Hz, 1H), 
7.30 (d, J = 8.37 Hz, 1H), 5.99 (ddd, J = 3.83, 10.10, 17.07 Hz, 1H), 5.42 – 5.26 (m, 3H); 
13C NMR (75.4 MHz, CDCl3): δ 150.6, 147.9, 139.1, 137.0, 136.9, 124.1, 116.7, 72.5; 
FTIR (neat): 1648, 1583, 1459, 1377, 1106, 1025, 932, 825, 746 cm-1; 













132 127  
 
Phosphorous tribromide (3.95 mL, 42.03 mmol) was introduced dropwise into a stirred 
solution of 132 (5.94 g, 35.02 mmol) in diethyl ether (350 mL) at 0 oC and the resulting 
mixture was allowed to stir for 5 hours.  When TLC had shown the full depletion of the 
starting material 132, saturated sodium bicarbonate (50 mL) was then used to quench the 
reaction. Diethyl ether (5 x 80 mL) was used to extract the aqueous layer and the combined 
extracts were washed with brine (50 mL), dried (MgSO4) and evaporated in vacuo. The crude 
solid was purified via flash column chromatography (15:1 hexane/ethyl acetate), yielding 7.98 
g (34.32 mmol, 98%) of the allylic bromide 127 as a white solid, where it was then stored as 
0.5 M solution in anhydrous THF. 
Rf = 0.38 (8:1 hexane/ethyl acetate); 
1H NMR (300 MHz, CDCl3): δ 8.33 (d, J = 2.44 Hz, 1H), 7.66 (dd, J = 8.36, 1.44 Hz, 1H), 
7.27 (d, J = 8.36 Hz, 1H), 6.58 (d, J = 16.02 Hz, 1H), 6.42 (m, 1H), 4.11 (dd, J = 0.70, 7.32 
Hz, 2H); 
13C NMR (75.4 MHz, CDCl3): δ 150.8, 148.2, 135.7, 130.5, 129.3, 128.2, 124.2, 32.0; 
FTIR (KBr): 1650, 1615, 1501, 1459, 1199, 1098, 970, 816, 580 cm-1; 













The commercially available optically pure (S)-Phenylglycine methyl ester hydrochloride salt 
(100.00 g, 495.91 mmol) was dissolved in saturated Na2CO3 (150 mL) and was extracted with 
diethyl ether (5 x 100 mL). The combined organic phases were washed with brine, before 
drying over MgSO4. The crude mixture was then filtered and concentrated in vacuo. The 
crude amine 134 was obtained as light yellow oil (79.66 g, 482.21 mmol) and was used for 
subsequent reaction without any purification. 




151: (S,E)-Methyl 2-(pent-4-enylideneamino)-2-phenylacetate 
 
H







134 151150  
 
A single-necked round bottom flask with Na2SO4 (2.00 g) and a magnetic stirring bar were 
septum and flame dried. After the apparatus had cooled down to room temperature, (S)-
phenylglycine methyl ester 134 (6.62 g, 40.08 mmol) and CH2Cl2 (66 mL) were introduced 
and the reaction mixture was further cooled to 0 oC. The commercially available aldehyde 150 
(1.98 mL, 20.04 mmol) was added slowly into the reaction mixture and the contents were 
allowed to stir for up to 5 hours. The reaction mixture was then filtered, concentrated in vacuo 
and was dried azeotropically using anhydrous THF (3 x 5 mL). The crude imine 151 (4.63 g, 
20.01 mmol) was obtained as a yellow oil and was used for subsequent reaction without any 
purification. 
1H NMR (300 MHz, CDCl3): δ 7.76 (t, J = 4.69 Hz, 1H), 7.43 – 7.32 (m, 5H), 5.89 – 5.76 (m, 
1H), 5.06 – 4.95 (m, 2H), 4.62 (s, 1H), 3.72 (s, 3H), 2.48 – 2.36 (m, 2H), 2.34 – 2.29 (m, 2H);  
13C NMR (75.4 MHz, CDCl3): δ 168.1, 137.1, 128.8, 128.7, 128.0, 127.7, 126.8, 115.4, 58.8, 






















127 (36.58 mL, 18.29 mmol) in THF was added slowly a stirred solution of 151 (2.35 g, 
10.16 mmol), activated Zn powder (1.33 g, 20.32 mmol) and THF (50 mL) at 0 oC and the 
reaction mixture was allowed to stir for up to 3 hours. 1M HCl (30 mL) was then slowly 
added the reaction mixture and the entire contents were evaporated in vacuo. CH2Cl2 (5 x 60 
mL) was used to extract the aqueous layer and the combined organic extracts were washed 
with water (2 x 15 mL) before drying in Na2SO4. The contents were then filtered and 
concentrated in vacuo. The crude solid was purified via flash column chromatography (24:1 
hexane/ethyl acetate), yielding 3.75 g (9.75 mmol, 96%) of the homoallylic amine 152 as a 
yellow oil. 
Rf = 0.43 (4:1 hexane/ethyl acetate); 
[α]D25 = + 21.3 o (0.5, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 8.17 (d, J = 2.78 Hz, 1H), 7.54 (dd, J = 8.32, 2.78 Hz, 1H), 
7.35 – 7.29 (m, 5H), 7.25 (d, J = 8.32 Hz, 1H), 6.04 (ddd, J = 1.85, 10.18, 17.10 Hz, 1H), 5.59 
(ddt, J = 6.94, 10.18, 17.11 Hz, 1H), 5.25 (d, J = 10.63 Hz, 2H), 5.13 (d, J = 17.11 Hz, 1H), 
4.87 – 4.82 (m, 2H), 4.45 (s, 1H), 3.66 (s, 3H), 3.52 (t, J = 6.94 Hz, 1H), 2.80 (q, J = 6.01 Hz, 
1H), 2.13 – 2.07 (m, 1H), 1.96 – 1.88 (m, 1H), 1.43 – 1.39 (m, 2H); 
13C NMR (75.4 MHz, CDCl3): δ 173.1, 149.9, 149.6, 138.7, 138.0, 136.7, 136.0, 128.7, 128.2, 
127.7, 123.9, 118.5, 114.9, 62.9, 58.1, 52.3, 49.9, 30.2, 29.4; 
FTIR (neat): 3448, 3074, 2945, 1736, 1637, 1458, 1383, 1311, 1207, 1172, 1104, 1018, 996, 
919, 740, 699, 632 cm-1; 

























Grubbs’ 2nd generation catalyst 147 (0.28 g, 0.33 mmol) was added in one portion a solution 
of 152 (2.53 g, 6.57 mmol) in CH2Cl2 (651 mL) at room temperature and the resultant 
solution was allowed to stir for 30 minutes. Another portion of the catalyst (0.28 g, 0.33 
mmol) was then added the reaction mixture. When TLC had shown the full depletion of the 
starting material 152, the reaction mixture was then filtered through a pad of celite and the 
resultant solution was then evaporated in vacuo. The crude product was purified via flash 
column chromatography (12:1 hexane/ethyl acetate), yielding 2.20 g (6.18 mmol, 94%) of the 
cyclohexenylamine 153 as a dark brown oil. 
Rf = 0.23 (4:1 hexane/ethyl acetate); 
[α]D25 = – 11.4 o (1.3, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 8.23 (d, J = 2.09 Hz, 1H), 7.49 (dd, J = 2.44, 8.01 Hz, 1H), 
7.32 – 7.23 (m, 6H), 5.92 – 5.86 (m, 1H), 5.47 (dq, J = 2.43, 9.76 Hz, 1H), 4.40 (s, 1H), 3.55 
(s, 3H), 3.34 – 3.31 (m, 1H), 2.66 (dt, J = 3.14, 9.76 Hz, 1H), 2.22 – 2.12 (m, 2H), 1.93 – 1.85 
(m, 2H), 1.60 – 1.47 (m, 1H); 
13C NMR (75.4 MHz, CDCl3): δ 173.3, 150.1, 139.1, 138.4, 128.9, 128.2, 127.5, 124.2, 62.7, 
57.1, 52.3, 45.8, 26.5, 23.8; 
FTIR (neat): 3433, 3027, 2947, 1735, 1643, 1455, 1207, 1170, 1103, 1024, 829, 731, 699, 654 
cm-1; 
HRMS (EI) Calcd for C20H21ClN2O2 [M+]: 356.1292, found: 357.1366 (M + 1) . 
Experimental Section 
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164: Major 165: Minor153  
 
Tetraethylammonium bromide (21.49 g, 102.30 mmol) was added into a stirred solution of 
1533 (3.65 g, 10.23 mmol) in CH2Cl2 (180 mL) and the solution was cooled to – 78 oC. After 
the reaction mixture had stirred for 45 minutes, bromine (1.58 mL, 30.69 mmol), which was 
diluted with CH2Cl2 (20 mL), was introduced slowly into the former at the same temperature. 
The resultant solution was allowed to stir for a further 2 hours. When TLC had shown the full 
depletion of the starting material 153, the reaction mixture was washed with saturated 
NaHSO3 (2 x 20 mL) and water (2 x 20 mL). After drying in Na2SO4, the reaction mixture 
was filtered and concentrated in vacuo. The crude product was purified via flash column 
chromatography (12:1 hexane/ethyl acetate), yielding 3.31 g (6.41 mmol) of the major isomer 
164 as a white solid and 1.71 g (3.30 mmol) of the minor isomer 165 as a viscous light brown 
oil (95% yield, 66:34 ratio). 
Experimental Section 
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Major diastereomer 164: (S)-Methyl 2-((1R,2S,3S,4S)-3,4-dibromo-2-(6-chloropyridin-3-
yl)cyclohexylamino)-2-phenylacetate 
Rf = 0.48 (3:1 hexane/ethyl acetate); 
[α]D25 = + 14.7 o (1.4, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 8.30 (d, J = 2.46 Hz, 1H), 7.79 (dd, J = 2.43, 8.37 Hz, 1H), 
7.36 (d, J = 8.34 Hz, 1H), 7.37 – 7.15 (m, 5H), 4.78 (d, J = 2.43 Hz, 1H), 4.52 (s, 1H), 4.39 
(d, J = 1.38 Hz, 1H), 3.68 (s, 3H), 3.61 (dd, J = 2.79, 10.80 Hz, 1H), 3.45 (dt, J = 4.18, 10.80 
Hz, 1H), 2.65 – 2.52 (m, 1H), 2.11 – 2.07 (m, 2H), 2.01 – 1.90 (m, 2H); 
13C NMR (75.4 MHz, CDCl3): δ 173.1, 150.6, 150.5, 139.8, 138.0, 133.0, 128.6, 128.1, 127.0, 
123.6, 61.4, 60.4, 52.5, 52.2, 51.0, 44.9, 27.2, 26.5; 
FTIR (KBr): 2949, 1738, 1456, 1433, 1311, 1204, 1173, 1103, 731, 698, 545 cm-1; 
HRMS (FAB) Calcd for C20H21Br2ClN2O2 [M+]: 516.9658, found: 516.9716. 





Crystal growing solvent Dichloromethane and hexane 
Empirical formula C20 H21 Br2 Cl N2 O2 
Formula weight 516.66 
Temperature 293(2) K 
Wavelength 0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 9.4496(5) Å 
b = 9.7695(5) Å 
c = 12.1143(7) Å 
α = 97.8950(10)o. 
β = 100.5530(10)o. 
γ = 108.2840(10)o. 
Volume 1020.95(10) Å3 
Z 2 
Density (calculated) 1.681 Mg/m3 
Absorption coefficient 4.119 mm-1 
F(000) 516 
Crystal size 0.40 x 0.30 x 0.14 mm3 
Theta range for data collection 1.75 to 27.50o. 
Index ranges -12<=h<=12, -12<=k<=12, -15<=l<=15 
Reflections collected 13486 
Independent reflections 4690 [R(int) = 0.0298] 
Completeness to theta = 27.50o 99.9 % 
Absorption correction Sadabs, (Sheldrick 2001) 
Max. and min. transmission 0.5963 and 0.2896 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4690 / 1 / 249 
Goodness-of-fit on F2 1.036 
Final R indices [I>2sigma(I)] R1 = 0.0323, wR2 = 0.0766 
R indices (all data) R1 = 0.0447, wR2 = 0.0809 
Largest diff. peak and hole 0.760 and -0.279 e.Å-3 
In depth discussion with Professor Koh Lip Lin revealed that this stereoisomer could still be 
optically active even though a P-1 space group was revealed. The minor isomer could have 
crystallized with an equal portion of major and desired isomer. 
Experimental Section 
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Minor diastereomer 165: (S)-Methyl 2-((1R,2S,3R,4R)-3,4-dibromo-2-(6-chloropyridin-
3-yl)cyclohexylamino)-2-phenylacetate 
Rf = 0.38 (3:1 hexane/ethyl acetate); 
[α]D25 = – 9.1 o (0.3, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 8.28 (d, J = 2.43 Hz, 1H), 7.54 (dd, J = 2.43, 8.34 Hz, 1H), 
7.38 (d, J = 8.34 Hz, 1H), 7.25 – 7.22 (m, 3H), 7.09 – 7.06 (m, 2H), 4.18 – 4.02 (m, 3H), 3.54 
(s, 3H), 2.92 (t, J = 10.44 Hz, 1H), 2.77 (dt, J = 3.84, 10.44 Hz, 1H), 2.56 – 2.47 (m, 1H), 
2.10 – 2.03 (m, 1H), 1.99 – 1.93 (m, 1H), 1.46 – 1.37 (m, 1H); 
13C NMR (75.4 MHz, CDCl3): δ 172.2, 150.4, 149.7, 137.6, 137.4, 134.4, 128.4, 127.8, 126.6, 
123.9, 61.9, 60.7, 57.7, 56.9, 5.3, 51.8, 35.2, 32.0; 
FTIR (neat): 3423, 3402, 2952, 2864, 2417, 1736, 1583, 1458, 1394, 1315, 1265, 1209, 1173, 
1104, 1022, 827, 735, 699 cm-1; 



















164 153  
 
Zinc powder (0.91 g, 13.99 mmol) was added a stirred solution of 164 (5.16 g, 9.99 mmol) 
and glacial acetic acid (100 mL) at room temperature. The resultant mixture was allowed to 
stir for up to 4 hours. When TLC had shown the full depletion of the starting material 164, the 
reaction mixture was concentrated in vacuo. The resultant mixture was then diluted with ethyl 
acetate (120 mL), washed with saturated NaHCO3 (3 x 20 mL) and brine (3 x 20 mL). After 
adding MgSO4, the reaction mixture was filtered and concentrated in vacuo. The crude 
product 153 (3.56 g, 9.97 mmol, ~100%) was obtained as a yellow oil and was used for 




















165 163  
 
A solution of 165 (1.03 g, 2.00 mmol) in dry toluene (40 mL) was refluxed for up to 45 hours. 
When TLC had shown the full depletion of the starting material 165, the reaction mixture was 
concentrated in vacuo. The crude product was purified via flash column chromatography (4/1 
hexane/ethyl acetate), yielding 0.69 g (1.60 mmol, 80%) of the bicyclo-product 163 as a light 
brown oil. 
Rf = 0.68 (1:1 hexane/ethyl acetate); 
[α]D25 = + 33.6o (3.52, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 8.21 (d, J = 2.44 Hz, 1H), 7.64 – 7.61 (m, 2H), 7.45 (dd, J = 
2.44, 8.36 Hz, 1H), 7.40 – 7.28 (m, 3H), 7.30 (d, J = 8.36 Hz, 1H), 4.34 (s, 1H), 4.04 (t, J = 
4.52 Hz, 1H), 3.91 (d, J = 4.53 Hz, 1H), 3.75 (t, J = 4.52 Hz, 1H), 3.68 (s, 3H), 3.40 (dd, J = 
1.05, 5.48 Hz, 1H), 1.91 – 1.88 (m, 1H), 1.78 – 1.73 (m, 1H), 1.37 – 1.31 (m, 2H); 
13C NMR (75.4 MHz, CDCl3): δ 171.7, 150.1, 148.8, 137.9, 136.9, 132.5, 128.7, 128.6, 128.3, 
124.1, 67.2, 64.2, 64.0, 57.2, 52.5, 52.3, 26.7, 20.0; 
FTIR (neat): 2953, 2884, 1745, 1583, 1561, 1259, 1209, 1168, 1131, 1106, 1023, 814, 731 
698 cm-1; 


















163 168  
 
DIBAL−H (4.18 mL, 4.18 mmol) was added slowly into a stirred solution of 163 (0.88 g, 2.01 
mmol) and CH2Cl2 (20.10 mL) at 0 oC. The reaction mixture was allowed to stir for up to 30 
minutes. When TLC had shown the full depletion of the starting material 163, MeOH was 
added dropwise at 0 oC till the disappearance of effervescence was observed. Potassium 
sodium tartrate (3 mL) was then added and the reaction mixture was allowed to stir for up to 5 
hours. Ethyl acetate (5 x 10 mL) was used to extract the aqueous layer and the combined 
organic extracts were washed with brine (3 x 7 mL) before drying with MgSO4. The contents 
were then filtered and concentrated in vacuo. The crude product was purified via flash column 
chromatography (4/1 hexane/ethyl acetate), yielding 0.67 g (1.65 mmol, 82%) of the alcohol 
168 as a white crystalline solid. 
Rf = 0.60 (1:1 hexane/ethyl acetate); 
[α]D25 = + 41.2o (0.05, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 8.21 (d, J = 2.31 Hz, 1H), 7.51 (d, J = 7.40 Hz, 2H), 7.45 (dd, 
J = 2.77, 8.33 Hz, 1H), 7.39 – 7.30 (m, 4H), 3.93 – 3.89 (m, 4H), 3.85 (brs, 1H), 3.68 (brs, 
1H), 3.47 – 3.44 (m, 1H), 1.86 – 1.84 (m, 1H), 1.81 – 1.78 (m, 1H), 1.37 – 1.25 (m, 2H); 
13C NMR (75.4 MHz, CDCl3): δ 150.1, 149.3, 148.8, 137.9, 128.6, 128.1, 128.0, 124.1, 67.7, 
66.4, 63.1, 61.6, 57.7, 52.9, 26.6, 19.9; 
FTIR (neat): 2953, 2361, 1561, 1459, 1370, 1106, 1026, 700 cm-1; 




Crystal data and structure refinement for 168 
 
Crystal growing solvent Dichloromethane and hexane 
Empirical formula C20 H21 Br Cl N2 O 
Formula weight 527.10 
Temperature 223(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group P2(1)/n 
Unit cell dimensions a = 14.602(4) Å 
b = 10.005(3) Å 
c = 15.505(5) Å 
α = 90o. 
β = 95.789(7)o. 
γ = 90o. 
Volume 2253.6(12) Å3 
Z 4 
Density (calculated) 1.554 Mg/m3 
Absorption coefficient 2.312 mm-1 
F(000) 1064 
Crystal size 0.60 x 0.50 x 0.50 mm3 
Theta range for data collection 1.83 to 25.00o. 




Reflections collected 12220 
Independent reflections 3947 [R(int) = 0.0621] 
Completeness to theta = 27.50o 99.6 % 
Absorption correction Sadabs, (Sheldrick 2001) 
Max. and min. transmission 0.3910 and 0.3376 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3947 / 0 / 254 
Goodness-of-fit on F2 1.015 
Final R indices [I>2sigma(I)] R1 = 0.0746, wR2 = 0.2125 
R indices (all data) R1 = 0.1043, wR2 = 0.2329 
Largest diff. peak and hole 1.287 and -0.876 e.Å-3 
 
In depth discussion with Professor Koh Lip Lin revealed that this stereoisomer could still be 
optically active even though a P2(1)/n space group (that includes both hands) was revealed. 




















165 171  
 
DIBAL−H (4.18 mL, 4.18 mmol) was added slowly into a stirred solution of 165 (1.80 g, 3.48 
mmol) and CH2Cl2 (23.20 mL) at 0 oC. The reaction mixture was allowed to stir for up to 30 
minutes. When TLC had shown the full depletion of the starting material 165, MeOH was 
added dropwise at 0 oC till the disappearance of effervescence was observed. Potassium 
sodium tartrate (7 mL) was then added and the reaction mixture was allowed to stir for up to 5 
hours. Ethyl acetate (5 x 20 mL) was used to extract the aqueous layer and the combined 
organic extracts were washed with brine (3 x 10 mL) before drying with MgSO4. The contents 
were then filtered and concentrated in vacuo. The crude product was purified via flash column 
chromatography (3:1 hexane/ethyl acetate), yielding 1.49 g (3.06 mmol, 88%) of the primary 
alcohol 171 as a viscous light brown oil. 
Rf = 0.33 (2:1 hexane/ethyl acetate); 
[α]D25 = – 8.3 o (0.1, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 8.27 (d, J = 2.43 Hz, 1H), 7.51 (dd, J = 2.43, 8.34 Hz, 1H), 
7.36 (d, J = 8.01 Hz, 1H), 7.30 – 7.27 (m, 3H), 7.11 (d, J = 7.65 Hz, 1H), 4.11 – 4.01 (m, 2H), 
3.35 – 3.33 (m, 1H), 3.24 – 3.18 (m, 1H), 3.18 – 3.16 (m, 1H), 2.88 (t, J = 10.80 Hz, 1H), 
2.73 (dt, J = 4.17, 11.13, 1H), 2.44 – 2.39 (m, 1H), 2.25 (brs, 1H), 1.93 (dd, J = 3.48 Hz, 1H), 
1.84 – 1.78 (m, 1H), 1.27 – 1.22 (m, 1H); 
13C NMR (75.4 MHz, CDCl3): δ 150.4, 148.7, 140.3, 137.9, 135.6, 128.6, 128.5, 128.0, 127.8, 
127.1, 124.2, 66.0, 64.1, 60.9, 59.9, 57.5, 55.3, 35.8, 34.1 
FTIR (neat): 2954, 1641, 1460, 1265, 1106, 1026, 737, 702 cm-1; 


















171 172  
 
Lead(IV) acetate (4.02 g, 9.06 mmol) was added into a stirred solution of 171 (4.43 g, 9.06 
mmol) in CH2Cl2 (200 mL) and MeOH (100 mL) at 0 oC. When TLC had shown the full 
depletion of the starting material 39, 10% NaOH (50 mL) was added slowly into the reaction 
mixture. The contents were evaporated in vacuo and subsequently extracted with CH2Cl2 (5 x 
30 mL). The organic layer was dried with Na2SO4, filtered and concentrated in vacuo. The 
crude product was purified via flash column chromatography (100:2 CH2Cl2/MeOH), yielding 
2.17 g (5.89 mmol, 65%) of the primary amine 172 as a viscous brown oil. 
Rf = 0.58 (8:1 ethyl acetate/MeOH); 
[α]D25 = – 63.0o (1.7, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 8.22 (d, J = 2.09 Hz, 1H), 7.49 (dd, J = 2.43, 8.36 Hz, 1H), 
7.30 (d, J = 8.36 Hz, 1H), 4.18 – 4.03 (m, 2H), 2.95 (dt, J = 3.83, 10.80 Hz, 1H), 2.72 (t, J = 
10.45 Hz, 1H), 2.51 (ddd. J = 3.83, 3.83, 13.59 Hz, 1H), 2.14 – 1.95 (m, 2H), 1.44 (dd, J = 
3.48, 11.15 Hz, 1H); 
13C NMR (75.4 MHz, CDCl3): δ 150.5, 149.6, 137.6, 135.3, 124.4, 60.5, 59.2, 55.6, 54.3, 
35.9, 34.8; 
FTIR (neat): 3403, 2947, 2835, 2609, 2129, ,1643, 1458, 1400, 1107, 1025 cm-1; 

















172 169  
 
172 (1.88 g, 5.10 mmol) in dry acetonitrile (500 mL) were heated to reflux where the 
temperature oil bath was strictly kept below 83 oC. The reaction mixture was allowed to stir 
for up to 2 days. When TLC had shown the near depletion of the starting material 172, the 
reaction mixture was cooled to room temperature and 10% NaOH solution (20 mL) was 
added. The resultant solution was stirred for a further 15 minutes and concentrated in vacuo. 
CH2Cl2 (5 x 50 mL) was used to extract the aqueous layer before the combined organic 
extracts were dried in anhydrous K2CO3. The mixture was then filtered and concentrated in 
vacuo. The crude product was purified via flash column chromatography (100:2:1 
CH2Cl2/MeOH/c.NH4OH), yielding 1.33 g [4.65 mmol, 85%(isolated yield); 
100%(convergent yield)] of the product 169 as a light brown oil. The starting material 172 
was usually recovered (0.24 g, 0.85 mmol, 10%) with the dehalogenated side product 173 
isolated as well (<5%). 
Rf = 0.50 (9:1 CH2Cl2/MeOH); 
[α]D25 = + 26.2o (0.6, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 8.21 (d, J = 1.38 Hz, 1H), 7.44 (dd, J = 1.41, 4.98 Hz, 1H), 
7.29 (d, J = 4.98 Hz, 1H), 4.15 (d, J = 2.49 Hz, 1H), 3.88 – 3.85 (m, 2H), 3.68 – 3.66 (m, 1H), 
1.90 – 1.84 (m, 1H),  
13C NMR (75.4 MHz, CDCl3): δ 150.0, 148.6, 137.6, 132.3, 124.1, 69.3, 61.9, 59.9, 55.6, 
28.2, 22.1; 
FTIR (neat): 2955, 2930, 1724, 1642, 1461, 1286, 1107, 808, 733 cm-1; 
HRMS (ESI) Calcd for C11H12BrClN2 [M+]: 285.9872, found: 286.9944 (M + 1). 
Experimental Section 
 151 
















Rf = 0.30 (9:1 CH2Cl2/MeOH); 
[α]D25 = + 28.7o (0.9, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 8.37 (d, J = 2.09 Hz, 1H), 7.61 (dd, J = 2.44, 8.36 Hz, 1H), 
7.27 (d, J = 8.36 Hz, 1H), 6.56 (d, J = 2.09 Hz, 1H), 4.65 (d, J = 2.79 Hz, 1H), 4.41 (s, 1H), 
2.06 – 2.03 (m, 2H), 1.33 – 1.18 (m, 2H); 
13C NMR (75.4 MHz, CDCl3): δ 150.2, 146.3, 144.7, 135.2, 1332.1, 127.9, 124.2, 61.2, 60.7, 
25.0, 23.4; 
FTIR (neat): 3419, 2954, 2545, 2421, 2243, 2136, 1651, 1580, 1462, 1366, 1267, 1209, 1140, 
1028, 956, 919, 875, 819, 735 cm-1; 

















169 174  
 
ACCN (0.48 g, 1.96 mmol) was added into a stirred solution of 169 (2.05 g, 9.81 mmol), 
Bu3SnH (26.38 mL, 98.1 mmol) and benzene (800 mL) and the resultant reaction mixture was 
heated to reflux at 81 oC for up to 2 hours. When TLC had shown the full depletion of the 
starting material 169, the reaction mixture was concentrated in vacuo. The crude product was 
purified via flash column chromatography (100:3:1 CH2Cl2/MeOH/c.NH3), yielding 2.04 g 
(9.78 mmol, 100%) of the endo adduct 174 as a light brown oil. 
Rf = 0.18 (6:1 CH2Cl2/MeOH); 
[α]D25 = – 6.3o (0.7, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 8.24 (d, J = 2.79 Hz, 1H), 7.46 (dd, J = 2.46, 8.37 Hz, 1H), 
7.27 (d, J = 7.32 Hz, 1H), 3.75 – 3.80 (m, 2H), 3.30 (ddd, J =  Hz, 1H), 2.11 (dddd, J =  Hz, 
1H), 1.70 – 1.52 (m, 1H), 1.50 (dd, J = 5.57, 12.54 Hz, 1H), 1.45 – 1.32 (m, 3H); 
13C NMR (75.4 MHz, CDCl3): δ 149.6, 149.2, 138.4, 135.9, 123.7, 61.1, 57.5, 44.9, 34.9, 
31.0, 24.1; 
FTIR (neat): 2963, 2876, 1582, 1561, 1459, 1366, 1197, 1105, 1025, 934, 870, 799, 740 cm-1; 
















174 122  
 
KOtBu (3.14 g, 28.02 mmol) was added into a stirred solution of 174 (1.95 g, 9.34 mmol) in 
tBuOH (300 mL) at room temperature. The reaction mixture was then heated to reflux at 85 
oC for 3 hours before the same amount of KOtBu was added again after the reaction mixture 
had cooled down. The sequential addition of the base was continued for up to 4 days. The 
reaction mixture was then concentrated in vacuo (Another workup method involved 
dissolving the reaction mixture in 10% K2CO3 solution before extracting it with CH2Cl2). The 
crude product was then purified by flash column chromatography (100:4:1 
CH2Cl2/MeOH/c.NH3), yielding 1.13 g [5.41 mmol, 58% (isolated yield); 81%(convergent 
yield)] of the exo adduct 122 as a faint yellow oil. The starting material 174 was recovered 
(0.078 g, 0.37 mmol, 30%).  
Rf = 0.51 (9:1:0.1 CH2Cl2/MeOH/c.NH4OH); 
[α]D25 = – 5.1o (0.6, CHCl3);103 
1H NMR (300 MHz, CDCl3): δ 8.27 (d, J = 2.43 Hz, 1H), 7.76 (dd, J = 2.43, 8.34 Hz, 1H), 
7.23 (d, J = 8.34 Hz, 1H), 3.79 (t, J = 4.20 Hz, 1H), 3.55 (s, 1H), 2.76 (dd, J = 5.22, 9.03 Hz, 
1H), 1.90 (dd, J = 9.03, 12.18 Hz, 1H), 1.63 – 1.56 (m, 5H); 
13C NMR (75.4 MHz, CDCl3): δ 148.8, 148.6, 141.0, 137.7, 123.9, 62.8, 56.5, 44.6, 40.3, 
31.4, 30.2; 
FTIR (neat): 3257, 2965, 2873, 1658, 1563, 1459, 1103, 1056, 1024, 820, 736 cm-1; 
HRMS (ESI) Calcd for C11H13ClN2 [M+]: 208.0767, found: 209.0842 (M + 1). 
 
 ____________________________ 60  Evans, D. A.; Scheidt, K. A.; Downey, C. W. Org. Lett. 2001, 3, 3009. 




1H and 13C NMR Spectral Comparison of Synthetic Epibatidine 
Lee and Loh 
(−)-epibatidine 
 
Evans et al. 
Org. Lett. 2001, 3, 3009 
(−)-epibatidine 
 
Kibayashi et al. 
J. Org. Chem. 1998, 63, 8397 
(−)-epibatidine 
1H NMR   
8.27 (d, J = 2.43 Hz, 1H) 
7.76 (dd, J = 2.43, 8.34 Hz, 1H) 
7.23 (d, J = 8.34 Hz, 1H) 
3.79 (t, J = 4.20 Hz, 1H) 
3.55 (s, 1H) 
2.76 (dd, J = 5.22, 9.03 Hz, 1H) 
1.90 (dd, J = 9.03, 12.18 Hz, 1H) 
1.63 – 1.56 (m, 5H); 
8.27 (d, J = 2.4 Hz, 1H) 
7.77 (dd, J = 2.4, 8.3 Hz, 1H) 
7.23 (d, J = 8.3 Hz, 1H) 
3.80 (dd, J = 4.4, 4.4 Hz, 1H) 
3.57 (d, J = 2.4 Hz, 1H) 
2.76 (dd, J = 4.9, 9.3 Hz, 1H) 
1.91 (dd, J = 9.3, 12.2 Hz, 1H) 
1.65 – 1.50 (m, 5H) 
8.27 (d, J = 2.5 Hz, 1H) 
7.76 (dd, J = 2.5, 8.3 Hz, 1H) 
7.23 (d, J = 8.3 Hz, 1H) 
3.80 (t, J = 4.0 Hz, 1H) 
6.60 (d, J = 2.0 Hz, 1H) 
2.77 (dd, J = 4.9, 9.0 Hz, 1H) 
1.91 not reported (?) 
1.65 – 1.48 (m, 5H) 





































3.5 ASYMMETRIC SYNTHESIS OF C-ALIPHATIC HOMOALLYLIC ALCOHOLS 
AND BIOLOGICALLY IMPORTANT CYCLOHEXENYLAMINE ANALOGS 
 
Preparation of (S)-Phenylglycine methyl ester for imine formation. 
(S)-Phenylglycine methyl ester (10 g, 60 mmol) was dissolved in saturated Na2CO3 (150 mL) 
and was extracted with diethyl ether (5 x 100 mL). The combined organic phases were 
washed with brine, before drying over MgSO4. The crude mixture was then filtered and 
concentrated in vacuo. The crude product was obtained as light yellow oil and was used for 
subsequent reaction without any purification. 
 
General procedure for the preparation of imines. 
To a stirred solution of aldehyde (1mmol, 1 equiv) and Na2SO4 (0.5 g) in dichloromethane (3 
mL, 0.33M) under nitrogen at 0 o C was added (S)-phenylglycine methyl ester (1.5 – 2.0 
mmol, 1.5 to 2.0 equiv). The reaction mixture was allowed to stir for 5 hrs. The resulting 
reaction mixture was then filtered and concentrated in vacuo. The crude product obtained was 
used without purification for subsequent steps. 
 
General reaction procedure for the Zn mediated allylation of chiral imines. 
To a stirred suspension of the chiral imine (1 mmol) in THF (5 mL) and “activated” Zn 
powder (3.2 mmol), was added the allylic bromide (3.0 mmol) at 0 oC and the reaction 
mixture was stirred for up to 7 hours. The reaction mixture was then quenched with saturated 
NaHCO3 (10 mL) before being extracted with CH2Cl2 (3 x 10 mL). The mixture was then 
washed with water (2 x 10mL), before being dried with Na2SO4 and concentrated in vacuo. 








 (76 % de) 
Light yellow oil (181 mg, 60 %);  
Rf = 0.65 (10:1 hexane/ethyl acetate); 
[α]D25 = + 29.2 o (0.4, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.40 – 7.28 (m, 5H), 5.87 – 5.73 (m, 1H), 5.13 – 5.03 (m, 2H), 
4.51 (s, 1H), 3.67 (s, 3H), 2.34 – 2.22 (m, 2H), 2.18 – 2.08 (m, 1H), 1.73 – 1.61 (m, 5H), 1.44 
– 1.35 (m, 1H), 1.18 – 0.97 (m, 5H); 
13C NMR (75.4 MHz, CDCl3) δ 173.9, 138.8, 136.4, 136.1, 128.5, 127.9, 127.8, 127.6, 117.1, 
116.9, 63.2, 59.2, 52.1, 40.6, 35.1, 29.1, 28.6, 26.7, 26.6, 26.5; 
FTIR (neat): 3332, 3064, 3028, 2925, 2852, 2668, 1739, 1638, 1450, 1313, 1204, 1170, 993, 
914, 783, 736, 698, 519 cm-1; 








(60 % de; syn : anti = 75 : 25) 
Light yellow oil (296 mg, 94 %);  
Rf = 0.58 (8:1 hexane/ethyl acetate); 
[α]D25 = + 26.4 o (0.4, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.38 – 7.27 (m, 5H), 5.93 – 5.80 (m, 1H), 5.07 – 4.98 (m, 2H), 
4.48 (s, 1H), 3.66 (s, 3H), 2.45 – 2.39 (m, 1H), 2.19 – 2.11 (m, 1H), 1.64 – 1.46 (m, 5H), 1.44 
– 1.33 (m, 1H), 1.21 – 1.04 (m, 8H); 
13C NMR (75.4 MHz, CDCl3) δ 173.9, 173.8, 143.3, 142.2, 128.3, 128.3, 127.9, 127.7, 114.4, 
113.4, 65.2, 64.8, 64.1, 51.9, 51.8, 41.0, 40.7, 40.5, 39.7, 31.3, 31.1, 28.8, 28.6, 26.8, 26.7, 
26.6, 26.6, 26.5, 17.8, 15.0; 
FTIR (neat): 3839, 3064, 2925, 2851, 1738, 1491, 1451, 1169, 1001, 912, 730, 699 cm-1; 








(78 % de) 
Light yellow oil (303 mg, 92 %);  
Rf = 0.69 (8:1 hexane/ethyl acetate); 
[α]D25 = + 17.5 o (0.4, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.42 – 7.28 (m, 5H), 5.90 (dd, J = 17.1, 11.2 Hz, 1H), 5.02 – 
4.96 (m, 2H), 4.50 (s, 1H), 3.68 (s, 3H), 2.06 (d, J = 1.7 Hz, 1H), 1.74 – 1.62 (m, 5H), 1.32 – 
1.24 (m, 1H), 1.09 – 0.99 (m, 11H); 
13C NMR (75.4 MHz, CDCl3) δ 173.9, 147.1, 139.5, 128.4, 127.8, 127.6, 111.6, 68.6, 66.2, 
51.8, 43.0, 39.2, 35.6, 29.1, 27.4, 26.8, 26.5, 24.6, 23.6; 
FTIR (neat): 3038, 3061, 2851, 2525, 1939, 1491, 1450, 1167, 1005, 912, 698, 575 cm-1; 









 (76 % de; syn : anti = 82 : 18) 
Yellow oil (245 mg, 65 %);  
Rf = 0.59 (8:1 hexane/ethyl acetate); 
[α]D25 = + 36.7 o (0.5, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.35 – 7.24 (m, 8H), 7.20 – 7.17 (m, 2H), 6.06 (dt, J = 17.7, 
9.4 Hz, 1H), 5.08 – 5.02 (m, 1H), 3.80 (s, 1H), 3.48 (s, 3H), 2.61 (dd, J = 8.7, 2.8 Hz, 1H), 
1.82 (brs, 2H), 1.73 (brs, 4H), 1.50 – 1.44 (m, 1H), 1.21 – 1.11 (m, 5H); 
13C NMR (75.4 MHz, CDCl3) δ 173.4, 140.1, 139.2, 128.6, 128.4, 128.2, 128.1, 127.7, 126.5, 
115.4, 64.2, 63.9, 55.0, 52.0, 40.4, 31.4, 31.5, 26.8, 26.6, 26.5; 
FTIR (neat): 3700, 3356, 3062, 3029, 2926, 2851, 2665, 1948, 1871, 1805, 1737, 1635, 1599, 
1491, 1305, 1247, 1173, 996, 915, 847, 760, 734, 517 cm-1; 








 (78 % de) 
Light yellow oil (205 mg, 65 %);  
Rf = 0.59 (8:1 hexane/ethyl acetate); 
[α]D25 = – 1.3 o (0.4, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.38 – 7.28 (m, 5H), 4.89 – 4.78 (m, 2H), 4.51 (s, 1H), 3.68 
(s, 3H), 2.52 – 2.47 (m, 1H), 2.14 – 2.05 (m, 2H), 1.76 – 1.52 (m, 8H), 1.46 – 1.40 (m, 1H), 
1.27 – 1.01 (m, 5H); 
13C NMR (75.4 MHz, CDCl3) δ 173.9, 143.6, 143.3, 138.9, 128.5, 127.8, 127.4, 113.4, 113.1, 
72.4, 63.0, 57.1, 52.0, 43.4, 42.9, 40.2, 39.6, 39.0, 28.8, 28.2, 27.8, 26.9, 26.8, 26.7, 26.6, 
26.3, 26.2, 22.2, 20.0; 
FTIR (neat): 3028, 2926, 2852, 1740, 1645, 1581, 1450, 1311, 1240, 1168, 892, 735, 698, 
627, 516 cm-1; 









 (64 % de) 
Yellow oil (65 mg, 20 %);  
Rf = 0.44 (8:1 hexane/ethyl acetate); 
[α]D25 = + 4.3 o (0.2, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.40 – 7.08 (m, 10H), 5.88 – 5.74 (m, 1H), 5.15 – 5.10 (m, 
1H), 4.51 (s, 1H), 3.67 (s, 3H), 2.67 – 2.54 (m, 3H), 2.36 – 2.16 (m, 3H), 1.72 (dt, J = 8.0, 2.1 
Hz, 2H); 
13C NMR (75.4 MHz, CDCl3) δ 173.8, 142.4, 138.7, 135.1, 128.8, 128.7, 128.6, 128.3, 128.3, 
128.2, 128.0, 127.6, 125.7, 117.7, 62.8, 54.1, 52.2, 38.4, 35.9, 31.7; 
FTIR (neat): 3063, 2927, 2587, 1949, 1737, 1638, 1600, 1452, 1367, 1206, 1170, 1072, 996, 
914, 744, 699 cm-1; 









 (56 % de; syn : anti = 79 : 21) 
Yellow oil (132 mg, 39 %);  
Rf = 0.58 (8:1 hexane/ethyl acetate); 
[α]D25 = + 22.7 o (0.4, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.29 – 7.05 (m, 10H), 5.75 – 5.58 (m, 1H), 5.10 – 5.04 (m, 
1H), 4.16 (s, 1H), 3.61 (s, 3H), 2.74 – 2.68 (m, 3H), 2.58 – 2.51 (m, 2H), 2.17 – 2.05 (m, 1H), 
0.8 (d, J = 6.9 Hz, 3H); 
13C NMR (75.4 MHz, CDCl3) δ 174.4, 142.0, 141.9, 141.8, 141.7, 140.2, 138.6, 137.1, 131.0, 
128.7, 128.6, 128.6, 128.5, 128.4, 128.3, 128.2, 128.1, 127.6, 127.5, 127.2, 127.0, 125.8, 
125.7, 125.6, 116.0, 114.2, 68.4, 65.0, 62.2, 51.7, 42.2, 36.1, 34.9, 33.3, 30.6, 18.2, 13.6; 
FTIR (neat): 3062, 3027, 2952, 1737, 1599, 1453, 1300, 1204, 1170, 997, 917, 733, 699, 551 
cm-1; 









 (78 % de) 
Yellow oil (253 mg, 72 %);  
Rf = 0.70 (8:1 hexane/ethyl acetate); 
[α]D25 = + 32.8 o (0.6, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.42 – 7.09 (m, 10H), 5.88 (dd, J = 17.1, 11.5 Hz, 2H), 5.04 – 
4.98 (m, 2H), 4.47 (s, 1H), 3.67 (s, 3H), 2.53 (dt, J = 5.6, 5.3 Hz, 1H), 2.28 – 2.17 (m, 2H), 
1.86 – 1.74 (m, 1H), 1.49 – 1.37 (m, 1H), 1.04 (s, 3H), 1.02 (s, 3H); 
13C NMR (75.4 MHz, CDCl3) δ 173.9, 146.9, 142.7, 139.7, 128.9, 128.6, 128.5, 128.4, 128.2, 
128.0, 127.9, 127.1, 125.6, 112.1, 65.2, 63.9, 52.1, 42.4, 34.3, 34.1, 24.1, 23.2; 
FTIR (neat): 3027, 2954, 2868, 1737, 1600, 1454, 1361, 1307, 1253, 1201, 1169, 1004, 914, 
738, 699 cm-1; 









 (76 % de; syn : anti = 90 : 10) 
Dark Yellow oil (231 mg, 58 %);  
Rf = 0.48 (8:1 hexane/ethyl acetate); 
[α]D25 = + 29.7 o (0.8, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.34 – 6.95 (m, 15H), 6.08 (dt, J = 10.5, 9.4 Hz, 1H), 5.21 – 
5.15 (m, 2H), 4.40 (s, 1H), 3.61 (3H), 3.57 – 3.48 (m, 1H), 2.86 (dt, J = 10.5, 3.8 Hz, 1H), 
2.71 (ddd, J = 10.5, 5.6, 5.2 Hz, 1H), 2.44 (ddd, J = 10.5, 6.3, 5.6 Hz, 1H), 1.80 – 1.63 (m, 
3H); 
13C NMR (75.4 MHz, CDCl3) δ 173.4, 142.6, 141.8, 138.9, 138.0, 128.6, 128.5, 128.4, 128.2, 
128.1, 128.0, 127.8, 126.6, 125.6, 117.2, 63.0, 58.6, 53.4, 52.2, 32.8, 31.0; 
FTIR (neat): 3027, 2949, 1737, 1601, 1491, 1452, 1305, 1171, 996, 920, 737, 700 cm-1; 









 (80 % de) 
Yellow oil (67 mg, 20 %);  
Rf = 0.68 (8:1 hexane/ethyl acetate); 
[α]D25 = + 23.0 o (0.7, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.35 – 7.13 (m, 10H), 4.91 (brs, 1H), 4.85 (brs, 1H), 4.30 (s, 
1H), 3.59 (s, 3H), 3.25 – 3.20 (m, 1H), 2.81 – 2.76 (m, 2H), 2.56 (q, J = 7.3 Hz, 2H), 2.13 – 
2.05 (m, 1H), 1.95 (brs, 1H), 1.79 (s, 3H); 
13C NMR (75.4 MHz, CDCl3) δ 174.1, 142.8, 141.8, 140.0, 138.7, 138.6, 129.2, 128.5, 128.4, 
128.3, 128.2, 128.1, 127.9, 127.6, 127.5, 127.0, 125.8, 125.7, 113.6, 61.8, 58.8, 51.6, 44.9, 
35.9, 33.6, 30.2, 21.5; 
FTIR (neat): 3062, 3027, 2927, 2854, 1737, 1641, 1600, 1492, 1452, 1309, 1205, 1170, 986, 
895, 735, 699 cm-1; 








 (80 % de) 
Yellow oil (71 mg, 26 %);  
Rf = 0.41 (8:1 hexane/ethyl acetate); 
[α]D25 = + 37.9 o (0.5, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.38 – 7.28 (m, 5H), 5.83 – 5.67 (m, 2H), 5.13 – 5.07 (m, 2H), 
4.98 – 4.86 (m, 2H), 4.50 (s, 1H), 3.68 (s, 3H), 2.52 (qn, J = 5.9 Hz, 1H), 2.25 – 2.15 (m, 2H), 
2.10 – 2.02 (m, 2H), 1.52 – 1.45 (m, 2H); 
13C NMR (75.4 MHz, CDCl3) δ 173.8, 138.6, 135.1, 128.6, 127.9, 127.5, 117.6, 114.5, 62.7, 
53.8, 52.2, 38.3, 33.3, 29.7; 
FTIR (neat): 3072, 2926, 2855, 1819, 1740, 1640, 1452, 1364, 1311, 1208, 1122, 1028, 995, 
914, 736, 699 cm-1; 








 (50 % de; syn : anti = 86 : 14) 
Yellow oil (169 mg, 59 %);  
Rf = 0.66 (8:1 hexane/ethyl acetate); 
[α]D25 = + 31.2 o (0.2, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.40 – 7.29 (m, 5H), 5.88 – 5.63 (m, 2H), 5.10 – 5.02 (m, 2H), 
4.91 – 4.85 (m, 2H), 4.51 (s, 1H), 3.67 (s, 3H), 2.47 – 2.41 (m, 1H), 2.39 – 2.32 (m, 1H), 2.19 
– 2.09 (m, 1H), 1.99 – 1.86 (m, 1H), 1.49 – 1.41 (m, 1H), 1.38 – 1.29 (m, 1H), 0.98 (d, J = 6.9 
Hz, 3H); 
13C NMR (75.4 MHz, CDCl3) δ 173.6, 141.7, 140.7, 138.9, 138.8, 138.7, 128.4, 127.8, 127.7, 
127.5, 114.9, 114.4, 63.0, 62.8, 58.4, 52.1, 39.9, 39.3, 30.3, 30.1, 29.5, 15.4, 14.8; 
FTIR (neat): 3072, 3029, 2958, 1739, 1600, 1639, 1452, 1373, 1315, 1252, 1203, 1171, 1132, 
998, 912, 785, 733, 699 cm-1; 








 (78 % de) 
Yellow oil (197 mg, 72 %);  
Rf = 0.64 (8:1 hexane/ethyl acetate); 
[α]D25 = + 40.6 o (0.5, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.38 – 7.28 (m, 5H), 5.88 (dd, J = 17.1, 11.5 Hz, 1H), 5.62 
(ddt, J = 13.9, 10.5, 6.6 Hz, 1H), 5.13 – 5.07 (m, 2H), 4.98 – 4.86 (m, 2H), 4.50 (s, 1H), 3.68 
(s, 3H), 2.56 – 2.48 (m, 1H), 2.25 – 2.15 (m, 2H), 2.10 – 2.02 (m, 2H), 1.52 – 1.45 (m, 2H); 
13C NMR (75.4 MHz, CDCl3) δ 173.8, 138.6, 135.1, 128.6, 127.9, 127.5, 117.6, 114.5, 62.7, 
53.8, 52.2, 38.3, 33.3, 29.7; 
FTIR (neat): 3072, 2926, 2855, 1819, 1740, 1640, 1452, 1364, 1311, 1208, 1122, 1028, 995, 
914, 736, 699 cm-1; 









 (80 % de; syn : anti = 95 : 5) 
Dark Yellow oil (216 mg, 62 %);  
Rf = 0.55 (8:1 hexane/ethyl acetate); 
[α]D25 = + 33.8 o (0.6, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.30 – 7.17 (m, 10H), 6.08 (dt, J = 16.7, 9.8 Hz, 1H), 5.64 
(ddt, J = 13.9, 9.8, 6.6 Hz, 1H), 5.19 – 5.12 (m, 2H), 4.86 – 4.82 (m, 2H), 4.39 (s, 1H), 3.62 
(s, 3H), 3.53 – 3.48 (m, 1H), 2.80 (q, J = 3.8 Hz, 1H), 2.21 – 2.11 (m, 1H), 2.09 – 1.93 (m, 
1H), 1.49 – 1.43 (m, 1H); 
13C NMR (75.4 MHz, CDCl3) δ 173.2, 141.8, 138.6, 137.9, 128.4, 128.4, 128.1, 127.8, 127.6, 
126.4, 117.0, 114.3, 62.7, 58.3, 23.3, 21.9, 29.9, 29.1; 
FTIR (neat): 3063, 3028, 2947, 2405, 1738, 1639, 1600, 1492, 1450, 1309, 1207, 1172, 996, 
915, 732, 700 cm-1; 








 (30 % de) 
Yellow oil (72 mg, 25 %);  
Rf = 0.48 (8:1 hexane/ethyl acetate); 
[α]D25 = + 4.1 o (0.4, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.37 – 7.28 (m, 5H), 5.74 (ddt, J = 14.3, 10.5, 6.6 Hz, 1H), 
4.98 – 4.85 (m, 4H), 4.50 (s, 1H), 3.68 (s, 3H), 2.63 (q, J = 5.9 Hz, 1H), 2.15 (d, J = 6.6 Hz, 
2H), 2.11 – 2.03 (m, 2H), 1.70 (s, 3H), 1.51 – 1.44 (m, 2H); 
13C NMR (75.4 MHz, CDCl3) δ 173.9, 143.0, 138.6, 128.7, 127.9, 127.5, 127.4, 114.5, 113.4, 
62.6, 52.1, 52.0, 43.4, 33.2, 29.5, 22.1; 
FTIR (neat): 3072, 2929, 2854, 1740, 1641, 1313, 1204, 1170, 996, 895, 736, 699 cm-1; 








 (74 % de) 
Yellow oil (75 mg, 25 %);  
Rf = 0.55 (8:1 hexane/ethyl acetate); 
[α]D25 = + 26.4 o (0.4, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.38 – 7.27 (m, 5H), 5.84 – 5.76 (m, 1H), 5.36 – 5.31 (m, 1H), 
5.27 – 5.22 (m, 1H), 5.15 – 5.09 (m, 2H), 4.50 (s, 1H), 3.68 (s, 3H), 2.53 (qn, J = 6.0 Hz, 1H), 
2.29 – 2.24 (m, 1H), 2.18 – 2.13 (m, 2H), 2.09 – 1.97 (m, 3H), 1.48 – 1.43 (m, 2H), 0.94 (t, J 
= 7.4 Hz, 3H); 
13C NMR (75.4 MHz, CDCl3) δ 173.8, 138.6, 135.2, 132.2, 131.9, 128.6, 128.6, 128.5, 127.9, 
127.5, 117.9, 117.5, 62.8, 54.2, 52.1, 41.9, 38.4, 367, 34.1, 23.4, 23.1, 20.5, 14.3; 
FTIR (neat): 3004, 2960, 2929, 1740, 1639, 1454, 1309, 1255, 1205, 1170, 996, 915, 735, 698 
cm-1; 








 (60 % de; syn : anti = 81 : 19) 
Yellow oil (167 mg, 53 %);  
Rf = 0.60 (8:1 hexane/ethyl acetate); 
[α]D25 = + 43.7 o (0.5, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.41 – 7.28 (m, 5H), 5.83 (ddd, J = 13.6, 10.5, 6.9 Hz, 1H), 
5.36 – 5.17 (m, 2H), 5.09 – 5.02 (m, 2H), 4.51 (s, 1H), 3.68 (s, 3H), 2.46 – 2.29 (m, 2H), 2.17 
– 1.84 (m, 4H), 1.49 – 1.23 (m, 2H), 1.99 (d, J = 6.9 Hz, 3H), 0.92 (t, J = 7.4 Hz, 3H); 
13C NMR (75.4 MHz, CDCl3) δ 173.8, 141.0, 138.9, 131.8, 128.8, 128.6, 128.5, 127.9, 127.7, 
127.5, 114.9, 62.9, 58.9, 52.2, 39.5, 31.1, 23.8, 20.5, 15.4, 14.3; 
FTIR (neat): 3003, 2962, 1873, 1740, 1638, 1454, 1374, 1204, 1170, 999, 914, 731, 698 cm-1; 








 (80 % de) 
Yellow oil (303 mg, 92 %);  
Rf = 0.71 (8:1 hexane/ethyl acetate); 
[α]D25 = + 43.7 o (0.4, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.41 – 7.28 (m, 5H), 5.92 (dd, J = 11.9, 10.4 Hz, 1H), 5.39 – 
5.15 (m, 2H), 5.07 – 5.07 (m, 2H), 4.50 (s, 1H), 3.68 (s, 3H), 2.23 (dd, J = 6.9, 3.5 Hz, 1H), 
2.06 (brs, 1H), 1.98 – 1.88 (m, 2H), 1.78 – 1.67 (m, 1H), 1.63 – 1.51 (m, 1H), 1.27 – 1.17 (m, 
1H), 1.06 (s, 3H), 0.96 (s, 3H), 0.93 (t, J = 6.9 Hz, 3H); 
13C NMR (75.4 MHz, CDCl3) δ 173.8, 146.9, 139.4, 131.6, 128.8, 128.4, 127.8, 127.6, 111.8, 
64.9, 63.8, 51.9, 42.1, 32.0, 25.8, 24.0, 22.9, 20.4, 14.3; 
FTIR (neat): 3004, 2963, 2872, 1740, 1690, 1637, 1434, 1454, 1363, 1257, 1199, 1166, 1130, 
1071, 913, 865, 728, 699 cm-1; 









 (80 % de; syn : anti = 88 : 12) 
Dark Yellow oil (253 mg, 67 %);  
Rf = 0.55 (8:1 hexane/ethyl acetate); 
[α]D25 = + 39.2 o (0.3, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.36 – 7.22 (m, 10H), 6.12 (ddd, J = 16.4, 15.3, 9.4 Hz, 1H), 
5.37 – 5.15 (m, 4H), 4.42 (s, 1H), 3.63 (s, 3H), 3.52 (dd, J = 9.4, 7.3 Hz, 1H), 2.89 – 2.83 (m, 
1H), 2.20 – 2.10 (m, 2H), 2.09 – 1.93 (m, 2H), 1.59 – 1.39 (m, 2H), 0.93 (t, J = 7.7 Hz, 3H); 
13C NMR (75.4 MHz, CDCl3) δ 173.3, 141.8, 138.6, 138.2, 131.7, 128.8, 128.6, 128.4, 128.1, 
127.9, 127.8, 127.5, 126.5, 116.8, 62.8, 58.6, 53.6, 51.9, 30.8, 22.5, 20.4, 14.3; 
FTIR (neat): 3063, 3028, 3004, 2960, 2932, 2872, 1738, 1600, 1492, 1453, 1306, 1204, 1170, 
995, 919, 731, 700 cm-1; 








 (46 % de) 
Yellow oil (66 mg, 21 %);  
Rf = 0.51 (8:1 hexane/ethyl acetate); 
[α]D25 = + 20.3 o (0.3, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.37 – 7.26 (m, 5H), 5.38 – 5.32 (m, 1H), 5.29 – 5.23 (m, 1H), 
4.87– 4.79 (m, 2H), 4.51 (s, 1H), 3.68 (s, 3H), 2.67 – 2.62 (m, 1H), 2.17 – 2.07 (m, 2H), 2.06 
– 1.98 (m, 5H), 1.72 (s, 3H), 1.53 – 1.39 (m, 2H), 0.95 (t, J = 7.4 Hz, 3H); 
13C NMR (75.4 MHz, CDCl3) δ 173.9, 143.0, 138.6, 131.9, 128.7, 128.7, 127.9, 127.4, 113.4, 
62.7, 52.3, 52.1, 43.4, 34.0, 22.9, 22.1, 20.5, 14.3; 
FTIR (neat): 3004, 2960, 1720, 1646, 1452, 1204, 1168, 892, 731, 698 cm-1; 









General reaction procedure for the ring-closing metathesis of homoallylic amines. 
To a stirred suspension of the chiral homoallylic amine (1 mmol) in CH2Cl2 (100 mL) was 
added the Grubbs’ 2nd generation catalyst (0.1 mmol) at two portions (interval of 30 minutes) 
at 25 oC and the reaction mixture was stirred for up to 12 hours. Reactions were heated to 
reflux at 40 oC if the TLC showed starting material after 12 hours of stirring at room 
temperature The reaction mixture was then filtered through a pad of celite before being 







Dark brown oil (216 mg, 88 %);  
Rf = 0.29 (8:1 hexane/ethyl acetate); 
[α]D25 = + 76.8 o (0.3, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.40 – 7.29 (m, 5H), 5.64 – 5.54 (m, 2H), 4.55 (s, 1H), 3.69 
(s, 3H), 2.71 – 2.61 (m, 1H), 2.29 – 2.24 (m, 1H), 2.09 – 1.79 (m, 3H), 1.52 – 1.39 (m, 2H); 
13C NMR (75.4 MHz, CDCl3) δ 173.9, 138.4, 128.8, 128.1, 128.0, 127.4, 126.9, 124.7, 62.6, 
52.3, 50.8, 32.1, 29.2, 24.4; 
FTIR (neat): 3025, 2920, 2839, 1752, 1295, 1246, 1203, 1170, 929, 783, 698 cm-1; 









Dark brown oil (218 mg, 84 %);  
Rf = 0.51 (8:1 hexane/ethyl acetate); 
[α]D25 = + 1.8 o (0.4, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.41 – 7.27 (m, 5H), 5.63 – 5.59 (m, 1H), 5.45 (ddd, J = 10.2, 
2.3, 1.8 Hz, 1H), 4.55 (s, 1H), 3.69 (s, 3H), 2.35 (dt, J = 9.7, 2.8 Hz, 1H), 2.14 – 1.93 (m, 3H), 
1.87 – 1.82 (m, 1H), 1.45 – 1.38 (m, 1H), 1.09 (d, J = 6.9 Hz, 3H); 
13C NMR (75.4 MHz, CDCl3) δ 174.0, 138.9, 131.6, 128.6, 128.5, 127.9, 127.5, 127.3, 125.8, 
125.6, 62.9, 58.2, 52.1, 36.4, 26.8, 23.8, 19.4; 
FTIR (neat): 3018, 2953, 2926, 2870, 1737, 1453, 1250, 1205, 1168, 1137, 1016, 729, 698 
cm-1; 









Dark brown oil (251 mg, 92 %);  
Rf = 0.61 (8:1 hexane/ethyl acetate); 
[α]D25 = + 25.1 o (0.5, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.45 – 7.28 (m, 5H), 5.50 (ddd, J = 10.2, 2.8, 1.8 Hz, 1H), 
5.36 (dt, J = 10.2, 1.9 Hz, 1H), 5.54 (s, 1H), 3.69 (s, 3H), 2.43 (dd, J = 11.1, 2.8 Hz, 1H), 2.06 
– 1.93 (m, 3H), 1.75 – 1.71 (m, 1H), 1.49 – 1.42 (m, 1H), 1.13 (s, 3H), 1.00 (s, 3H); 
13C NMR (75.4 MHz, CDCl3) δ 174.0, 139.1, 137.6, 128.5, 127.9, 127.3, 123.7, 63.7, 61.0, 
51.9, 36.2, 28.4, 24.7, 24.4, 22.9; 
FTIR (neat): 3013, 2954, 1738, 1454, 1363, 1298, 1204, 1168, 916, 737, 698 cm-1; 










Dark brown oil (276 mg, 86 %);  
Rf = 0.40 (8:1 hexane/ethyl acetate); 
[α]D25 = + 44.1 o (0.4, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.38 – 7.25 (m, 10H), 5.86 – 5.82 (m, 1H), 5.59 (ddd, J = 
10.2, 2.3, 1.9 Hz, 1H), 4.40 (s, 1H), 3.50 (s, 3H), 3.36 – 3.33 (m, 1H), 2.72 (dt, J = 10.6, 2.8 
Hz, 1H), 2.33 – 2.16 (m, 4H), 1.97 – 1.92 (m, 1H), 1.60 – 1.53 (m, 1H); 
13C NMR (75.4 MHz, CDCl3) δ 173.3, 143.4, 138.5, 129.0, 128.5, 128.4, 127.8, 127.3, 127.2, 
126.7, 62.8, 58.1, 51.9, 49.2, 27.0, 24.0; 
FTIR (neat): 3025, 2947, 2925, 2860, 1737, 1491, 1453, 1290, 1248, 1207, 1169, 1135, 1029, 
787, 760, 733,701 cm-1; 









Dark brown oil (202 mg, 78 %);  
Rf = 0.38 (8:1 hexane/ethyl acetate); 
[α]D25 = + 12.6 o (0.2, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 7.39 – 7.27 (m, 5H), 5.32 (brs, 1H), 4.56 (s, 1H), 3.69 (s, 3H), 
2.70 – 2.64 (m, 1H), 2.14 – 2.04 (m, 3H), 1.98 – 1.77 (m, 3H), 1.63 (s, 3H), 1.42 – 1.34 (m, 
1H); 
13C NMR (75.4 MHz, CDCl3) δ 173.8, 138.5, 131.8, 128.7, 128.0, 127.4, 120.7, 62.5, 52.2, 
51.3, 37.0, 28.8, 24.2, 23.5; 
FTIR (neat): 3029, 2920, 2839, 1738, 1492, 1450, 1435, 1377, 1314, 1203, 1171, 1008, 925, 
787, 730, 699 cm-1; 




























Grubbs’ 2nd generation catalyst 147 (0.11 g, 0.13 mmol) was added in one portion into a 
solution of 176 (1.01 g, 2.63 mmol) in CH2Cl2 (260 mL) at room temperature and the 
resultant solution was allowed to stir for 30 minutes. Another portion of the catalyst (0.11 g, 
0.13 mmol) was then added into the reaction mixture. When TLC had shown the full 
depletion of the starting material 176, the reaction mixture was then filtered through a pad of 
celite and the resultant solution was then evaporated in vacuo. The crude product was purified 
via flash column chromatography (12:1 hexane/ethyl acetate), yielding 0.82 g (2.31 mmol, 
88%) of the cyclohexenylamine 177 as a dark brown oil. 
Rf = 0.19 (4:1 hexane/ethyl acetate); 
1H NMR (300 MHz, CDCl3): δ 8.14 (d, J = 2.32 Hz, 1H), 7.28 (d, J = 2.31, 8.32 Hz, 1H), 
7.20 – 7.13 (m, 5H), 6.94 (d, J = 8.32 Hz, 1H), 5.83 – 5.79 (m, 1H), 5.41, (dd, J = 1.85, 9.71 
Hz, 1H), 4.33 (s, 1H), 3.60 (s, 3H), 3.23 – 3.20 (m, 1H), 2.38 – 2.34 (m, 1H), 2.12 – 2.05 (m, 
2H), 2.02 – 1.98 (m, 1H), 1.55 – 1.47 (m, 1H); 
13C NMR (75.4 MHz, CDCl3): δ 172.8, 149.7, 149.3, 138.3, 137.9, 137.4, 128.4, 128.3, 127.7, 
127.4, 127.1, 123.6, 62.3, 56.6, 52.0, 46.2, 26.8, 24.1; 





























178: Major 179: Minor177  
 
Tetraethylammonium bromide (4.30 g, 20.46 mmol) was added into a stirred solution of 177 
(0.73 g, 2.05 mmol) in CH2Cl2 (36 mL) and the solution was cooled to – 78 oC. After the 
reaction mixture had stirred for 45 minutes, bromine (0.32 mL, 6.14 mmol), which was 
diluted with CH2Cl2 (4 mL), was introduced slowly at the same temperature. The resultant 
solution was allowed to stir for a further 2 hours. When TLC had shown the full depletion of 
the starting material 177, the reaction mixture was washed with saturated NaHSO3 (2 x 10 
mL) and water (2 x 10 mL). After drying in Na2SO4, the reaction mixture was filtered and 
concentrated in vacuo. The crude product was purified via flash column chromatography 
(12:1 hexane/ethyl acetate), yielding 0.65 g (1.26mmol) of the major isomer 178 as a light 
yellow oil and 0.22 g (0.42 mmol) of the minor isomer 179 as a dark yellow paste (82% yield, 
75:25 ratio). 
Major diastereomer 178: (S)-Methyl 2-((1S,2R,3S,4R)-3,4-dibromo-2-(6-chloropyridin-3-
yl)cyclohexylamino)-2-phenylacetate 
Rf = 0.32 (3:1 hexane/ethyl acetate); 
1H NMR (300 MHz, CDCl3): δ 8.14 (d, J = 1.74 Hz, 1H), 7.38 – 7.36 (m, 3H), 7.19 – 7.15 
(m, 4H), 4.76 (d, J = 2.79 Hz, 1H), 4.47 (s, 1H), 4.39 (d, J = 2.09, 1H), 3.65 – 3.60 (m, 4H), 
3.09 (dt, J = 4.18, 10.80 Hz, 1H), 2.33 – 2.31 (m, 1H), 2.20 – 2.15 (m, 1H), 1.94 – 1.81 (m, 
2H); 
13C NMR (75.4 MHz, CDCl3): δ 172.9, 150.5, 150.3, 139.7, 137.4, 133.4, 128.7, 128.4, 127.6, 
123.4, 61.8,60.5, 52.6, 52.4, 49.9, 44.9, 27.4, 26.7; 
HRMS (ESI) Calcd for C20H21Br2ClN2O2 [M+]: 516.9658, found: 516.9712. 
Experimental Section 
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Major diastereomer 179: (S)-Methyl 2-((1S,2R,3S,4S)-3,4-dibromo-2-(6-chloropyridin-3-
yl)cyclohexylamino)-2-phenylacetate 
Rf = 0.25 (3:1 hexane/ethyl acetate); 
1H NMR (300 MHz, CDCl3): δ 8.15 (s, 1H), 7.29 – 7.22 (m, 5H), 6.85 – 6.82 (m, 2H), 4.16 
(s, 1H), 4.12 (dd, J = 4.53, 12.19 Hz, 1H), 3.99 – 3.92 (m, 1H), 3.59 (s, 3H), 2.93 (t, J = 10.80 
Hz, 1H), 2.59 – 2.42 (m, 1H), 2.24 – 2.17 (m, 1H), 2.00 – 1.86 (m, 2H), 1.51 – 1.37 (m, 1H); 
13C NMR (75.4 MHz, CDCl3): δ 172.4, 150.7, 149.7, 137.9, 136.6, 134.9, 128.8, 128.5, 127.2, 
124.2, 62.3, 60.6, 57.2, 55.3, 52.5, 35.6, 31.9, 29.7; 
HRMS (ESI) Calcd for C20H21Br2ClN2O2 [M+]: 516.9658, found: 516.9709. 






Crystal growing solvent Dichloromethane and hexane 
Empirical formula C20 H21 Br2 Cl N2 O2 
Formula weight 516.66 
Temperature 295(2) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group P2(1)/n 
Unit cell dimensions a = 9.5571(7) Å 
b = 20.2210(17) Å 
c = 11.8903(10) Å 
α = 90o. 
β = 111.691(2)o. 
γ = 90o. 
Volume 2135.1(3) Å3 
Z 4 
Density (calculated) 1.607 Mg/m3 
Absorption coefficient 3.939 mm-1 
F(000) 1032 
Crystal size 0.34 x 0.26 x 0.10 mm3 
Theta range for data collection 2.01 to 27.50o. 
Index ranges -9<=h<=12, -19<=k<=26, -15<=l<=15 
Reflections collected 14583 
Independent reflections 4690 [R(int) = 0.0434] 
Completeness to theta = 27.50o 99.9 % 
Absorption correction Sadabs, (Sheldrick 2001) 
Max. and min. transmission 0.6941 and 0.3477 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4690 / 1 / 249 
Goodness-of-fit on F2 1.019 
Final R indices [I>2sigma(I)] R1 = 0.0585, wR2 = 0.1366 
R indices (all data) R1 = 0.1097, wR2 = 0.1555 
Largest diff. peak and hole 1.036 and -0.632 e.Å-3 
In depth discussion with Professor Koh Lip Lin revealed that this stereoisomer could still be 
optically active even though a P2(1)/n space group (that includes both hands) was revealed. 












129 182  
 
Phosphorous tribromide (2.00 mL, 21.50 mmol) was introduced dropwise into a stirred 
solution of 129 (2.57 g, 17.80 mmol) in diethyl ether (150 mL) at 0 oC and the resulting 
mixture was allowed to stir for 5 hours.  When TLC had shown the full depletion of the 
starting material 129, sodium bicarbonate (20 mL) was then used to quench the reaction. 
Diethyl ether (5 x 40 mL) was used to extract the aqueous layer and the combined extracts 
were washed with brine (2 x 15 mL), dried (MgSO4) and evaporated in vacuo. The crude solid 
was purified via flash column chromatography (20:1 hexane/ethyl acetate), yielding 2.57 g 
(12.43 mmol, 72%) of the allylic bromide 182 as a white solid. 
Rf = 0.60 (4:1 hexane/ethyl acetate); 
1H NMR (300 MHz, CDCl3): δ 8.40 (d, J = 2.44 Hz, 1H), 7.70 (dd, J = 2.44, 8.36 Hz, 1H), 
7.33 (d, J = 8.36 Hz, 1H), 4.44 (s, 2H);  
13C NMR (75.4 MHz, CDCl3): δ 151.3, 149.5, 139.4, 132.6, 124.5, 28.4; 
FTIR (neat): 3679, 3047, 3031, 2857, 2662, 1583, 1460, 1381, 1099, 399, 835, 741, 692 cm-1; 














182 183  
 
Triphenylphosphine (0.74 g, 2.80 mmol) was added into a stirred solution of 182 (0.58 g, 2.80 
mmol) in THF (28 mL) at room temperature and the resulting mixture was heated to reflux. 
When TLC had shown the full depletion of the starting material 182, the reaction mixture was 
concentrated in vacuo. Hexane/Diethyl ether (9:1) was used to dilute the solid and the 
resultant suspension was filtered. The residual white solid was used immediately for the 











184 185  
 
A mixture of 184 (5.00 mL, 42.00 mmol), concentrated H2SO4 (0.15 mL) in water (11.50 mL) 
was heated at 100 oC for 2 hours. The reaction mixture was cooled and the aqueous phase was 
extracted with ether (3 x 20 mL). The combined organic extracts were washed with brine (2 x 
10 mL), dried over anhydrous MgSO4, filtered and concentrated by blowing N2 over the 
solution. The yellow liquid 185 obtained was used immediately for the next reaction without 


















Butyl lithium (1.6 M in hexane solution) (1.75 mL, 2.80 mmol) was introduced dropwise into 
a stirred solution of 183 (2.571.31 g, 2.80 mmol) in THF (20.70 mL) at – 78 oC and the 
resulting mixture was allowed to stir for 30 minutes.  185 (0.68 mL, 5.60 mmol) was then 
added slowly into the stirred solution at the same temperature and the resultant reaction 
mixture was allowed to stir for a further 2 hours. Sodium bicarbonate (15 mL) was used to 
quench the reaction and diethyl ether (5 x 20 mL) was used to extract the aqueous layer. The 
combined extracts were washed with brine (2 x 15 mL), dried (MgSO4) and evaporated in 
vacuo. The crude solid was purified via flash column chromatography (30:1 hexane/ethyl 
acetate), yielding 0.51 g with E/Z = 45/55 (2.21 mmol, 79%) of the allylic bromide 186 as a 
clear oil. 
Rf = 0.43 (4:1 hexane/ethyl acetate); 
1H NMR (300 MHz, CDCl3): δ 8.31 (d, J = 2.44 Hz, 1H), 7.60 (dd, J = 2.44, 8.01 Hz, 1H), 
7.30 (d, J = 8.01 Hz, 1H), 6.45 (d, J = 11.49 Hz, 1H), 6.13 – 6.04 (m, 1H), 4.01 (dd, J = 0.70, 
8.71 Hz, 2H);  
13C NMR (75.4 MHz, CDCl3): δ 149.6, 149.3, 138.3, 129.7, 129.6, 128.2, 123.9, 27.1; 
FTIR (neat): 1650, 1615, 1501, 1459, 1199, 1098, 970, 816, 580 cm-1; 












THF, 0 oC EtO2C
130 189  
 
A solution of 130 (1.42 g, 10.00 mmol) in THF (10L) was added into a stirred solution of the 
ylide (4.18 g, 12.00 mmol) in THF (23 mL) at 0 oC and the resultant solution was allowed to 
stir for up to 30 minutes. When TLC had shown the full depletion of the starting material 130, 
the reaction mixture was then concentrated in vacuo. The residual oil was purified via flash 
column chromatography (8:1 hexane/ethyl acetate), yielding 1.95 g (9.21 mmol, 92%) of the 
ester 189 as a white solid. 
Rf = 0.58 (2:1 hexane/ethyl acetate); 
1H NMR (300 MHz, CDCl3): δ 8.51 (d, J = 2.44 Hz, 1H), 7.79 (dd, J = 2.78, 8.36 Hz, 1H), 
7.63 (d, J = 16.38 Hz, 1H), 7.36 (d, J = 8.36 Hz, 1H), 6.48 (d, J = 16.03 Hz, 1H), 4.28 (q, J = 
7.32 Hz, 2H), 1.34 (t, J = 7.32 Hz, 3H); 
13C NMR (75.4 MHz, CDCl3): δ 166.0, 152.6, 149.5, 139.3, 136.6, 129.2, 124.6, 121.1, 60.9, 
14.2; 
FTIR (neat): 1711, 1465, 1379, 1296, 1266, 1205, 1103, 984, 831 cm-1; 
















189 190  
 
Br2 (0.52 mL, 10.00 mmol) was added slowly into a stirred solution of 189 (1.76 g, 8.33 
mmol) in CCl4 (39.6 mL) at 0 oC and the resultant solution was allowed to stir for 15 minutes. 
Triethylamine (0.27 mL, 1.92 mmol) was then added into the stirred reaction mixture at 0 oC 
and the resultant reaction mixture was allowed to stir for a further 18 hours. When TLC had 
shown the full depletion of the starting material 189, water (15 mL) was then added to quench 
the reaction. CH2Cl2 (3 x 20 mL) was used to extract the aqueous layer and the combined 
organic extracts were washed thoroughly with NaHCO3 (2 x 10 mL) and brine (2 x 15 mL). 
The mixture was further dried over Na2SO4, filtered and concentrated in vacuo. The residual 
oil was purified via flash column chromatography (8:1 hexane/ethyl acetate), yielding 3.09 g 
(8.33 mmol, ~100%) of the dibromo 190 as a yellow solid. 
Rf = 0.68 (2:1 hexane/ethyl acetate); 
1H NMR (300 MHz, CDCl3): δ 8.43 (d, J = 2.44 Hz, 1H), 7.70 (dd, J = 2.44, 8.36 Hz, 1H), 
7.38 (d, J = 8.02 Hz, 1H), 5.33 (d, J = 11.49 Hz, 1H), 4.72 (d, J = 11.85 Hz, 1H), 4.36 (q, J = 
7.32 Hz, 2H), 1.37 (t, J = 7.32 Hz, 3H); 
13C NMR (75.4 MHz, CDCl3): δ 167.2, 152.2, 149.2, 138.0, 132.9, 124.7, 62.9, 46.3, 46.1, 
13.9; 
FTIR (KBr): 2984, 1736, 1567, 1470, 1149, 1113, 1027, 836, 589 cm-1; 

















190 191  
 
DBU (1.21 mL, 8.13 mmol) was added slowly into a stirred solution of 190 (3.02 g, 8.13 
mmol) in CH3CN (40 mL) at 0 oC and the resultant solution was allowed to stir for 12 hours. 
When TLC had shown the full depletion of the starting material 190, water (20 mL) was then 
added to quench the reaction. The reaction mixture was concentrated in vacuo before ethyl 
acetate (3 x 30 mL) was used to extract the aqueous layer. The combined organic extracts 
were washed thoroughly with brine (2 x 15 mL) and dried over MgSO4. The crude solution 
was then filtered and concentrated in vacuo. The residual oil was purified via flash column 
chromatography (10:1 hexane/ethyl acetate), yielding 1.06 g (3.66 mmol, 45%) of the bromo-
alkene 191 as a dark yellow oil. 
Rf = 0.53 (4:1 hexane/ethyl acetate); 
1H NMR (300 MHz, CDCl3): δ 8.68 (d, J = 2.44 Hz, 1H), 8.30 (dd, J = 2.44, 8.36 Hz, 1H), 
8.14 (s, 1H), 7.40 (d, J = 8.71 Hz, 1H), 4.36 (q, J = 6.97 Hz, 2H), 1.39 (t, J = 6.97 Hz, 3H); 
13C NMR (75.4 MHz, CDCl3): δ 162.5, 152.4, 151.5, 138.7, 135.9, 128.8, 124.0, 116.6, 63.2, 
14.1; 
FTIR (neat): 2093, 1641, 1580, 1460, 1373, 1242, 1106, 1037, 825 cm-1; 














191 192 + 193  
 
NaBH4 (0.44 g, 11.60 mmol) was added slowly into a stirred solution of 191 (0.84 g, 2.90 
mmol) in THF (5.25 mL) and MeOH (1.75 mL) at 0 oC and the resultant solution was allowed 
to stir for up to 30 mins. When TLC had shown the full depletion of the starting material 191, 
1M HCl (15 mL) was then added to quench the reaction. The reaction mixture was 
concentrated before dichloromethane (3 x 20 mL) was used to extract the aqueous layer. The 
combined organic extracts were dried over Na2SO4, filtered and concentrated in vacuo. The 
residual oil was purified via flash column chromatography (7:1 hexane/ethyl acetate), yielding 
0.38 g (1.54 mmol, 53%; E/Z = 35/65) of the primary alcohol as a yellow oil. 
Experimental Section 
 194 





Rf = 0.38 (2:1 hexane/ethyl acetate); 
1H NMR (300 MHz, CDCl3): δ 8.49 (d, J = 2.44 Hz, 1H), 8.02 (dd, J = 2.44, 8.36 Hz, 1H), 
7.33 (d, J = 8.36 Hz, 1H), 7.08 (s, 1H), 4.43 (s, 2H);  
13C NMR (75.4 MHz, CDCl3): δ 150.4, 150.0, 138.3, 130.2, 129.9, 123.8, 122.4, 68.6; 
FTIR (neat): 2907, 1645, 1365, 1110,1086, 1030, 817, 733 cm-1; 
HRMS (ESI) Calcd for C8H7BrClNO [M+]: 246.9400, found: 247.9479 (M + 1). 
 






Rf = 0.53 (2:1 hexane/ethyl acetate); 
1H NMR (300 MHz, CDCl3): δ 8.30 (d, J = 2.43 Hz, 1H), 7.58 (dd, J = 2.44, 8.36 Hz, 1H), 
7.34 (d, J = 8.36 Hz, 1H), 7.05 (s, 1H), 4.41 (s, 2H); 
13C NMR (75.4 MHz, CDCl3): δ 150.6, 148.9, 138.3, 130.4, 130.3, 129.9, 124.2, 63.6; 















192 194  
 
PBr3 (0.60 mL, 6.20 mmol) was added slowly into a stirred solution of 192 (1.28 g, 5.16 
mmol) in ether (51.6 mL) at 0 oC and the resultant solution was allowed to stir for up to 5 
hours. When TLC had shown the full depletion of the starting material 192, saturated 
NaHCO3 (10 mL) was then added slowly to quench the reaction. Ether (3 x 20 mL) was used 
to extract the aqueous layer and the combined organic extracts were washed with brine (2 x 
15 mL) before drying over MgSO4. The resultant mixture was then filtered and concentrated 
in vacuo. The crude solid was purified via flash column chromatography (10:1 hexane/ethyl 
acetate), yielding  g (mmol, 65%) of the allylic bromide 194 as a light brown solid. 
Rf = 0.45 (4:1 hexane/ethyl acetate); 
1H NMR (300 MHz, CDCl3): δ 8.51 (d, J = 2.43 Hz, 1H), 8.06 (dd, J = 2.43, 8.36 Hz, 1H), 
7.34 (d, J = 8.36 Hz, 1H), 7.09 (s, 1H), 4.42 (s, 2H); 
13C NMR (75.4 MHz, CDCl3): 150.2, 138.1, 129.6, 127.6, 127.4, 124.2, 123.8, 39.3; 
FTIR (neat): 2960, 1570, 1453, 1369, 1215, 1107,1074, 619 cm-1; 














193 195  
 
PBr3 (0.34 mL, 3.60 mmol) was added slowly into a stirred solution of 193 (0.74 g, 3.00 
mmol) in ether (30 mL) at 0 oC and the resultant solution was allowed to stir for up to 5 hours. 
When TLC had shown the full depletion of the starting material 193, saturated NaHCO3 (10 
mL) was then added slowly to quench the reaction. Ether (3 x 20 mL) was used to extract the 
aqueous layer and the combined organic extracts were washed with brine (2 x 15 mL) before 
drying over MgSO4. The resultant mixture was then filtered and concentrated in vacuo. The 
crude solid was purified via flash column chromatography (10:1 hexane/ethyl acetate), 
yielding  g (mmol, 87%) of the allylic bromide 195 as a light brown solid. 
Rf = 0.60 (4:1 hexane/ethyl acetate); 
1H NMR (300 MHz, CDCl3): δ 8.39 (d, J = 2.44 Hz, 1H), 7.66 (dd, J = 2.44, 8.36 Hz, 1H), 
7.38 (d, J = 8.36 Hz, 1H), 7.02 (s, 1H), 4.30 (s, 2H); 
13C NMR (75.4 MHz, CDCl3): δ 151.2, 148.8, 137.6, 131.6, 130.0, 125.3, 124.5, 33.7; 
FTIR (neat): 2361, 1577, 1454, 1105, 1026, 646 cm-1; 















153 198  
 
DIBAL−H (9.81 mL, 9.81 mmol) was added slowly into a stirred solution of 153 (1.00 g, 2.80 
mmol) and CH2Cl2 (14.00 mL) at 0 oC. The reaction mixture was allowed to stir for up to 30 
minutes. When TLC had shown the full depletion of the starting material 153, MeOH was 
added dropwise at 0 oC till the disappearance of effervescence was observed. Potassium 
sodium tartrate (3 mL) was then added and the reaction mixture allowed to stir for up to 5 
hours. Ethyl acetate (5 x 10 mL) was used to extract the aqueous layer and the combined 
organic extracts were washed with brine (3 x 5 mL) before drying with MgSO4. The contents 
were then filtered and concentrated in vacuo. The crude product was purified via flash column 
chromatography (3:1 hexane/ethyl acetate), yielding 0.58 g (1.76 mmol, 63%) of the primary 
alcohol 198 as a viscous light brown oil. 
Rf = 0.43 (1:1 hexane/ethyl acetate); 
[α]D25 = – 30.9 o (1.4, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 8.11 (d, J = 2.44 Hz, 1H), 7.38 (dd, J = 2.44, 8.36 Hz, 1H), 
7.29 – 7.17 (m, 6H), 5.86 (dd, J = 2.09, 9.75 Hz, 1H), 5.45 (dd, J = 2.79, 10.10 Hz, 1H), 3.69 
– 3.64 (m, 1H), 3.53 – 3.48 (m, 1H), 3.35 – 3.32 (m, 1H), 2.65 – 2.59 (m, 1H), 2.08 – 2.06 (m, 
2H), 1.67 – 1.57 (m, 1H), 1.44 – 1.32 (m, 1H); 
13C NMR (75.4 MHz, CDCl3): δ 149.6, 149.0, 141.3, 138.6, 138.5, 129.0, 128.3, 127.3, 127.1, 
127.0, 126.4, 123.7, 66.3, 62.6, 57.4, 44.6, 26.8, 23.0; 
FTIR (neat): 3799, 3026, 1864, 2666, 2326, 2124, 1951, 1673, 1563, 1457, 1271, 1265, 1194, 
1079, 904, 836, 737, 543 cm-1; 















198 199  
 
Lead(IV) acetate (0.78 g, 1.75 mmol) was added into a stirred solution of 198 (0.56 g, 1.75 
mmol) in CH2Cl2 (20 mL) and MeOH (10 mL) at 0 oC. The reaction mixture was allowed to 
stir up to 20 minutes. When TLC had shown the full depletion of the starting material 1988, 
10% NaOH (15 mL) was added slowly into the reaction mixture. The contents were 
evaporated in vacuo and subsequently extracted with CH2Cl2 (5 x 10 mL). The organic layer 
was dried with Na2SO4, filtered and concentrated in vacuo. The crude product was purified 
via flash column chromatography (40:1 CH2Cl2/MeOH), yielding 0.25 g (1.19 mmol, 68%) of 
the primary amine 199 as a viscous brown oil. 
Rf = 0.48 (5:1 CH2Cl2/MeOH); 
[α]D25 = – 42.9 o (0.6, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 8.29 (d, J = 2.09 Hz, 1H), 7.52 (dd, J = 2.44, 8.36 Hz, 1H), 
7.29 (d, J = 8.37 Hz, 1H), 5.94 – 5.87 (m, 1H), 5.49 (dd, J = 2.09, 9.75 Hz, 1H), 3.21 – 3.18 
(m, 1H), 2.94 – 2.87 (m, 1H), 1.96 – 1.89 (m, 1H), 1.71 – 1.58 (m, 1H), 0.87 – 0.82 (m, 2H); 
13C NMR (75.4 MHz, CDCl3): δ 149.9, 149.8, 138.6, 138.0, 128.9, 127.2, 124.3, 53.9, 48.2, 
30.1, 29.7, 24.5; 
FTIR (neat): 3648, 3048, 2967, 2857, 2666, 2383, 2127, 1562, 1457, 1264, 1139, 1101, 923, 
824, 738, 587 cm-1; 






















200: Major 172: Minor199  
 
Tetraethylammonium bromide (1.74 g, 8.27 mmol) was added into a stirred solution of 199 
(0.17 g, 0.83 mmol) in CH2Cl2 (17 mL) and the solution was cooled to – 78 oC. After the 
reaction mixture had stirred for 45 minutes, bromine (0.13 mL, 2.48 mmol) was introduced 
slowly at the same temperature. The resultant solution was allowed to stir for a further 2 
hours. When TLC had shown the full depletion of the starting material 199, the reaction 
mixture was washed with saturated NaHSO3 (2 x 10 mL) and water (2 x 10 mL). After drying 
in Na2SO4, the reaction mixture was filtered and concentrated in vacuo. The crude product 
was purified via flash column chromatography (40:1 CH2Cl2/MeOH), yielding 0.16 g (0.45 
mmol) of the major isomer 200 as a viscous yellow oil and 0.05 g (0.15 mmol) of the minor 
isomer 172 as a viscous light brown oil (72% yield, 75:25 ratio). 
Major diastereomer 200: (1R,2S,3S,4S)-3,4-Dibromo-2-(6-chloropyridin-3-
yl)cyclohexanamine 
Rf = 0.53 (5:1 CH2Cl2/MeOH); 
[α]D25 = + 24.9 o (1.3, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 8.29 (d, J = 2.09 Hz, 1H), 7.52 (dd, J = 2.44, 8.36 Hz, 1H), 
7.30 (d, J = 8.36 Hz, 1H), 4.78 – 4.77 (m, 1H), 4.40 (q, J = 2.44 Hz, 1H), 3.54 (dt, J = 4.53, 
10.46 Hz, 1H), 3.46 – 3.42 (m, 1H), 2.70 – 2.59 (m, 1H), 2.58 – 2.07 (m, 2H), 1.86 – 1.79 (m, 
2H); 
13C NMR (75.4 MHz, CDCl3): δ 150.9, 150.4, 139.5, 133.7, 123.9, 59.9, 52.7, 46.9, 46.8, 
30.0, 27.7; 
FTIR (neat): 3420, 3050, 2926, 2850, 2083, 1638, 1586, 1460, 1394, 1265, 1139, 1104,1024, 
957, 833, 734, 689 cm-1; 
HRMS (ESI) Calcd for C11H13Br2ClN2 [M+]: 365.9134, found: 366.9210 (M + 1). 
Experimental Section 
 200 
Minor diastereomer 172: (1R,2S,3R,4R)-3,4-Dibromo-2-(6-chloropyridin-3-
yl)cyclohexanamine 
Rf = 0.35 (5:1 CH2Cl2/MeOH); 
[α]D25 = – 63.0o (1.7, CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ 8.22 (d, J = 2.09 Hz, 1H), 7.49 (dd, J = 2.43, 8.36 Hz, 1H), 
7.30 (d, J = 8.36 Hz, 1H), 4.18 – 4.03 (m, 2H), 2.95 (dt, J = 3.83, 10.80 Hz, 1H), 2.72 (t, J = 
10.45 Hz, 1H), 2.51 (ddd. J = 3.83, 3.83, 13.59 Hz, 1H), 2.14 – 1.95 (m, 2H), 1.44 (dd, J = 
3.48, 11.15 Hz, 1H); 
13C NMR (75.4 MHz, CDCl3): δ 150.5, 149.6, 137.6, 135.3, 124.4, 60.5, 59.2, 55.6, 54.3, 
35.9, 34.8; 
HRMS (ESI) Calcd for C11H13Br2ClN2 [M+]: 365.9134, found: 366.9215 (M + 1). 
 
